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Thesis Abstract 
 
 
This thesis explores different aspects of parents’ perceptions of Autism Spectrum Disorder 
(ASD) across three individual papers.  
The first paper presents a systematic review focusing on parents’ beliefs about the cause 
and course of their child’s autism. The review synthesises the results of fifteen studies which 
met the inclusion criteria to update the findings of a previous review. Parents held a range of 
etiological beliefs, although genetics/heritability, pre and post natal exposure, brain 
abnormalities and religious beliefs were the most common. Culture and socio-demographic 
variables were associated with parents’ beliefs and influenced their perceptions about the 
course of ASD along with a number of personal and healthcare decisions. Methodological 
constraints and variation in reporting results presented difficulties in comparing these findings 
to the previous research and providing an accurate conclusion regarding the most widely 
accepted belief. Areas for future research are highlighted along with clinical recommendations 
for improved parent-professional communication and the provision of evidence-based 
information to facilitate informed decision-making. 
The second paper presents the results from an empirical study which looked at parents’ 
lived experience of the ASD assessment process when a diagnosis was not given. Parents’ 
views in this context have previously been underrepresented. In total six interviews were 
conducted and parents’ experiences were explored using interpretative phenomenological 
analysis. Three superordinate themes transpired which illustrated the issues that parents 
encountered in recognising, disclosing and celebrating their child’s differences, the emotional 
and psychological impact of the assessment, along with difficulties in understanding the 
outcome. Research limitations and clinical implications are discussed. 
The final paper considers the clinical and theoretical implications arising from both 
papers. Recommendations for best practice include more professional training, pre and post 
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assessment counselling, needs-led service provision, policy development and ongoing audit 
and evaluation. A personal reflection of the research process is provided. 
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Abstract 
 
Background: Despite extensive research investigating the etiological factors associated with 
autism spectrum disorder (ASD) the outcome remains unclear. Without clear guidance from 
scientists or professionals, parents are left to construct their own interpretation of the disorder.  
This area has been largely neglected in the research, although a previous review (Hebert & 
Koulouglioti, 2010) identified that parents hold a range of etiological beliefs and that these 
beliefs can have serious implications for both the parent and child. The aim of this paper was 
to provide a comprehensive and updated review of the literature regarding parents’ beliefs 
about the cause and course of autism, factors associated with these beliefs and their 
implications.  
Methods: Electronic databases, Ovid (including Medline, Embase and PsychINFO) and 
CINAHL were searched systematically for articles published between 2009-2017. Fifteen 
studies which met the inclusion criteria were identified.  
Results: Parents believed a wide range of factors were responsible for causing their child’s 
autism, but most frequently endorsed genetics/heritability, pre and postnatal exposure, brain 
abnormalities and religious causes. In many cases, beliefs were associated with culture and 
socio-demographic variables. Healthcare, treatment and family planning decisions were 
influenced by parents’ etiological beliefs, along with their communication with clinicians, their 
own well-being and perceptions about their child. 
Conclusions: Given the range and impact of parents’ causal beliefs about their child’s autism, 
clinicians should openly discuss this with parents during the assessment. In addition, evidence-
based information should be provided to facilitate informed decision-making. Limitations, 
clinical implications and recommendations for future research are discussed.  
 
Keywords: autism; parents; beliefs; culture; systematic review.
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1.0 Introduction 
Autism Spectrum Disorder (ASD) is a complex, lifelong neurodevelopmental disorder, 
affecting approximately 700,000 individuals in the United Kingdom and 1% of the population 
worldwide (Centres for Disease Control and Prevention [CDC], 2014). There is no specific test 
for autism and diagnosis is made in accordance with an observable set of behaviours or the 
absence of age-appropriate social interaction, communication and imaginative play skills 
(Diagnostic & Statistical Manual of Mental Disorders, 5th ed.; DSM-5; American Psychiatric 
Association [APA], 2013).  
 To date, there is no conclusive evidence regarding the precise etiological factors which 
predispose someone to ASD (Huguet, Ey & Bourgeron, 2013). However, the pursuit to expose 
and understand these factors is an area of increasing interest due to the recent rise in prevalence 
rates (Matson & Kozlowski, 2011). Since the earliest identification of autism, theories 
regarding its etiology have oscillated between explanations of nature and nurture. Original 
theories were influenced by psychogenic perspectives, which predominantly blamed parents, 
particularly mothers, for their child’s atypical behaviours (Kanner, 1943). As such, inadequate 
attachments between the mother and child or early childhood trauma were implicated as the 
primary cause (Bettelheim, 1967). However, these theories were strongly refuted by parents 
with the support of Rutter (1968), who introduced the idea that abnormalities within the child’s 
neurological development was a more credible explanation. This prompted a greater focus on 
biomedical explanations, which are now widely accepted due to extensive research using 
behavioural genetic analysis, including twin and family studies (Tick, Bolton, Happé, Rutter 
& Rijsdijk, 2016). Nevertheless, whilst the research suggests that autism has a substantial 
genetic foundation with strong heritability, the exact genomic architecture remains unknown 
(NICE, 2011). Consequently, the role of environmental influences as either the sole cause, or 
as a risk factor, which may trigger the development of autism for individuals with a genetic 
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predisposition have been considered (Grabrucker, 2013). Within this literature, pre, peri and 
postnatal factors are considered and include; advanced parental age, maternal diabetes, 
prematurity and hypoxia (Kolevzon, Gross & Reichenberg, 2007; Krakowiak et al., 2012); 
drug use during pregnancy (Boukhris, Sheehy, Mottron & Bérard, 2016); maternal infection 
(Zerbo et al., 2015) and toxin exposure (Kalkbrenner, Schmidt & Penlesky, 2014). In most 
cases, however, the evidence remains inconclusive. In the case of toxin exposure, specifically 
the association between the measles, mumps and rubella (MMR) vaccine and autism 
(Wakefield et al., 1998), the research has been discredited (Flaherty, 2011). Despite 
inconsistent findings, there is a growing appreciation that autism could be caused by the 
complex interplay between genetic and environmental factors (Matelski & Van de Water, 
2016; Sandin et al., 2014).   
 Current research is dominated by academic and scientific explanations and little is 
known about parents’ etiological beliefs. “Beliefs are the lenses through which we view the 
world” (Wright, Watson & Bell, 1996, p.67). They are constructed and shaped through cultural 
and societal values, personal experiences, attitudes, interactions with professionals and are 
susceptible to change; particularly in response to life changing events, such as parenting a child 
with autism (King et al., 2006). When a child is diagnosed with an illness or disability, parents 
often search for explanations regarding the cause, course and treatment options (Morgan & 
Tan, 2011). During this search process, parents create “Explanatory Models” (EMs), which are 
frameworks used to comprehend and navigate the child’s difficulties (Kleinman, 1980).  
Given the absence of a definitive causal explanation and treatment advice, despite 
extensive research on etiological factors and behavioural, educational and alternative therapies, 
parents are consequently left to construct their own interpretations of ASD (Gona et al., 2015). 
Personal and cultural beliefs, social class, spirituality and education influence the development 
of an individuals’ EM (Pachter, 1994). This implies that EMs are likely to vary significantly 
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between individuals and most recognisably across different cultural backgrounds. Several 
studies have examined the development and impact of parents’ EMs in relation to help-seeking 
behaviours. Their findings demonstrate that parents’ and professionals’ explanations 
frequently differed regardless of whether the child had ASD (Gray, 1995), Attention Deficit 
Hyperactivity Disorder (Klasen & Goodman, 2000) or asthma (Bokhour et al., 2008). 
Exploring parents’ beliefs is clinically important to determine the influence of such beliefs on 
treatment decisions, the parent-child relationship and their own psychological acceptance of 
the diagnosis. 
Hebert and Koulouglioti (2010) attempted to address this research gap. In a review of 
twelve studies they found that parents held a number of causal factors accountable for their 
child’s ASD. These included, genetics, environmental factors and complications during birth 
through to early childhood. Despite retraction of the vaccine-autism link, many parents still 
believed this to be a causal factor, although later studies suggested the prevalence of this was 
decreasing. The impact of parents’ causal beliefs affected three areas; 1) maternal mental 
health; 2) healthcare decisions; and 3) family planning. Whilst these findings offer a useful 
insight to parents’ beliefs prior to 2009, more research was recommended. In line with other 
disabilities, Hebert and Koulouglioti (2010) suggested additional research was needed to 
determine the impact of culture on parents’ etiological beliefs and to determine the relationship 
between beliefs and treatment selection.  
For professionals to support parents effectively, understanding their perceptions about 
autism is invaluable. In view of the evolving beliefs suspected in the previous review, the 
present aim was to provide an updated review of the literature and improve knowledge in this 
area. In accordance with the previous review, and to compensate for diagnostic changes in the 
DSM-5 during the time frame of reviewed studies (2009-2017) all forms of ASD including 
classic or high functioning autism, Asperger syndrome and Pervasive Developmental Disorder 
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– Not Otherwise Specified (PDD-NOS) will be considered and referred to as autism or ASD 
(APA, 2000, 2013).  
 
1.1 Aims 
The current review aimed to explore the following questions: 
1. What causal beliefs do parents hold about their child’s ASD? 
2. What do parents perceive about the course of ASD? 
3. What are the implications of these perceptions? 
 
2.0 Method 
2.1 Search Strategy 
A systematic search was performed in February 2017 using the following electronic databases; 
Ovid (including Medline, Embase and PsychINFO) and CINAHL. The following terms were 
adopted to search abstracts and titles: ‘autism spectrum disorder’, ‘autistic disorder’, ‘parents’, 
‘beliefs’, ‘perceptions’, ‘cause’, ‘etiology’, ‘aetiology’, ‘culture’ and their associated 
deviations (e.g. autis*, caus*, parent* and cultur*). In all databases language and date 
parameters were restricted to studies published in English between 2009 and 2017. For the 
three databases searched via Ovid an additional parameter was set to remove duplicates. 
 
2.2 Inclusion Criteria  
Studies were included if they met the following criteria: 
 Published between 1st January 2009 and 28th February 2017. 
 Published in English. 
 Published in a peer-reviewed journal. 
 Findings reported parents’ beliefs about the cause or course of ASD. 
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2.3 Quality Assessment 
A review of quality assessment tools asserted that whilst there are many effective tools for 
clinical trial research, tools for assessing other methodologies including observational 
epidemiological research are inadequate (Sanderson, Tatt & Higgins, 2007). Given the nature 
of this research, clinical trials were not applicable in the selected studies and therefore quality 
was appraised by the authors, rather than a formal assessment tool.  
 
2.4 Study Selection Process 
Selection was guided by the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA; Moher, Liberati, Tetlzaff & Altman, 2009). The initial search returned 1466 
records, of which 183 duplicates were removed by EndNoteTM (a reference management 
software) and by hand. A further 1195 articles were excluded subsequent to screening abstracts 
in accordance with the inclusion criteria. In total, 88 articles were read in full and 16 met 
criteria. One paper (Selkirk, Veach, Lian, Schimmenti & LeRoy, 2009) was included in the 
previous review (Hebert & Koulouglioti, 2010) and was therefore discarded, leaving a total of 
15 articles. A hand search of all reference lists for further studies was performed, but none were 
found. Figure 1. Illustrates the selection process and reasons for exclusion. 
 
[INSERT FIGURE 1] 
 
2.5 Data Extraction 
The final articles (n=15) were analysed by the first author and data was extracted systemically. 
Extracted data included; 1) author and year of publication; 2) research location; 3) sample size 
and response rate; 4) recruitment method; 5) parent characteristics; 6) child characteristics; and 
  
26 
7) method of data collection (Table 1). A summary of the findings was also extracted and 
included, 1) research focus; 2) measurement method; 3) parents’ beliefs about the cause or 
course of autism); 4) implications; and 5) limitations (Table 2).  
 
2.6 Data Synthesis 
Due to the heterogeneity of the final studies regarding research design, sampling methods and 
outcomes, this review will be presented as a narrative synthesis as opposed to a meta-analysis. 
This was considered the most appropriate method to summarise and explore the qualitative and 
quantitative findings presented in each study (Hong, Pluye, Bujold & Wassef, 2017). 
 
3.0 Results 
 
3.1 Descriptive Overview  
Sample Characteristics  
Of the 15 studies reviewed, seven were conducted in the United States (Bazzano, Zeldin, 
Schuster, Barrett & Lehrer, 2012; Fischbach, Harris, Ballan, Fischbach & Link, 2016; Goin-
Kochel, Mire & Dempsey, 2015; Jegatheesan, Miller & Fowler, 2010; Wasserman, Weisman 
de Mamani & Mundy, 2010; Zuckerman, Lindley, Sinche & Nicoliaidis, 2015; Zuckerman, 
Lindley & Sinche, 2016). Two were conducted in Taiwan (Chen et al., 2015; Shyu, Tsai & 
Tsai, 2010) and one each in France (Dardennes et al., 2011), Turkey (Bilgic et al., 2012), Saudi 
Arabia (Alqahtani, 2012), Jordan (Al Dababneh, Al-Zboon & Baibers, 2016) and the Kenyan 
Coast (Gona et al., 2015). The final study was an internet survey completed in multiple 
locations, including Canada, USA and Kuwait (Ravindran & Myers, 2012).  
Collectively, the findings report on 2,645 parents of children with ASD. This was based 
on 14 studies, given that two studies used the same sample to examine different outcomes 
(Zuckerman et al., 2015, 2016). The sample sizes varied significantly from six participants 
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(Jegatheesan et al., 2010) to 1420 participants (Zuckerman et al., 2015, 2016). Three studies 
compared parental beliefs to the beliefs of others, including professionals (Gona et al., 2015; 
Fischbach et al., 2016) and parents of children with schizophrenia (Wasserman et al., 2010). 
The comparative participants were not included in the sample characteristics. Of the eight 
studies who reported participants’ parental role, 633 were mothers whilst 86 were fathers, their 
age ranged from 27-75 years. Ten studies reported demographic information for the children, 
revealing that 1645 were boys and 389 were girls, who ranged from 2-44 years in age. The 
inclusion of more boys than girls reflects current prevalence rates (Lai et al., 2015).  
Whilst all studies included parents of children with ASD, seven classified diagnosis 
subtype, four classified severities, and although five classified diagnosis age, only one reported 
the time frame between the diagnosis and the research (Bilgic et al., 2012). Diagnostic 
information was corroborated in eleven studies using parental self-report (Ravindran & Myers, 
2012; Zuckerman et al., 2015, 2016), researcher validation (Alqahtani 2012; Bazzano et al., 
2012; Gona et al., 2015; Fischbach et al., 2016; Wasserman et al., 2010), independent clinicians 
(Bilgic et al., 2012; Shyu et al., 2010) or DSM-IV screening (Dardennes et al., 2011).  
Most studies reported socio-demographic information including the participants’ 
religious or ethnic status (n=12), parents’ education status (n=11) and household income (n=8). 
However, reporting varied significantly across the studies (Table 1) and thus will be discussed 
in more detail as appropriate to individual findings. 
 
Method and Design 
There were seven qualitative studies. Of these, five used face-to-face semi-structured 
interviews (Alqahtani, 2012; Al-Dababneh et al, 2016; Chen et al., 2015; Shyu et al., 2010), 
one of which also incorporated focus-groups (Gona et al., 2015). One used an online or 
telephone semi-structured questionnaire (Ravindran & Myers, 2012) and one combined face-
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to-face and telephone interviewing (Jegatheesan et al., 2010). Six studies were quantitative, 
five included interviewer-administered questionnaires either in person (Bilgic et al., 2012; 
Zuckerman et al., 2015, 2016) or via telephone (Bazzano et al., 2012; Fischbach et al., 2016) 
and one mailed questionnaires (Dardennes et al., 2011). The two remaining studies used mixed 
methodology. Goin-Kochel et al., (2015) used mailed questionnaires to determine parents’ 
agreement with a list of causal beliefs, followed by an open-ended question. Wasserman et al., 
(2010) provided an interviewer-administered questionnaire to assess causal beliefs, followed 
by a five-minute speech sample to determine attributions parents make about their child. All 
studies were cross-sectional except for Jegatheesan et al., (2010), which involved 17 months 
of ethnographic fieldwork, interviewing families in their home and community. 
Regarding recruitment, three studies advertised through autism-related groups or 
websites, six recruited via education or medical settings, one of which (Jegatheesan et al., 2010) 
also recruited using participants’ contacts. The remaining six studies re-contacted parents 
subsequent to previous participation in research.  
 
Outcome Measures 
Five of the quantitative studies utilised widely recognised questionnaires to ascertain parents’ 
etiological beliefs. The most common being the Illness Perception Questionnaire, revised for 
Autism (IPQ-R), a validated measure for assessing health beliefs in parents of children with 
ASD (Al Anbar, Dardennes, Prado-Netto, Kaye & Contejean, 2010). This revised 
questionnaire used by Goin-Kochel et al., (2015) and Zuckerman et al., (2015, 2016) utilised 
adapted wording to facilitate caregiver responses alongside the addition of autism-related 
symptoms and potential causes. Although the sample in Zuckerman et al., (2015, 2016) were 
all parents of children with ASD, they were recruited from a larger study where children could 
have additional diagnoses. Correspondingly they further adapted the wording to enquire about 
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causes of the child’s “learning and developmental conditions” rather than “autism” per se and 
thus results are considered with caution. Dardennes et al., (2011) used the Lay-Beliefs about 
Autism Questionnaire (LBA-Q; Furnham & Buck, 2003). This explores etiological beliefs 
based on parents’ responses to a 7-point Likert scale which indicates their agreement with 24 
causal statements. Wasserman et al., (2010) used a variation of the Causal Dimension Scale 
(CDS; Russell, 1982) to determine parents’ attributions about symptoms and causes of ASD in 
a comparative study between parents of adult children with autism or schizophrenia. All other 
studies created their own questions to assess outcomes. 
 
[INSERT TABLE 1] 
 
3.2 Parents’ beliefs about the causes of ASD 
Fourteen studies examined parents’ causal beliefs regarding their child’s ASD (Table 2).  
 
3.2.1 Quantitative Findings 
Six studies used quantitative analysis. Amongst these, four studies reported that parents 
predominantly believed that genetic/hereditary factors caused their child’s autism. Studies 
which asked participants to rate their agreement with a list of factors, found that agreement 
with genetics/heritability ranged from 66.3% (Zuckerman et al., 2016) to 75.8% (Goin-Kochel 
et al., 2015) of the total sample. Notably, Zuckerman et al., (2016) found that socio-
demographic variables were associated with these beliefs. Biological parents, parents of 
Hispanic children and children without private health insurance were less likely to “definitely” 
agree on genetics/heritability as a cause compared to non-biological parents or parents of 
Caucasian or privately insured children. Studies which calculated responses from open-ended 
questions found that genetics/heritability was cited by between 43% (Bilgic et al., 2012) and 
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55% (Fischbach et al., 2015) of samples. The later study also provided a comparison to 
scientists’ beliefs (n=60), of which a much higher percentage (95%) agreed with 
genetics/heritability as the primary cause. 
Another commonly cited factor was pre and post-natal toxin exposure. Two studies 
listed exposure as one potential cause. Zuckerman et al., (2016) reported that 35.4% and 41% 
“somewhat/definitely” agreed with pre and post-natal exposure causes, respectively. They 
further specified that parents of black children and those with low incomes were more likely 
to “definitely” agree with post-natal exposure as the cause of their child’s ASD. Parents whose 
children showed functional limitations were also more likely to endorse post-natal causes 
compared to those without. Similarly, Goin-Kochel et al., (2015) reported that 41.7% agreed 
toxins in vaccines were to blame whilst 37.3% believed ASD resulted from exposure to 
environmental pollution. This study examined whether ASD-onset type (early onset, plateau, 
delay + regression or pure regression) was associated with causal beliefs. Whilst no significant 
differences were detected initially due to the small sample size and low power to detect 
between-group differences the authors combined the categories (regression / no regression) and 
repeated the analysis to determine whether witnessing regression influences beliefs. Repeated 
analysis revealed a significant difference between groups regarding their belief that toxins in 
vaccines cause ASD, F(1,66) = 3.74; p<0.05. Parents who witnessed their child regress had 
stronger beliefs in vaccines as a cause (M = 2.4, SD = 1.2) compared to those whose children 
demonstrated early symptom onset and thus did not regress (M = 1.8, SD = 1.3). A trend 
[approaching significance, F(1,66) = 3.25, p = 0.07] was also revealed showing that parents 
whose child regressed held stronger beliefs in environment pollution as a cause (M = 2.3, SD 
1.0) compared to those whose children had early-onset ASD (M = 1.7, SD = 1.4).  
Two studies analysed freely cited responses. In Bilgic et al., (2012) which was 
conducted in Turkey, 16% endorsed vaccines as the cause of ASD whilst 14% specified it was 
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due to the toxicity of mercury. However, this was much lower than other factors within their 
sample, which included birth complications (46%), genetics (43%) and poor parenting (20%). 
Fischbach et al., (2016) which is the most recent study and conducted in the USA found that 
parents’ agreement with vaccines was lower as only 13% cited “vaccines” and 9% cited 
“environmental exposure”. 
Vaccines as a causal belief was the primary focus in Bazzano et al., (2012). They 
surveyed a large sample (n=460) to assess whether parents did or did not attribute ASD to 
vaccines. A relatively even spilt was found as 32% of parents believed vaccines was the cause 
and 17% assumed they possibly contributed, whilst 34% believed vaccines were not 
responsible and 17% were unsure. Factors including the child being vaccinated prior to 
diagnosis, higher parental education and parents’ ethnicity being Latino or African American 
as opposed to Caucasian, were associated with a stronger belief that vaccines caused ASD. The 
high number of parents (n=225) who endorsed vaccines as a causal factor, despite the retraction 
of the vaccine-autism link (Wakefield et al., 1998), potentially highlights the long-term media 
influence along with communication deficits between parents and professionals. Conversely, 
in a French study Dardennes et al., (2011) found that from 88% of 78 parents who 
spontaneously cited causal beliefs, only six cited vaccines and only three cited vaccines as the 
primary cause. Unfortunately, it is not possible to determine whether the rates of parents 
endorsing such beliefs are reducing as suggested in the previous review (Hebert & 
Koulouglioti, 2010) as the extent to which parents agreed with this factor was unreported.  
Brain abnormality, development and structure were also most commonly cited. 
Agreement was reported by 59.7% in Goin-Kochel et al., (2010) and was the strongest belief 
(m=6.04) as rated on a 7-point Likert scale in a study which asked parents to rate their 
agreement with 12 causal factors (Dardennes et al., 2011). 
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Other factors commonly reported, albeit only by a small percentage of each sample, 
included; diet (Bilgic et al., 2012; Fischbach et al., 2016); prematurity or birth complications 
(Bilgic et al., 2012); and childhood accident, injury or illness (Zuckerman et al., 2016). The 
later study found that parents with low income were more likely to endorse accident, illness or 
injury causes. Only two quantitative studies reported beliefs associated with religious factors 
such as ‘destiny’ reported by 4% in Bilgic et al., (2012) and belief in ‘God’s will’ reported by 
46.3% in Goin-Kochel et al., (2015), who also found that 90% of parents believed in two or 
more factors. 
Some studies reported that participants did not know what the cause was, a finding 
which ranged from 7% (Fischbach et al., 2016) to 30.6% (Zuckerman et al., 2016). This reflects 
the uncertainty of scientists but also highlights the potential confusion facing families. 
 
3.2.2 Qualitative Findings 
Some qualitative studies presented results as themes with illustrative quotes whilst others used 
content analysis and presented findings as percentages. In comparison to the quantitative 
studies more variation was reported. However, genetic/heritability was still one of the most 
common beliefs. Chen et al., (2015) specifically examined 39 Taiwanese parents’ perceptions 
about genetics as a cause of ASD, and separately as a cause of their child’s ASD. Whilst the 
majority of parents (74%) agreed that genetics cause ASD, less than half (43%) agreed it caused 
their child’s ASD. The authors attributed this finding to the Theory of Cognitive Dissonance 
(Festinger, 1962), stating that parents show preference for non genetic/hereditary causes as a 
coping mechanism. It absolves them of responsibility for their child’s condition and helps them 
to avoid stigma and community isolation, which are often experienced by families raising 
children with genetic conditions in Asian cultures. Shyu et al., (2010) also studied Taiwanese 
parents. They used a grounded theory approach and unlike Chen et al., (2015) found that all 
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participants endorsed biological factors (albeit including genetics and brain abnormalities). 
However, most parents endorsed more than one causal factor, which predominantly included 
nutrition deficiency and supernatural causes. 
Other studies reporting genetics as the most popular belief include Goin-Kochel et al., 
(2015). They found that when asked to write their top three causal beliefs, 42.6% of parents 
stated genetics, followed by 22.1% who stated environmental factors (of note, 76.6% of those 
parents specified vaccines). The majority of participants in Wasserman et al., (2010) also 
reported genetics alone or combined with environmental factors. Similarly, when the 22 
participants in Ravindran and Myers (2012) were asked to spontaneously cite their beliefs, 
most (38%) reported genetic or environmental causes, followed by parents who did not know 
(30%) and parents who stated vaccines (25%). This study specifically looked at the impact of 
culture on parents’ beliefs, by assessing parents who had relocated from India to live in Western 
cultures. They found that when asked to rate agreement with a list of causal factors, parents’ 
had stronger beliefs in factors typically associated with Western culture (environmental toxins, 
genetics and vaccines) compared to those associated with traditional Indian culture (destiny, 
karma and punishment for parental mistakes in a past-life). However, a high proportion of 
parents drew beliefs and practices from both cultures without conflict.  
Of the remaining studies, three (Alqahtani et al., 2012; Al-Dababneh et al., 2016; Gona 
et al., 2015) reported mixed findings between biomedical factors (e.g. genetics, medical 
investigations during pregnancy, parental age, birth complication) and preternatural causes 
(e.g. a gift from God, a curse, witchcraft, evil eye, black magic). However, Alqahtani (2012) 
found that beliefs altered dependent upon treatment success. For example, some parents 
initially reported beliefs associated with medical explanations, yet retracted this if medical 
interventions failed to demonstrate improvement. The final study (Jegatheesan et al., 2010) 
reported that all parents’ believed ASD was a gift from Allah.   
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3.3 Parents perceptions about the course of ASD 
Five studies reported relevant findings, which appeared somewhat related to parents’ causal 
beliefs. Parents from the Kenyan Coast who perceived ASD to be a bad omen caused by 
preternatural factors, were hopeful that treatment was curative (Gona et al., 2015). 
Alternatively, American parents who perceived ASD as a gift held positive expectations about 
the child’s future (Jeagatheesan et al., 2010).  
The previous review considered the concept of vicarious futurity, described as “the 
hope and despair one has for another’s future” (Hebert & Koulouglioti, 2010, p. 157). Similar 
findings were presented in Al-Dababneh et al., (2016). Parents were optimistic about their 
child’s future, but were either doubtful that they would achieve a satisfactory level or 
highlighted the time and patience this would require. Some parents cited particular worries 
about their child’s future, including their societal role, inheritance rights and rights to vote 
(Shyu et al., 2010). These worries are likely to be influenced by societal expectations and their 
lack of acceptance around disability. 
Zuckerman et al., (2015) found that socio-demographic variables influenced parents’ 
ASD-related expectations, because whilst 70.8% “definitely” believed ASD was lifelong, this 
was predominantly reported by parents of Caucasian compared to Hispanic children. 
 
3.3 Implications of parents’ beliefs  
 
3.3.1 Treatment selection and parent-professional relationships 
Six studies found associations between causal beliefs and treatment selection. Gona et al., 
(2015) found cultural beliefs to be influential in treatment decision-making, as those who 
endorsed supernatural beliefs consulted with fortune-tellers or traditional healers rather than 
  
35 
medical professionals. In a Taiwanese study, Shyu et al., (2010) also found that parents’ EMs 
affected therapy decisions and that parents could combine multiple beliefs (biomedical and 
supernatural beliefs) without apparent conflict. Correspondingly, this was reflected in their 
decision to consult both fortune-tellers and medical professionals simultaneously. Similarly, in 
Alqahtani (2012) where parents from Saudi Arabia largely believed in cultural causes or 
medical investigations during pregnancy, all parents reported using cultural-based treatments 
(e.g. reading the “Al-Quran” or liaising with religious healers), with the exception of special 
diets or hyperbaric oxygen therapy. Whilst etiological beliefs were thought to be related to 
treatment choice, over half of the sample used special diets, despite complete absence of food-
related factors as a perceived cause.  
Nevertheless, two studies reported more specific associations. Dardennes et al., (2011) 
found that etiological beliefs of early trauma were associated with less use of behaviour 
therapies and communication aids; illness beliefs were associated with increased medication 
use; and beliefs about food allergies were positively associated with detoxification and special 
diets.  Bilgic et al., (2012) who examined parents’ beliefs and complementary and alternative 
medicine (CAM) use, reported no association with socio-demographic or diagnostic factors. 
However, they did find that parents who endorsed genetic beliefs were less likely to use CAM 
(X2=7.1, p=0.008) and those who endorsed vaccine beliefs were more likely to use CAM 
(X2=4.8, p=0.03). They further reported that whilst over half of their sample (56%) used CAM, 
only 23% disclosed this to the child’s clinician. 
In addition to treatment selection, etiological beliefs impact on parent-therapist 
relationships. Jegatheesan et al., (2010) found that parents who perceived ASD as a gift, 
objected to clinicians focusing on the child’s difficulties rather than their accomplishments. 
Consequently, this caused conflict regarding treatment options. Parents opted for full inclusion 
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of the child into their multilingual community, whereas professionals advocated for basic, 
segregated, monolingual teaching opportunities. 
 
3.3.2 Vaccine Schedules 
The previous review highlighted that parents who suspected that vaccines caused their child’s 
ASD frequently altered their vaccination schedule (Hebert & Koulouglioti, 2010). Consistent 
results were reported by Bazzano et al., (2012). They found that whilst 48% of parents 
“definitely” or “possibly” believed vaccines were the cause, 35% varied how vaccines were 
administered and 21% discontinued vaccines altogether. Although beliefs in vaccines were 
associated with Latino and African American parents, altered vaccine decisions were more 
strongly associated with Caucasian parents. No association was found between altered 
decisions and parents’ education or insurance status. The most recent study, Fischbach et al., 
(2016), highlights that the issue of vaccine decisions is ongoing for many parents. They found 
that despite only 13% of their sample (n=502) believing in vaccines as the cause, 37% would 
hesitate getting their child vaccinated.   
 
3.3.3 Perception of child 
The comparative study by Wasserman et al., (2010) found that parents of children with autism 
were less critical and made fewer blameworthy attributions about their child than parents of 
children with schizophrenia. The authors postulated that the early onset of autism, compared 
to schizophrenia, and the stronger causal beliefs in genetics from parents of children with 
autism contributed to their perception that the diagnosis was beyond the individuals’ control. 
Although these findings are based on different diagnoses, they offer insight into children whose 
autism is diagnosed later, or for parents who believe in non-biological causes. 
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3.3.4 Family Planning 
Chen et al., (2015) evaluated the impact of causal beliefs in relation to family planning. They 
found that 38.5% of parents reported high recurrence risk, whom had all decided against further 
children or would terminate future pregnancies. Interestingly, only one parent based their 
recurrence risk on medical advice, whilst others drew on assumptions about family histories, 
intuition or their own research. However, the authors reported parents’ perceived recurrence 
risk was inaccurately high. 
  
3.3.5 Maternal Impact 
In two studies, conducted in Saudi Arabia and Jordan, mothers expressed guilt for potentially 
causing their child’s diagnosis (Alqahtani, 2012; Al-Dababneh et al., 2016). The second study 
found that this was to due to their perceived carelessness or psychological stress during 
pregnancy, although the authors argued that this perception was also likely to be instilled by 
community attitudes. 
 
[INSERT TABLE 2] 
 
4.0 Discussion  
The current review aimed to explore parents’ beliefs about the cause and course of their child’s 
autism to update the literature. The findings will be discussed and subsequently compared to 
the previous review. 
Parents held a range of beliefs, which predominantly included: genetic/hereditary 
factors, pre and postnatal exposure including vaccinations, abnormal brain structure and 
religious beliefs. Whilst little is known about why parents’ perceptions are held, some studies 
reported associated factors, including culture and socio-demographic variables. One study 
  
38 
which examined the impact of culture and the effect of acculturation found that parents drew 
from both their traditional (Indian) and current (Western) cultural environments, but the extent 
of this varied between families (Ravindran & Myers, 2012). This suggests that culture is not 
only a strong influential factor in the formation of beliefs, but that parents’ beliefs are fluid and 
adapt accordingly. This highlights the importance of clinicians becoming more culturally aware 
and developing cross-cultural competencies.  
 Another variable implicated in the formation of beliefs and expectations related to the 
child’s developmental trajectory in terms of symptom onset and time of diagnosis. As found in 
the previous review, regressive symptom-onset was associated with beliefs in external factors 
such as vaccines or environmental pollution (Goin-Kochel et al., 2015). Whereas the early 
diagnosis of autism, compared to other conditions such as schizophrenia, caused parents to 
perceive the disorder as being beyond the individuals’ control. Consequently, this had positive 
implications for parents’ perceptions of their child (Wasserman et al., 2010).  
 The gap in scientific knowledge regarding the exact cause or best treatment options for 
autism, leads parents to develop their own beliefs. Whilst some parents reported that they did 
not know what to believe, others held multiple etiological beliefs, which were found to coexist 
without conflict (Shyu et al., 2010). Alternatively, some parents were more confident to report 
factors they did not believe in compared to those in which they did (Goin-Kochel et al., 2015). 
Although, understanding the beliefs of others was not central to this review, one study which 
drew comparisons revealed significant discordance between the beliefs of parents and scientists 
(Fischbach et al., 2016).  
 Understanding parents’ etiological beliefs, offered a number of important insights into 
the parent-child relationship, their goals and aspirations for the child, service utilisation and 
preferred treatment approaches. Treatment selection in particular appeared to have strong 
associations with the parents’ beliefs. Those who held religious etiological beliefs were more 
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likely to consult non-medical treatments (Gona et al., 2015) compared to a belief in illness 
causes (Dardennes et al., 2012). Other treatment decisions were associated with vaccine 
schedules (Bazzano et al., 2012). A large number of parents reported to alter or discontinue 
their child’s vaccination schedule, despite the potential for serious consequences. Therefore, 
healthcare providers need to ensure they communicate openly and provide sufficient 
information to ensure parents make well-informed decisions for their child with ASD and their 
siblings. Again this was consistent with results from the previous review, and thus highlights 
that despite the MMR vaccine-autism link being discredited a number of years ago, the 
attention this received in the media at the time continues to have a lasting impact. One study 
also reported that due to the unknown etiological factors, parents were willing to try any 
treatment (Shyu et al., 2010). Without guidance from healthcare providers the implications 
could be serious, and to some extent are already a concern given the high number of parents 
using CAM therapies, many of which are costly to families and are not scientifically-validated 
(Bilgic et al., 2012).  A recent review on CAM use, by Jobski, Höfer, Hoffmann and Bachmann 
(2016) recommended that clinicians should be aware of CAM therapies and specifically 
enquire about this with families. 
 The outcome of beliefs can have additional implications for the parent. In line with the 
attribution theory (Weiner, 1985), the attributions people make about a given event can also 
impact on their own well-being and coping ability. Parents who attributed etiological beliefs to 
internal causal attributions, such as hereditary factors or their own carelessness during 
pregnancy felt guilty and responsible for their child’s difficulties (Alqahtani, 2012). In previous 
research, similar findings have further reported that such attributions impact on the parents’ 
level of involvement with the child (Dale, Jahoda & Knott, 2006).  
 Another parent outcome related to family planning decisions. Many parents reported 
that having one child with ASD negatively influenced their decision for more children. 
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However, Chen et al., (2015) found that parents’ perceived recurrence risk was often 
inaccurately high and based on unscientific sources of information. Therefore, clinical 
awareness of such issues is important. Services need to ensure families are provided with 
evidence-based information, the opportunity to discuss concerns and where appropriate are 
referred for genetic counselling to support well-informed reproductive decisions.   
 Whilst there are a number of findings related to outcomes of parents’ beliefs, 
information regarding their views about the course of autism was limited. Although, of the 
published results, parents’ level of optimism regarding their child’s future and their ability to 
progress was guarded (Al-Dababneh, 2012). 
 Collectively, the current findings largely support the previous review (Hebert & 
Koulouglioti, 2010). Both highlight the wide variation in parents’ etiological beliefs and that 
parents often held more than one belief. Whilst some of the variables that contribute to the 
formation of these beliefs were consistent in both reviews (e.g. symptom onset and culture), 
the current findings provide further insight. In particular, specific cultural influences and socio-
demographic variables associated with beliefs are now better understood. In terms of parents’ 
perceptions about the course of autism, both reviews found that expectations are associated 
with etiological beliefs. However, the current findings also indicated the significant role of 
socio-demographic factors in this area. Yet factors including finding a cure and improved 
societal acceptance of autism in relation to their future expectations were not mentioned, unlike 
in the previous review. The outcome of parents’ beliefs were mostly consistent. For example, 
they impacted on maternal mental health, healthcare and reproductive decisions and were 
associated with parents’ internal or external attributions. One finding that was not documented 
in the previous review, however, was the association between parents’ beliefs and how this can 
alter their perceptions of the child. Finally, an area that has been largely extended compared to 
the previous review is the association between parents’ beliefs and treatment selection. Overall, 
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whilst consistent findings are reported, the current review provides considerably more detail to 
enrich our understanding and allow for better comparisons with future reviews. 
 
4.1 Implications 
As discussed in the introduction, it is critical for clinicians to be aware of parents’ beliefs. To 
summarise, the clinical implications are threefold; 1) open and honest discussions improve 
parent-professional relationships and may enhance parents’ willingness to disclose 
information; 2) awareness enables clinicians to challenge known inaccuracies (e.g. the MMR-
autism link) to ensure parents are well-informed about the evidence-base prior to decision-
making; 3) providing information that resonates with parents’ beliefs is more likely to be 
accepted and lead to positive change (Gona et al., 2015).  
 The introduction of discussing parents’ etiological beliefs should form part of the 
standard diagnostic assessment protocol, and clinicians should remain aware of the variables 
that influence parents’ views and beliefs as highlighted throughout this review. In addition, the 
findings from this review could also have implications for improving clinicians’ awareness of 
parents’ beliefs regarding other developmental conditions. 
 
4.2 Limitations 
A number of limitations relevant to the individual studies and this review require consideration. 
Individual limitations included methodological constraints, small non-generalisable samples 
and inappropriate measures (Table 2).   
 Many studies reported outcomes based on parental self-report. For example, 
confirmation of the child’s diagnosis (Zuckerman et al., 2015, 2016) or outcomes such as 
altering their child’s vaccination schedules (Bazzano et al., 2012). Studies would have 
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benefitted from stringent methodological protocols to clarify information using medical 
records.  
 As previously discussed, the use of adapted measures such as the IPA-R in Zuckerman 
et al., (2015, 2016) limit validity and reliability. Therefore, more accurate and consistent 
outcome measures would have been beneficial. 
 Participant response rate was rarely reported and a large proportion of studies recruited 
through advertisements at autism-related groups or re-contacting families from previous 
research. This may have caused bias in both sampling and parents’ responses. Given the impact 
of community judgement in some cultures (Al-Dababneh et al., 2016) and the frequent use of 
researcher-administered questionnaires or interviews, participants may have presented socially 
desirable answers. This is also relevant to studies that exposed the research focus to 
participants. For example, parents in genetic-focused research may be more likely to endorse 
genetics as a causal factor of ASD (Goin-Kochel et al., 2015). 
    Regarding the review, the restricted inclusion criteria of studies published in a peer-
reviewed journal and in English may have limited the findings. Furthermore, the wide range in 
samples, design and outcome measures utilised within the studies limited the authors’ ability 
to assess the quality of the included studies and draw comparisons between findings. However, 
as the research in this area increases it would be beneficial for future reviews to address these 
issues. Additionally, as the literature search, study selection and data extraction were 
completed independently by the first author, consultation with a reviewing team may improve 
reliability. 
 
4.3 Future Research 
Due to a number of limitations and unanswered questions further research is required. Firstly, 
almost all studies utilised cross-sectional designs. The one exception, Jegatheesan et al., 
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(2010), used a longitudinal design, however the findings did not report on the stability of beliefs 
over time. Many of the studies also failed to report the time period between diagnosis and 
asking parents about their beliefs. Therefore, as beliefs are susceptible to change and can evolve 
as a consequence of external influences such as the media or through interactions with others, 
longitudinal or follow-up data should be collected. This would provide further insight into the 
extent to which beliefs can change and factors associated with change, both of which are vital 
for clinicians to be aware of, in order to support open and ongoing discussions with parents. 
 Secondly, more research is needed to explore gender-related variations including: 1) 
the etiological beliefs and expectations of fathers, as samples were mostly dominated by 
mothers; and 2) whether parents’ perceptions differ according to the child’s gender. 
Understanding how culture is associated with these outcomes would be helpful. Particularly as 
parents in some cultures hold strong expectations about their child’s future occupation or 
family role according to their gender. Therefore, the potential interference of an autism 
diagnosis may impact on their ability to accept the diagnosis and readjust expectations 
accordingly. With reference to culture, whilst the included studies were geographically diverse, 
there remains a need for future research to explore cultures that were not considered within the 
current review.  
 Additionally, whilst the research has highlighted the importance of clinicians asking 
parents about their beliefs, expectations and treatment preferences, further research to evaluate 
the impact and effectiveness of this is essential. This knowledge is invaluable if best practice 
guidelines are to be developed.  
 
4.4 Conclusion 
This review highlights that parents hold a range of etiological beliefs about autism and that 
these beliefs are somewhat influenced by culture and socio-demographic variables. The 
  
44 
methodological limitations and variation in studies make it difficult to provide an accurate and 
valid conclusion regarding the most widely accepted beliefs and their associated implications. 
Nevertheless, the insights have been valuable in order to raise awareness of the importance of 
clinicians inquiring about parents’ beliefs. Future research to compensate for limitations should 
contribute further to the development of best practice guidelines in this area and for other 
developmental conditions. 
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Figure 1. PRISMA diagram outlining the study selection process (adapted from Moher, 
Liberati, Tetzlaff & Altman, 2009) 
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Hand search of reference lists for final 
studies (n = 15) revealed no new records  
Duplicate records removed 
(n = 183) 
Records (title & abstract) screened 
(n = 1,283) 
Records excluded 
(n =  1,195) 
 
Reasons: dissertation 
abstracts (n = 102), policy 
statements (n = 4), 
symposium (n = 1), 
conference abstract (n = 1), 
irrelevant content or 
population (n = 1087). 
 
Full-text articles assessed for 
eligibility 
(n = 88) 
Full-text articles excluded 
(n = 73) 
 
Reasons: Irrelevant 
content, population or 
insufficient content (n = 
65), book chapters (n = 5), 
unable to obtain (n = 1), 
results duplicated in 
secondary analysis (n = 1), 
article included in the 
previous review (n = 1). 
 
 
 
Studies included in narrative 
synthesis 
(n = 15) 
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Table 1.  
Study Characteristics 
Author / 
Year 
Country Sample  
(Response) 
Recruitment 
Method 
Parent 
 
Children 
 
Data 
collection 
    Status / Age         Education Household Income         Religion / 
Ethnicity 
Gender / Age Diagnosis  
Jegatheesa
n, et al., 
(2010) 
USA 6 (3 families) 
(n.a.) 
Professionals 
identified 2 
families, final 
family 
identified via 
contacts of 
the selected 
families  
3 Mothers, 
3 Fathers; 
30-49 years 
 $20-60,000 annually Sunni/Muslim 
(n=2 families), 
Shai/Muslim (n= 
1 family) 
3 Boys; 
5-6 years 
Sample limited to 
autism;  
Diagnosis age: 
5-6 years 
Longitudinal, 
Ethnographic. 
Face-to-face 
or telephone 
conversational 
interviews 
 
Shyu et al,  
(2010) 
Taiwan 13 
(n.a.) 
Identified via 
psychiatry 
clinic and 
autism day 
care settings  
12 Mothers, 
1 Father; 
34-45 years 
(m=37.4 years) 
 
<College (n=3), 
College (n=4), 
University (n=4), 
Masters degree 
(n=2) 
 Buddhism (n=5), 
Taoism (n=3), 
Folk beliefs 
(n=3), None (n=2) 
 
100% Boys Mental retardation 
(n=9); 
Diagnosis age: 
2-4years 
(m=2.6years) 
 
Semi-
structured 
face-face 
interview 
Wasserma
n et al., 
(2010) 
USA 13 parents 
(ASD); 
36 parents 
(schizophrenia) 
(n.a.) 
Emailed from  
‘Autism and 
Related 
Research’ 
university 
database 
11 Mothers, 
2 Fathers; 
36-66 years 
(m=56.8 years)a 
  Caucasian (n=8), 
Hispanic (n=5)a 
10 Males, 
3 Females; 
18-24years 
(m=26.2 years)a 
Sample limited to 
high functioning 
autism or 
Aspergers 
Interviewer 
administered 
questionnaire 
(CDS) and 5-
minute speech 
sample 
Dardennes 
et al., 
(2011) 
France 78 
(n.a.) 
Advertised 
through 
autism 
websites and 
parent groups 
57 Mothers, 
18 Fathers, 
3 Primary 
Caregivers 
12-31 years  
(m=16.4 years) 
65.4% had income 
considered enough for 
living 
 60 Boys, 
18 Girls; 
2.3-44.5 years 
(m=13.5 years) 
Autism (59%) 
PDD-NOS (21.8%) 
Aspergers (15.4%) 
Unspecified (3.8%) 
Diagnosis age: 
8months-35 years 
(m=5.5 years) 
Mailed 
Questionnaire 
(LBA-Q). 
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Alqahtani 
(2012) 
Saudi 
Arabia 
47 
(82%) 
 
 
 
 
 
Purposive 
sampling 
from medical 
center, 
contacted via 
phone 
22 Mothers, 
25 Fathers; 
27-57 years 
Primary (n=8), 
Secondary (n=13), 
Higher (n=30) 
  26 Boys, 
21 Girls; 
3-15 years 
Sample limited to 
autism 
Diagnosis age:  
1.5-3 years (n=15) 
4-5 years (n=25) 
>6years (n=6) 
Face to face 
semi-
structured 
interview 
Bazzano et 
al., (2012) 
USA 197 
(43%) 
Part of a 
larger survey 
 ≤ High school 
(n=41) 
College (n=22) 
College graduate 
(n=71) 
University graduate 
(n=63) 
 
 
 Caucasian (n=91), 
Hispanic/Latino 
(n=52), African 
American (n=26), 
Other (28) 
 
159 Boys, 
38 Girls; 
<18 years 
Autism (n=165) 
Asperger (n=12) 
PDD-NOS (n=12) 
Diagnosis age: 
11months-13 years 
(m=2.8 years) 
Severity:  
Low (n=60) 
Medium (n=79) 
High (n=39) 
Unsure (n=19) 
 
Telephone 
survey 
Bilgic et 
al., (2012) 
Turkey 172 
(n.a.) 
Families 
approached in 
medical 
centers across 
five locations 
 Mothers education 
(m=7.8 years); 
Fathers education 
(m=9.1 years) 
≤ $330 monthly 
(n=14), $330-660 
monthly (n=51), $660-
1,320 monthly (n=61), 
$1320-1980 monthly 
(n=33), > $1980 
monthly (n=12) 
 139 Boys, 
33 Girls; 
<18 years 
(m=8.8 years) 
Autism (n=146) 
PDD-NOS (n=24) 
Aspergers (n=2); 
(m=5.6 years since 
diagnosis) 
Interviewer- 
administered 
questionnaire 
Ravindran 
& Myers 
(2012) 
USA 
Canada 
Kuwait 
24 
(n.a.) 
Advertised on 
autism 
websites and 
support 
groups  
21 Mothers, 
3 Fathers; 
27-14 years 
(m=36 years) 
90% ≥ Bachelor 
degree 
50% earned 
US$90,000+ per year 
Hindu (n=18) 
Jain (n=1), 
Christian (n=1), 
unreported (n=3). 
21 Boys, 
3 Girls; 
3-15 years 
(m=7.3 years) 
Autism (n=20), 
PDD-NOS (n=4) 
Severity:  
Mild (n=12) 
Moderate (n=10) 
Sever (n=1) 
Unreported (n=1). 
Online / 
telephone 
semi-
structured 
questionnaire 
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Chen et 
al., (2015) 
Taiwan 39 
(n.a.) 
Recruited via 
Autism 
groups (one 
of which was 
lead by the 
author)  
31 Mothers, 
8 Fathers; 
34-52 years 
(m=42 years) 
≤ High school 
(n=9), 
Some college 
(n=6), 
≥College graduate 
(n=24)  
<US$20,000 (n=13), 
US$20,000- 
US$33,000 (n=13), 
≥US$33,000 (n=13) 
None (n=6), 
Buddhism (n=21), 
Folk (n=7), Taoist 
(n=5), Christian 
(n=5), Other 
(n=4) 
40 children 
(one parent had 
two children). 
Sample limited to 
autism 
Severity: 
Mild (n=24) 
Moderate (n=13) 
Severe (n=3) 
Face-to-face 
semi-
structured 
interview 
   
Goin-
Kochel et 
al., (2015) 
USA 68 
(n.a.) 
Re-contacted 
following 
participation 
in SSC 
  <$20,000-$50,000 
(n=13), 
$51,000-$100,000 
(n=22), $101,000-
>$161,000 
African American 
(n=5), Asian 
(n=4), White 
(n=50), Hispanic 
(n=16) 
59 Boys, 
9 Girls; 
4.2-17.8 years 
(m=9.2 years) 
 
 Mailed 
Questionnaire 
(IPQ-R) 
Gona et 
al., (2015) 
Kenyan 
Coast 
 
 
 
 
51parents 
52professionals 
(n.a.) 
Purposive-
convenience 
sampling, via 
clinics and 
educational 
resource 
centres 
2 Locations: 
Mombasa (n=21), 
Kilifi (n=30); 25-
75 yearsa 
≤ Secondary school 
(n=51)a 
 Traditional, 
Christianity, 
Islama 
 No formal measure 
of autism in Kenya, 
presumptive 
diagnosis used. 
In-depth 
interviews and 
focus groups 
Zuckerma
n et al., 
(2015) 
USA 1420 
(n.a.) 
Recruited via 
the Pathways 
survey and 
the 2009-10 
(NS-CSHCN) 
 
 ≤ High school 
(n=200), >High 
school (n=1220) 
0-99% Federal poverty 
level (FLP) (n=198), 
100-199% FLP 
(n=277), 200-300% 
FPL (n=475), ≥400% 
FPL (n=470) 
 
White non-
Hispanic (1056), 
Hispanic (n=118), 
Black, non-
Hispanic (n=89), 
other (145) 
1155 Boys, 
264 Girls; 
6-17 years 
 
Autism, 
Asperger’s, PDD-
NOS 
Interviewer 
administered 
IPQ-R. 
Zuckerma
n et al.,  
(2016). 
USA 1420 
same as above 
(n.a.) 
 
 
 
As Above  As Above As Above As Above As Above As Above As Above 
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ASD: autism spectrum disorder; PDD-NOS: Pervasive developmental disorder – Not Otherwise Specified; SSC: Simon Simplex Collection (a large American dataset of 2700 
families who have one child aged 4-18 years with ASD and where ASD is absent in siblings or parents); LBA-Q: Lay-Beliefs about Autism Questionnaire; NS-CSHCN: 
National Survey of children with special health care needs (data collected three times between 2001-2010); CDS: Causal Dimension Scale; IPQ-R: Illness perception 
questionnaire revised for autism. 
a Sample characteristics refer to parents of children with ASD only. 
b Full sample included 3 groups of children with either ASD, intellectual disabilities or specific learning disabilities.  
 
 
Al-
Dababneh 
et al., 
(2016) 
Jordan 
 
15 - represents 
24% of full 
sample. 
(n.a.) 
 
Recruited via 
educational 
settings 
Parents of 
children with 
ASD extracted so 
individual 
characteristics 
unknown 
Full sampleb: 
54 Mothers 
9 Fathers 
18-≥54 years 
Full sampleb: 
Primary school 
(n=10), 
Secondary school 
(n=31), 
≥College (n=22) 
 
 
  Full sampleb: 
35 Boys, 
28 Girls; 
6-8years 
(n=19), 
9-12 years 
(n=25), 
13-16 years 
(n=19) 
Mild-moderate 
autism (n=15) 
extracted from 
sample. 
  
Face-to-face 
semi-
structured 
interviews 
Fischbach 
et al., 
(2016) 
 
USA 
 
 
 
 
 
 
 
502 parents 
(91%) 
 
60 scientists 
(80%) 
 
 
 
Families re-
contacted 
following 
participation 
in SSC. 
 
476 Mothers, 
26 Fathers; 
39-47 years 
(m=43 years) 
 
 
≤ 8th grade (n=1), 
High school (n=1), 
High school 
graduate (n=32), 
College (n=112), 
College graduate 
(n=192), 
>College (n=164) 
 
 
 
 
 
 
 
 
 
White (n=409), 
Hispanic/Latino 
(n=39) Asian 
(n=24), 
Black/Non 
Hispanic (n=19), 
Native American 
(n=8), Hawaiian 
(n=3). 
 
 
 
 
 
 
 
Autism (n=262), 
PDD-NOS 
(n=137), Aspergers 
(n=86), ASD (n=6), 
High functioning 
(n=5), Other (n=5), 
Unreported (n=1) 
Telephone 
interviews 
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Table 2.  
Summary of findings 
Author / 
Year 
Research Focus Measurement 
Method 
Findings Limitations 
Parental beliefs about the cause(s) of ASD Parental beliefs about the 
course of ASD 
Cause / Implications of parental beliefs  
Jegatheesa
n et al., 
(2010) 
Examine parental 
beliefs about 
ASD and future 
goals. 
Conversational 
interviewing 
over 17 months. 
Mothers 
interviewed 8 
times (15hours). 
Fathers 
interviewed 5 
times (8hours). 
Allah chose family to raise “his special 
child”. Beliefs also attributed to fate and 
karmic connection: one family believed the 
mother and child were reincarnated to have 
ASD/parent the child with ASD due to 
events in their past life.  
All parents held positive 
expectations of their children. 
Two themes emerged for 
parents’ goals: full inclusion 
into everyday life and into 
their multi-lingual world.   
Due to the belief that ASD was a gift from 
Allah, parents’ objected to professionals 
highlighting the child’s deficits rather than 
their accomplishments. This presented 
conflict in treatment decisions. Parents 
believed the child should be integrated 
into the multilingual community. Whereas 
professionals advocated that teaching the 
child basic interactions in one language 
would facilitate their development.  
Small sample. One of the 
families was recruited 
through participant’s 
contacts. Interviewer spent 
17 months with the 
families, this could have 
impacted on the findings.  
 
 
Shyu et 
al.,  (2010) 
Examine 
Twainese parents’ 
EMs (beliefs and 
treatment 
selection). 
Open-ended 
questions. 
100% endorsed biological factors (including 
genetics and brain damage in pregnancy), 
84.6% supernatural causes, 46.2% nutrition 
deficiency, 7.7% mercury-containing 
vaccines. 
Future worries: child’s 
welfare, societal role, voting 
and inheritance rights. 
Treatment choice was associated with 
causal beliefs. Supernatural beliefs were 
associated with seeking advice from 
fortune-tellers. Many parents would try 
any treatment due to the unknown 
etiology. 
Small sample, one area in 
Twain. Sample were all 
young children. Diagnosis 
unconfirmed. 
Wasserma
n et al., 
(2010)  
Explore 
etiological beliefs 
about ASD and 
the impact on 
attributions 
towards their 
child. A 
comparison 
between parents 
of children with 
autism vs 
schizophrenia.  
 
Agreement with 
listed 
symptoms, 
causes and 
attributions; 
revised CDS. 
Criticism was 
assessed via a 
five-minute 
speech sample.  
 
 
Parents of children with autism: 77% cited 
genetics or genetics combined with other 
factors as the primary causal factor. Causes 
of ASD cited in order of frequency: genetics 
(n=4), combination of genetics and other 
factors (n=4), organicity (n=2), parental 
drug use (n=1), birth complications (n=1), 
and prenatal injury (n=1). 
 
 
 Parents of children with ASD made less 
critical and blameworthy attributions 
about their child compared to those with 
schizophrenia. Diagnosis of ASD at a 
younger age, compared to schizophrenia, 
contributed to parents’ perception that it 
was beyond the child’s control and were 
therefore less critical towards them. 
Parents of adults with ASD rated genetics 
as the most significant causal factor, 
unlike parents of those with schizophrenia. 
Again this contributed to parental 
perception that if the disorder is biological 
it is beyond the individuals control. 
Small sample. In the 
comparative data – the 
effect size reported 
moderate differences 
between attributions made 
by each group, yet 
statistical significance was 
not found through a test of 
mean differences. This 
could be explained by the 
small sample. Onset age 
was not measured and 
could have explained 
between group 
differences.  
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Dardennes 
et al., 
(2011). 
 
 
 
 
 
 
 
 
 
Examine the 
relationship 
between causal 
beliefs about 
ASD and 
associated 
treatment choices.  
1. Agreement 
with 24 named 
causes.   
2. Open-ended 
question: 
Parents cite 
their top 3 
etiological 
beliefs. 
1. Most common belief was brain 
abnormalities (m=6.04), followed by 
genetics (m=5.65). Parents neither agreed or 
disagreed with chemical imbalance 
(m=4.38). Other, less cited, factors included 
food allergies (m=3.43), pre-natal illness 
(2.81), early trauma (m=2.73) as rated on a 
7-point scale. Etiological beliefs of poor 
parenting were rejected. 2. 88% freely cited 
beliefs. Most common were 1) genetics; 2) 
heredity; 3) hazard. Vaccines, diet, 
immunity dysfunction, toxins and pollution 
were cited, but only by 1-3 parents.   
 
 Causal beliefs are associated with 
treatment choice. Parents who believed in 
early trauma were less likely to use 
behaviour therapy and PECS. Beliefs of 
pre-natal illness increased the use of 
prescribed medication. Beliefs about food 
allergy increased association with 
detoxifications treatments, special diets 
and vitamins, but reduced the likelihood of 
drug use. Vitamin’s were negatively 
associated with beliefs about brain 
abnormalities. 
Likert scale. 
Alqahtani 
(2012) 
Explore parents’ 
etiological beliefs 
about ASD. 
Open-ended 
questions   
Causes were listed as themes and illustrated 
by quotes. Most frequently cited causes 
were medical investigations during 
pregnancy, cultural causes (evil eye or 
victim of black magic) and vaccines. Other 
causes include; difficulties / vitamin 
deficiency during pregnancy, neurological 
deficit, poor emotional parenting, childhood 
trauma, lack of breast feeding. 
 Beliefs influenced by treatment outcome. 
Some parents cited medical explanations 
but retracted this when medical 
interventions were unsuccessful. Parents, 
mostly mothers, felt guilty for causing 
their child’s ASD. All cited treatments 
were cultural (e.g. reading the “Al-
Quran”) except autism-diets or hyperbaric 
oxygen therapy. More than half of parents 
used gluten-casein-free diet, yet diet was 
not cited as a causal factor. No parent 
cited genetics - potentially due to social 
stigma. 
82% response rate – 15 
felt uncomfortable 
discussing the topic and 
thus may have held 
alternative views. 
Religious explanations are 
commonly accepted in 
Saudi to cope with 
unexplained medical 
disorders.  
Bazzano et 
al., (2012) 
To determine the 
impact of parents’ 
etiological beliefs 
on vaccine 
decisions. 
Multiple choice 
and open-ended 
questions. 
Even spilt between parents’ who did and did 
not believe vaccines caused ASD. Parents 
who vaccinated their child prior to diagnosis 
were more likely to state vaccines as the 
cause. Latino and African American and 
highly educated parents were more likely to 
endorse vaccines than Caucasian parents. 
 Over half of parents altered or 
discontinued vaccine schedules. 63% who 
believed that vaccines caused ASD 
changed doctors, 47% altered vaccine 
practice, 34% discontinued. No 
association between altering or 
discontinuing schedules and parents’ 
education or insurance status. Caucasian 
parents more likely to change or 
discontinue vaccination schedules. 
Limited response rate. 
Sample from one 
geographic location. 
Self-reported outcomes, 
vaccine records not 
checked. 
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Bilgic et 
al., (2012) 
Examine the use 
of conventional 
and CAM 
treatments, and 
explore parents’ 
etiological beliefs 
about ASD.  
Open-ended 
questions. 
Genetics/congenital (43%), birth 
complications (46%), poor parenting (20%), 
toxicity of mercury (14%), vaccines (16%), 
food (8%), physical trauma (8%), infection 
(8.8%), antibiotics (3%), prematurity (5%), 
medical interventions or physician mistakes 
(5%), febrile convulsion (4%), destiny (4%), 
other (14%), no idea (10%). (NB. Parents 
could cite multiple factors, hence total 
percentage exceeds 100). 
 99% used conventional treatments. 56% 
used CAM – most prevalent = spiritual 
healing, food supplements, diet and 
vitamin supplements. The economic 
burden of CAM use was very high. 
Parents who cited genetic/congenital 
factors as the primary cause were less 
likely to use CAM. Parents who cited 
vaccines were more likely to use CAM. 
Parent demographics 
unreported. Face-to-face 
interviews in a hospital 
setting may present 
demand characteristics. 
Parents may have been 
more inclined to cite 
biological factors to 
reduce risk of judgment.   
Ravindran 
& Myers 
(2012) 
Explore the 
influence of 
acculturation on 
parental beliefs 
and practices for 
Indian families 
living outside 
India in Western 
cultures.  
1. Open-ended 
questions. 
2. Agreement 
with named 
causes. 
 
1. Open-ended responses: vaccines (25%), 
environmental and genetic/biomedical 
factors combined (38%), unsure (30%), 
genetics alone (1 parent), food allergy (1 
parent). 2. Higher agreement with western 
cultural beliefs (92% environmental toxins/ 
biological factors, 79% genetics, 75% 
vaccines), compared to traditional Indian 
beliefs (33% destiny, 29% karma, 17% 
mistakes in a past life). 
 58% drew on a combination of Western 
and Indian causal beliefs and treatments. 
17% preferred Indian only, 17% preferred 
western only, 2 failed to answer.  
   
Self-reported diagnosis. 
Likert scale. Small 
sample. Acculturation 
measured indirectly. 
 
 
 
Chen et 
al., (2015) 
Explore 
perceptions about 
genetics and 
recurrence risk 
amongst 
Taiwanese 
parents.  
1. Agreement 
with genetics as 
a cause of ASD, 
and their child’s 
ASD. 
2.Agreement 
with perceived 
recurrence risk. 
(high, low, 
moderate, no 
risk or 
unknown).  
1. 74.4% agreed genetics is a causal factor 
in ASD, 17.9% were undecided and 7.7% 
believed otherwise. Of the 74% who agreed; 
this was based on their family history 
(n=17), knowledge of other ASD families 
(n=6), media (n=3), intuition (n=3), self-
research (n=2) and physician (n=1). When 
asked about genetics as a causal factor in 
their child’s ASD, only 43% (n=17) agreed. 
The majority of these parents (n=14) had 
diagnosed family history and the remaining 
(n=3) had traits within the family history. 
 
 2. 38.5% reported high recurrence risk, 
most (n=13) would avoid / terminate 
future pregnancies. 23.1% reported low 
risk, 20.5% were unsure, 12.8% perceived 
no recurrence risk and 5.1% perceived risk 
to be moderate. Causal beliefs and 
perceptions of recurrence were based on 
family history, knowledge of other 
families, media, intuition and own 
research. Only one participant was 
informed by their physician. 
All but one parent had 
only one child with ASD. 
Perception about genetics 
may alter for parents with 
more than one child. The 
influence of demographics 
variables was unreported.  
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Goin-
Kochel et 
al., (2015) 
To explore the 
association 
between parents’ 
causal beliefs and 
patterns of 
symptom onset. 
1. Open-ended 
questions. 
Parents cited 
three most 
important 
causal factors. 
2. Agreement 
with named 
causes (IPQ-R) 
1.Genetic/hereditary (42.6%), 
environmental factors (22.1%; 76.6% 
specifically stated toxins in vaccines). When 
the top three factors were considered 
together over 80% reported external causes, 
compared to genetics/hereditary factors 
reported by 60%. 2. Internal factors (75.8% 
genetics, 59.7% child’s brain structure). 
External factors (46.3% God’s will, 41.8% 
toxins in vaccines, 37.3% environmental 
pollution). 90% believed in 2 or more 
factors. 
 Observing a child losing skills contributes 
to parents’ causal beliefs. Parents who 
witnessed regressive onset had 
significantly stronger agreement with 
toxins in vaccines being a causal factor 
and a trend for stronger agreement with 
environmental pollution. 
Parent demographics 
unreported. Sample from 
one geographic location. 
Recruited from the SSC 
(study examined genetic 
causes in families). This 
could have biased genetics 
responses. Onset 
measured by parents’ 
retrospective self-report. 
Gona et 
al., (2015) 
Explore parents 
and professionals 
perceptions about 
causes and 
treatments of 
ASD in a 
multicultural 
context. 
Open-ended 
questions. 
Preternatural causes (curse, witchcraft, evil 
spirits), biomedical causes (infection, drugs, 
birth complications, malnutrition) or 
hereditary (genetics). All cited regardless of 
geographical location. 
 
Parents hoped treatment was 
curative due to societal 
perspectives that ASD is a 
bad omen.  
Treatments included traditional healers, 
prayers and medical interventions.  
All participants from the 
Kenyan Coast. Limited 
number of participants 
without any formal 
education. Socio-
economic status 
unreported. 
Zuckerma
n et al., 
(2015) 
Examine beliefs 
about the course 
of ASD in 
relation to 
ethnicity, income 
and educational 
attainment. 
Secondly, to 
explore whether 
beliefs are 
influenced by 
service utilisation 
and healthcare 
quality.   
Agreement with 
4 named causes 
(IPQ-R). 
Agreement with 
service 
utilisation and 
social 
determinants of 
health (race, 
income and 
parental 
education).  
 70.8% “definitely’ believed 
difficulties were lifelong. 
Parents of Hispanic children 
were less likely to believe the 
condition was lifelong 
compared to parents of white 
children. 81.5% agreed the 
condition could be prevented / 
reduced with treatment. 
44.5% thought the condition 
was a mystery. 44.8% agreed 
they had the power to alter the 
condition.   
 
 
ASD health disparities were mostly not 
related to parental beliefs. Parents with 
lower income believed the condition was a 
mystery and were less likely to believe it 
could be prevented, treated or that they 
had the power to change it. High parental 
education was associated with a tendency 
to believe it could be prevented / reduced 
with treatment and less likely to believe it 
was a mystery. 
 
 
 
 
Parent demographics 
unreported. Sample 
recruited from previous 
research (Pathways 
survey). All children had 
ASD but could also have 
other developmental 
disorders. Therefore, as 
the study asked about the 
cause of the child’s 
learning/developmental 
difficulties, responses 
could have been related to 
other conditions. Other 
potential influences (e.g. 
media, health literature or 
social networks) were 
unreported. 
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Zuckerma
n et al., 
(2016). 
Assess parents’ 
etiological beliefs 
about learning 
and 
developmental 
difficulties in 
children with 
ASD. Secondly, 
to assess whether 
socio-
demographic 
variables are 
associated with 
beliefs.  
Agreement with 
4 named causes 
(IPA-RA). 
66.3% of parents definitely or somewhat 
agreed with genetic/hereditary causes. 41% 
somewhat / definitely agreed with post-natal 
exposure. 35.4% somewhat / definitely 
agreed with in utero exposure. Only 19.1% 
definitely agreed with accident / injury / 
illness. However, 80.9% definitely 
disagreed. 39.6% had no definite beliefs, 
40.9% had 1 definite belief and 19.6 % held 
2 or more definite beliefs.  
 Socio-demographic variables impacted on 
parental beliefs. Hispanic parents were 
less likely to definitely agree with 
genetic/hereditary factors compared to 
white parents (even after controlling for 
other variables). Parents of children with 
private, compared to public health 
insurance were twice as likely to 
somewhat agree (but not definitely agree) 
with genetic/hereditary causes. Non-
biological parents were significantly more 
likely to endorse genetic/hereditary 
causes. Black parents and parents with low 
income were more likely to agree with 
post-natal exposure causes. Parents of 
children with private, compared to public, 
insurance were less likely to endorse post-
natal exposure factors. Low income was 
associated with accident / illness / injury 
causal beliefs. No significant association 
was detected between child’s age, gender 
or religion and parents’ causal beliefs. 
Same as above. 
Al-
Dababneh 
et al., 
(2016) 
Investigate 
parents’ beliefs 
about the cause 
and course of 
their child’s 
disability 
Open-ended 
questions.  
Biomedical causes (pre-natal risk factors, 
mothers age, stress, medication use during 
pregnancy and birth complications), 
genetics, early childhood illness, vaccines 
and the most common explanation cited by 
half of the parents was fatalism (ASD as a 
“gift from God”). 
 
 
Most held positive expectations 
about the child’s potential 
progress. Some believed they 
would work and attend high 
school, but acknowledged the 
time / patience this required. 
Half were proud of their child’s 
progress regardless of it’s 
significance, others believed the 
progress level would not be 
satisfactory. Low expectations 
were related to vulnerability. 
Social and communication 
skills were the most important 
skills for a child to reach their 
potential.  
Parents’ causal beliefs impact on their 
beliefs about the course of their child’s 
ASD. Some mothers felt responsible for 
causing their child’s ASD due to their own 
carelessness or psychological stress during 
pregnancy. Their guilt may be a result of 
community attitudes.  
 
 
Parents of children with 
ASD were extracted from 
the research only and 
therefore sample size is 
small. Furthermore, parent 
demographics are unclear 
for this subset of the 
sample. Due to the nature 
of qualitative research, 
results only comment 
upon generated themes, so 
the extent to which each 
parent held certain beliefs 
is unknown. 
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ASD: Autism Spectrum Disorder; EMs: Explanatory Models; PECS: Picture Exchange Communication System; CAM: complimentary and alternative medicine; SSC: 
Simons Simplex Collection (A large American dataset of 2700 families who have one child aged 4-18 years with ASD and where ASD is absent in siblings or parents); CDS: 
Causal Dimension Scale; IPQ-R: Illness perception questionnaire revised for autism. 
 
Fischbach 
et al., 
(2016) 
Investigate 
concordance 
between parents’ 
and professionals’ 
etiological beliefs 
about ASD. 
Open-ended 
questions. 
Parents’ beliefs: genetic (55%), vaccines 
(13%), environmental toxin exposure (9%), 
parental age (3%), others (prematurity, diet, 
prenatal events, immune system, medication 
in pregnancy, environment-genetic 
interaction, 13%), unsure (7%). Scientists’ 
beliefs: genetics (95%), toxin exposure 
(3%), other (maternal vitamin D deficiency, 
idiopathic autism, 2%).  
  Parents and scientists differed 
significantly, but had high agreement for 
genetic testing, disclosure of results and 
heighted levels of concern for future 
generations if a genetic cause is identified. 
Treatment was agreed as the most 
important goal of research. 37% of parents 
would hesitate getting a child vaccinated, 
97% of professionals would not.  
Parents recruited from the 
SSC. Homogeneous 
sample (predominantly 
white, high IQ). 
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Abstract 
 
 
 
The aim of this research was to explore parents’ lived experience of the Autism Spectrum 
Disorder (ASD) assessment process when a diagnosis was not received. Six mothers and one 
step father were interviewed using a semi-structured schedule. The results were analysed using 
interpretative phenomenological analysis (IPA) through which three superordinate themes 
emerged: “My child is different”; the emotional and psychological journey; and understanding 
the outcome. These themes illustrated the issues that parents encountered during both the 
assessment process and in parenting a child with autistic-like characteristics but without a valid 
label. As this is an area that has been previously understudied, a number of clinical implications 
at the professional, service and policy level are discussed. 
 
 
Key words: autism, assessment, parents, interpretative phenomenological analysis. 
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In recent years, recognition of Autism Spectrum Disorders (ASD) has become 
widespread. Advocacy organisations such as Autism Speaks and the National Autistic Society 
(NAS), have campaigned to increase awareness and acceptance of the disorder (Wallace et al., 
2012). Some researchers argue that heightened awareness has contributed to increased 
prevalence rates, however opposing views propose influential factors such as earlier diagnosis, 
changes to diagnostic criteria and better resourced services (Matson & Kozlowski, 2011; 
Neggars, 2014). Nevertheless, one point of agreement is the increased number of families 
accessing diagnostic services for their children. 
Many families initiate this process to gain a definitive diagnosis. Parents believe that 
classification of their child’s difficulties will explain their missed milestones and unusual 
behaviours, helping them to better understand their child’s needs (Avdi, Griffin & Brough, 
2000). This understanding reduces parents’ confusion and equips them with more realistic 
expectations for the future (Midence & O’Neill, 1999). Within the intellectual disability 
literature, Makela, Birch, Friedman and Marra (2009) assessed the perceived value of a 
diagnosis by comparing families with and without a diagnostic label. Several themes were 
noted, with the most common being ‘validation’, as this enabled parents to explain their child’s 
difficulties using a recognised label. 
Many children with autism, or autism traits, find it difficult to navigate social situations 
and the overwhelming accumulation of sensory information can lead to behavioural outbursts 
(Wigham, Rodgers, South, McConachie & Freeston, 2015). In a recent survey, 74% of families 
experienced disapproving noises from the public due to their child’s behaviours, whilst 87% 
were subjected to staring (NAS, 2016). Yet, having a tangible explanation for their behaviours 
reduced the impact of critical bystanders and empowered parents to advocate for their child.  
Other values of diagnosis identified by Makela et al., (2009) included access to 
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information, timely interventions and improved social support. Likewise, the perception that 
an ASD diagnosis permitted access to funding and therapeutic intervention was reported by 
Keenan, Dillenburger, Doherty, Bryne and Gallagher (2010). These factors were considered 
fundamental components in helping families to overcome uncertainty and achieve acceptance 
(Midence & O’Neill, 1999). Correspondingly, some families reported that the positives of 
gaining a diagnosis outweighed the negatives (Wong, Keyes & McGrew, 2016). 
Despite the benefits associated with diagnosis, families described their experience of 
pursuing this as unsatisfactory. In a large UK survey (n=1295), Howlin and Moore (1997) 
found that 49% of parents were ‘not very’ or ‘not at all’ satisfied with the assessment process. 
Although this study was published twenty years ago, similar findings were reported in more 
recent literature. For example, in a sample of 56 parents, 51% were dissatisfied (Siklos & 
Kerns, 2007) and in a separate sample of over 1000 parents, 52% were dissatisfied (Crane, 
Chester, Goddard, Henry & Hill, 2016). Factors influencing parents’ satisfaction included 
diagnostic delay, the number of professionals involved and professionals’ communication 
(Watson, Hayes & Radford-Paz, 2011). 
Parents who saw fewer professionals and received an early diagnosis were more 
satisfied with the process (Goin-Kochel, Makintosh & Myers, 2006). In their questionnaire 
study of 494 parents, they reported that on average, parents typically saw four or five 
professionals. Unsurprisingly, age at diagnosis was positively associated with the number of 
professionals seen (r = 0.15, p = 0.002) and negatively associated with satisfaction (r = -0.15, 
p = 0.001).  
ASD can be diagnosed as young as two (Lord et al., 2006). However, Crane et al., 
(2016) found that parents typically waited 12 months to seek professional advice, and upon 
initial contact their concerns were often dismissed or referred onwards. Average time from first 
contact to obtaining a diagnosis was a further 3.5 years, with children typically being diagnosed 
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at 7.5 years (SD = 5.0 years). For many, this delay caused frustration relating to the missed 
opportunity for early intervention. Disappointingly, these results show no great reduction from 
the findings of Howlin and Moore (1997). The finding that professionals dismissed parents’ 
concerns is unfortunate, as Brogan and Knussen (2003) found that families were more 
accepting of delays if professionals validated their concerns. 
The frustration regarding assessment delays and lack of post-diagnostic support is 
shared by professionals (Rogers, Goddard, Hill, Henry & Crane, 2016). However, such delays 
are not always related to inadequate service provision. Autism is a complex disorder, as there 
is no medical test, and unlike other neurodevelopmental conditions such as Fetal Alcohol or 
Down syndrome, there are no physical symptoms to aid early diagnosis (Diagnostic & 
Statistical Manual of Mental Disorders, 5th ed.; DSM-5; American Psychiatric Association 
[APA], 2013).  
Another factor influencing parent’s satisfaction, was the parent-professional 
relationship and the quality of information provided by professionals. Moh and Magiati (2012) 
found that higher parental assessment satisfaction was associated with higher perceived 
collaboration with professionals. This was indicated by professionals acknowledging their 
concerns, collaborating in making decisions and discussing the diagnosis and post-diagnostic 
support. Likewise, feedback from 15 UK parent focus groups reviewing professionals’ 
communication skills, advocated for more professional training to improve awareness, 
diagnostic competency, interpersonal skills for disclosing diagnosis and intervention 
knowledge (Osborne & Reed, 2008).  
Generally, the experiences of parents whose child receives a diagnosis are well 
documented. Whilst it is clear that the assessment process can be distressing, parents often 
reported a sense of relief once the diagnosis was made (Avdi et al., 2000). Thus allowing them 
to work towards accepting the diagnosis (Midence & O’Neill, 1999).  
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However, little is known about the experience of parents who embark on the same 
prolonged and stressful assessment journey, but do not receive a diagnosis or the diagnosis is 
vague, for example, having autism ‘traits’ or ‘features’. In the limited ASD research available, 
these parents felt vague descriptions were unhelpful and reduced their assessment satisfaction 
(Howlin & Moore, 1997). Nevertheless, findings from the wider literature may be applicable. 
Lenhard, Breitenbach, Ebert, Schindelhauer-Deutscher and Henn (2005) found that mothers of 
children with Down syndrome, reported less emotional burden than mothers whose child had 
no specific diagnosis. Similarly, families of children with non-epileptic attack disorder reported 
distress during the assessment process and felt disbelieved by professionals (McWilliams, 
Reilly, McFarlane, Booker & Heyman, 2016). Furthermore, with medically unexplained 
diagnoses, parents struggled to accept the absence of a specific medical explanation (Moulin, 
Akre, Rodondi, Ambresin & Suris, 2015). These researchers speculated that parents’ 
uncertainty regarding the prognosis, unresolved concerns and a lack of professional recognition 
cause increased emotional burden and disrupted family functioning. 
Therefore, this research aimed to explore parents’ lived experience of the ASD 
assessment process when a diagnosis is not received. To the researchers’ knowledge this is the 
first study to explore this objective. It is hoped that in addition to enhancing professionals’ 
understanding, the findings will inform service development to improve ASD assessments and 
consider how best to communicate a non-diagnosis outcome.  
 
Method 
 
Study Design 
 This research explored parents’ experiences of the ASD assessment process when their 
child did not receive a diagnosis. Interpretative phenomenological analysis (IPA) was 
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considered the most suitable qualitative methodology, as it allows detailed exploration of an 
individual’s lived experience (Smith, Flowers & Larkin, 2009). IPA is informed by concepts 
derived from three fundamental areas of philosophy; phenomenology, hermeneutics and 
idiography (Pietkiewicz & Smith, 2014). Phenomenology (the study of experience) focuses on 
how parents perceive and talk about their assessment experience. Hermeneutics (the theory of 
understanding and interpretation) allows the researcher to explore the individuals’ experience 
using their own interpretation. This analytic process is described as a ‘double hermeneutic’; 
“the researcher is trying to make sense of the participant trying to make sense of what is 
happening” (Smith et al., 2009, p.3). The third concept, idiography, refers to the thorough 
analysis of each participants’ perspectives, rather than drawing a conclusion of probability 
from a large group like most empirical research (Smith, Harré & Van Langenhove, 1995). 
Consequently, IPA employs small, purposively-selected samples and given the rich insight into 
individuals’ experiences, IPA research is influential in clinical settings (Brocki & Wearden, 
2006).  
 
Ethics 
Approval was granted by the Health and Care Wales Research Ethics Committee (Appendix A 
and B), Bangor University School of Psychology (Appendix C) and Betsi Cadwaladr 
University Health Board (BCUHB) Research and Development Committee (Appendix D). 
 
Participants 
A small purposive sample of parents (six mothers and one stepfather) of six children was 
recruited through a neurodevelopmental team in North East Wales, between November 2016 
and February 2017. In line with IPA (Smith et al., 2009) the sample size was appropriate as 
this enabled in-depth examination of the parents’ experiences. In IPA the sample must be 
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reasonably homogenous. Therefore, participants were recruited using the following criteria: 
they were over 18, had children aged 5-19 years who had undergone an ASD assessment in 
BCUHB between February 2016 and February 2017; they had attended the feedback 
appointment and were not given a diagnosis. Parents were excluded if they could not provide 
informed consent; their child was accessing professional support for other neurodevelopmental 
difficulties; they received an alternative diagnosis, such as Attention Deficit Hyperactivity 
Disorder or a Speech and Language Therapy diagnosis during the assessment. 
 
Procedure 
Potential participants were identified and contacted via the clinician who conducted their 
child’s assessment. Bilingual (Welsh and English) recruitment packs were provided and 
included a letter of invitation, participant information and an opt-in form (Appendix E, F and 
G). On receipt of completed opt-in forms, the first author contacted potential participants using 
a telephone protocol to discuss the research and arrange a time for interview (Appendix H). 
Fifty packs were prepared, however, as recruitment was conducted by clinicians it is not 
possible to determine a definitive response rate. Interviews were completed at the same clinic 
as their assessment and written informed consent was obtained from all individual participants 
prior to interview (Appendix I). A £10 voucher was provided as a gesture of appreciation for 
sharing their time and expertise.  
 
To protect anonymity, participants and their children were ascribed pseudonyms. Table 1 
displays participant characteristics.
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Table 1.  
Participant Characteristics 
Participant* Parental 
Status 
Child* Child’s 
Gender 
Age at assessment Age at first 
concern 
Person who raised concern / 
requested assessment 
Approximate interval between 
feedback and interview 
Jane Mother Oliver Boy 5 years 3 years Mother 4 months 
Melissa Mother Erin Girl 12 years 2.5 years Professional then mother 5 months 
Martha Mother George Boy 8 years 5 years School Teacher then mother 3 months 
Emma  Mother James Boy 4 years; 9 years*** 9 months Mother 6 months 
Vicky 
Paul**  
Mother 
Step Father 
Charlie Boy 9 years; 13 years*** 8 years Mother 12 months 
Sarah  Mother Henry Boy 15 years 15 years Professional 3 months 
*Pseudonyms 
**Parents interviewed together 
***Second assessment
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Data Collection 
Face-to-face semi-structured interviews were conducted in English over a four-month period 
by the first author. Interviews were audio-recorded and ranged from 36 to 80 minutes in length. 
Six interviews were conducted in total, five individual interviews (mother only) and one joint 
interview (mother and step father). As suggested by Smith and Osborn (2003), interviews were 
guided by a schedule, although participants’ experiences were explored further where 
necessary (Appendix J). The schedule was developed by the authors and reviewed by the 
neurodevelopmental team. Following recommendations from Elliott and Timulak (2005) field 
notes to record observations and reactions were produced during each interview to aid initial 
coding. Audio-recordings were transcribed verbatim and included vocalisations, pauses and 
laughter. All identifying information was removed or anonymised.  
 
Data Analysis 
In accordance with the hermeneutic phenomenological approach, interviews were transcribed 
and analysed consecutively by the first author. Following guidance from Smith et al., (2009), 
the author read and re-read each transcript to become immersed in the data. A line-by-line 
analysis was subsequently undertaken and three types of exploratory comments (descriptive, 
linguistic and conceptual) were added to each transcript to enable the identification of abstract 
concepts (Appendix K). Similarities between concepts were highlighted to identify emergent 
themes, which reflected shared meanings within the individual’s experiences (Appendix L). 
This process was applied to each transcript and a table summarising emergent themes and 
illustrative quotes was produced (Appendix M and N). The final stage, a cross-case analysis, 
involved searching for similarities between the transcripts to generate superordinate themes. 
All stages of the analysis were completed manually.   
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Quality 
To ensure the study was conducted to a high standard, an evaluative framework for qualitative 
research was consulted during the design phase (Yardley, 2000; 2015). Additionally, the first 
author wrote a reflective diary to record subjective thoughts or assumptions. This allowed the 
researcher to explore the personal impact of the process, promote transparency and consider 
how this might influence the analysis. The data was predominantly analysed by the first author, 
with one transcript analysed simultaneously by both authors. The analysis of additional 
transcripts and emerging themes were discussed during regular consultations between authors. 
 
Results 
Three superordinate themes emerged: 1) “My Child is Different”; 2) The Emotional and 
Psychological Journey; 3) Understanding the Outcome. Themes are displayed in Table 2.  
 
Table 2.  
Summary of Themes 
Superordinate Themes Subthemes 
“My Child is Different” Emphasising Difference 
 Talking about and Disclosing Difference 
 Celebrating Difference 
The Emotional and Psychological Journey Alone 
 Judged 
 Impact on self 
 Unrelenting Battle 
Understanding the Outcome Lack of Closure 
 Relief 
 The Future  
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“My Child is Different”  
1. Emphasising Difference: All parents acknowledged or described their child as different. 
Some parents described their child as “non neuro-typical”, “complex”, “not normal”, or listed 
characteristics which set their child apart. As illustrated by Melissa, noticing disparities with 
other young people was often the catalyst for parents identifying, and later accepting, their 
child as being “different”. 
 
I could see she was emotionally quite behind (…) I sort of made excuses for it a bit 
y’know and sort of at high school everyone was boyfriends and makeup and all that 
and she wasn’t and I could just really notice – Melissa.1 
 
Other parents emphasised their child’s differences by recognising their similarities to 
children with a diagnosed neurodevelopmental condition. They also used the severity of 
symptoms and diagnostic label as a benchmark for interpreting their own child’s differences.    
 
I’m not saying that he has got a very bad case of it (...) I’d say he is…he he has…he 
shows traits (…) my brother’s son had autism (...) he didn’t speak until about five years, 
so I know there is extreme cases. Charlie’s not like that (...) but he is…he does have the 
traits of it…I watch the programme The Undateables2 and there are sometimes some 
characters in that and I’ll go “that’s Charlie!” – Vicky. 
 
For Vicky, the possible variability in presentation caused some confusion. To her, 
Charlie’s characteristics were synonymous with people diagnosed with autism, and whilst she 
                                                     
1 Transcript conventions will be used throughout: … speech hesitation; (…) words removed. 
 
2 A television programme about people with often-misunderstood conditions, such as autism. 
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appreciated the spectrum of symptom severity, she believed the similarities were compelling. 
Consequently, she was confused and frustrated as to why Charlie had not received a diagnosis. 
This is detected through the repetition and hesitation in her quote. Like Vicky, many parents 
affirmed that they knew their child best and by emphasising the differences, were attempting 
to highlight their need for diagnosis.   
 
2. Talking about and Disclosing Difference: Most parents did not want their child to be 
defined by a “label”. However, this provided them with a dilemma of how best to describe their 
child’s difficulties. 
 
I hate using the word different or not normal but it’s the only language I’ve got – Emma. 
 
Emma further illustrated that her lack of knowledge about how to explain her child’s 
differences were also experienced by her son. This appeared to be a painful experience for both 
of them, and indicates how powerless Emma feels as a mother and being unable to explain his 
experiences to him. 
 
He will say, “I know mummy that my mind isn’t built like everyone else, but I can’t 
cope with it” which is difficult to hear – Emma.  
 
Some parents reflected on the dilemma of disclosing their child’s differences as a way 
of preempting potentially difficult situations. Jane reported “you’re constantly battling between 
do I point out that he is different or do we wait until there’s a crisis?” Alternatively, Melissa 
described that without a valid label, preempting such situations is futile.    
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I’d gone to the high school before and said these are Erin’s traits (…) this is what she’s 
going to have difficulty with (…) they said “oh we have lots of people like that”. So I 
think because there wasn’t any specific diagnosis (...) they just thought I was like a 
worried mum – Melissa. 
 
3. Celebrating Difference: Parents acknowledged that their child’s differences formed their 
character and made them who they were.  
 
Even though I want to take all this away from him, actually I don’t because if I did that 
he wouldn’t be my James – Emma. 
 
He’s super clever where the computer is concerned. He’s designing his own games (…) 
and he’s like “I’m going to go and work for Google” and I’m like ‘you’re going to own 
Google’ (…) that makes me feel really happy (…) I couldn’t be prouder – Vicky.  
 
Throughout the interview Vicky highlighted her son’s fascination with computers as an 
“autistic trait” and something which impacts negatively on his ability to make friends. Yet this 
quote illustrates her recognition that this unique attribute sets him apart from others in a positive 
manner and should be celebrated.  
 
The Emotional and Psychological Journey  
1. Alone: Throughout the journey, many parents felt alone. Some reported feeling marginalised 
by friends due to their child’s behaviour or their lack of time for socialisation. Others perceived 
their loneliness to be the result of their concerns being dismissed. 
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Loneliness was predominantly experienced at the beginning of the journey as parents 
interpreted symptoms differently. Emma stated “my husband was in denial for a lot of the 
time”. She reflected on how difficult this was for her, but interpreted his optimism as a disguise 
for fear of “stigma”. Martha’s views also differed to her husband’s, however, she interpreted 
this as “mother’s intuition” and deemed it was her responsibility to seek support. The quote 
below demonstrated that other parents reflected more on their feelings of loneliness after the 
assessment.   
 
We’ve just been left (…) I feel like I’ve been blindfolded and put in the most peculiar 
maze ever and I can’t find my way out and I’m trying to get to Charlie…and I can’t, I 
can’t get to him, because I…try and help him but he just doesn’t understand and that’s 
frustrating, that’s why as a family we need help – Vicky. 
 
Vicky’s use of a metaphor emphasises her feeling of being abandoned due to a lack of 
professional support. Her quote demonstrates a sense of ambivalence too; she wants to get out 
of the maze while being aware that Charlie is stuck in the maze. There is a sense of feeling lost, 
hopeless and that everybody in the family needs guidance, as they are struggling to understand 
and communicate with him. Her words “I’m trying to get to Charlie and I can’t” gives a sense 
of Charlie’s loneliness and isolation too.  
 
If you’ve got a diagnosis they say right, we’ll take you on all these training courses (...) 
but if you’ve got a diagnosis of non neuro-typical (...) you sort of drift and you’re alone. 
There’s no counselling (...) or no one to talk to, because you can’t talk to your husband 
cos it’s painful – Jane. 
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Jane illustrated her belief that gaining a diagnosis would have prevented the feeling of 
being marginalised by professionals. She also highlights the emotional impact of parents 
feeling unable to support each other and how this can exacerbate feelings of loneliness. 
Parents placed a high value on a shared identity. However, most participants reported 
to seek support and shared experiences from outside the family due to the heightened emotional 
impact within the immediate family. Jane, who had a supportive family network, reflected that 
parenting a child with autistic traits and undergoing assessment was “the undoing of a lot of 
families!” Although she and her husband struggled to comfort one another, she valued the 
supportive aspect of attending “groups with other children with special needs”. Similarly, 
Emma valued the support and friendship of a mother whose son had autism, stating “that’s the 
one positive thing that’s come out of this.” This demonstrates the importance of belonging, 
acceptance and sharing this experience with others. Many parents felt that having a diagnosis 
to explain their child’s unique behaviours would offer commonality with other parents. 
 
2. Judged: The majority of parents worried about whether their concerns would be validated. 
This was heavily influenced by the perceived judgment or “paranoia” they would receive in 
the event that a diagnosis was not given.             
 
I did say to Dr A I hope you don’t think this is some sort of Munchausen by proxy 
thing. I’m not afraid to say that [laughs]. I’m afraid that you think that (...) because 
obviously Oliver had been in and out of hospital for lots of reasons, medical reasons, 
and of course when it’s medical you can see it can’t you? – Jane. 
 
Judgment or “paranoia” is driven by fear and anxiety, as illustrated in Jane’s quote. She 
was anxious that due to a lack of visual symptoms her concerns would be disregarded. 
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Consequently, she feared that professionals would judge her for fabricating her son’s 
symptoms. Jane’s own use of the phrase “Munchausen by proxy” suggests that naming this 
openly would provide a level of control over this thought and ease her anxiety of this being 
considered by others. Her laughter, however, demonstrated that she felt uncomfortable about 
raising the topic.  
 
I was so apprehensive because I thought if she turns around and goes nah there’s 
nothing wrong with him, then I thought it’s going to be all in my head, but when she 
said she might see him like very low on the spectrum I thought oh at least she is seeing 
something – Martha. 
 
Martha’s quote highlights the extent to which parents are affected by the perceived 
judgment of professionals not validating their concerns. Martha initially felt there was no need 
for the assessment, but requested it to satisfy the school’s concerns. Nevertheless, she was 
relieved that “something” of concern was identified, as this alleviate the burden of it being in 
her head. 
 
Because he hasn’t had a diagnosis I kind of get the feeling that other people think…erm 
it’s just in her head because they’ve said there’s nothing you know…clearly wrong 
there…she’s just making it up, or…it used to be really really hard to deal with. Now as 
time’s progressing I kind of think “well stuff what anyone else thinks” - Emma 
 
Emma illustrated that she had learnt to manage her worries about being judged and 
recognised this as an area of self-growth. Whilst diagnosis is not appropriate in all cases, the 
importance of feeling heard was valued. One mother stated “I had a good experience with Dr 
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C, he listens and doesn’t say no you’re wrong or that’s not it, it’s easier when you have a “it 
doesn’t fit”, it’s easier because people have actually listened”.   
 
3. Impact on self: Throughout the interviews all parents described a great sense of 
responsibility. This was largely due to their own expectations of how they “should” react and 
their desire to feel in control of the situation. 
 
Horrendous, just horrendous. I felt helpless. As his mother, I should be able to help him 
and I couldn’t. I couldn’t take it away from him. Whatever it was I couldn’t take it 
away. I couldn’t help him – Emma.  
 
Emma’s use of the words “horrendous”, “helpless” and repetition of “I couldn’t” 
illustrate the strong emotional impact on parents when they were unable to meet their own 
expectations of parenting.  
Some parents described the multifaceted roles of being a parent, including being “an 
investigative journalist”, “the best most organised diary keeper”, “an advocate”, a “teacher” 
and a “therapist”. Trying to fulfill these roles could be a way of trying to gain control and 
minimise the feeling of hopelessness. However, parents highlighted that this required 
sacrificing other commitments to focus on supporting their child. Having this level of 
involvement in the child’s life, presented difficulties for parents during the assessment process. 
They described their emotions as “bubbling up” and felt they had to “put a lid on them” to 
present the child’s case coherently. 
The pressure of ‘getting it right’ differed between parents. Sarah described the 
assessment as “a lot of pressure”, because she “didn’t want a label more than anything.” She 
stated “I was trying not to get upset, cos I was trying to put into context how we felt it had all 
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happened”. Whereas Jane, who believed her son will be diagnosed with autism in the future, 
described “it was sadness I felt, I felt that I’d let him down.” Martha described difficulty with 
her memory during the assessment and worried that this had impacted on her responses. These 
examples demonstrate the pressure parents experience during the assessment and their 
subsequent feelings of doubt that the outcome was affected by their poor reporting. 
 
4. Unrelenting Battle: Parenting a child with autistic characteristics and the journey of seeking 
diagnosis and support was described as a “huge battle”. Melissa stated “you’re continually 
fighting for services, fighting for support, fighting for a better life”. Parents used words such 
as “painful”, “exhausting”, “disheartening”, “a sinking feeling” and “like you’re walking 
through mud” to describe the emotional impact of their perceived battle of the assessment 
process. A major factor contributing to this perception was long waiting times and the 
involvement of multiple professionals. This was evident as some families reported that they 
had been “under services” for years. Additionally, using the word “under” suggests that 
services are viewed as powerful and further denotes the parents’ feelings of losing control. 
 
I have waited long enough. It’s…he’s been battling this since he was about eight and 
erm…no (...) I’ve been battling it since he was about eight – Vicky. 
 
There’s always a road block at the end of the road we go down so we just have to do 
U-turn (…) there are very long waiting lists to get seen, so if you do get knocked back 
and do try to do it again it’s another six months – Paul.  
 
Vicky and Paul illustrated their frustration about long waiting lists and their use of the 
first person shows how the journey can be all encompassing for the whole family. Other parents 
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noted that being informed of long waiting times, albeit frustrating, helped to manage their 
expectations. 
 
I’m angry now because I should have been stronger (...) I should have fought harder 
(…) one side of me was kind of saying right well, there’s nothing wrong so that’s good 
(...) the other side was like no this isn’t right! – Emma. 
 
Emma described that she “should” have fought harder, signifying an internal battle as 
if she did not do herself or her son justice. Another mother, Jane, emphasised the need to be 
strong and emotionally in control. She described mothers who were “fighting” for diagnosis as 
“Lions…they’re strong women (…) y’know that overly dead sweet nurturing lioness thing, but 
y’know fiercely protective.” 
  
Another aspect of the battle reported by parents was trying to gain public acceptance. 
Typical daily activities were described as a “challenge”. The lack of public awareness for 
autism and misinterpretation of the child’s behaviours often resulted in criticism or “staring”. 
This was illustrated by Melissa, whose quote depicts her interpretation that continually fighting 
with services and being subjected to judgment in public led to personal self-growth. 
Consequently, she felt determined and “more confident” to tackle situations head on to protect 
her daughter.  
 
I’m a lot more protective (…) if we’re in Tesco and you know she’s having a tantrum, 
which looks quite strange to most people at 13, erm and somebody will say something, 
I do sort of turn around (laughs). Whereas one time I would have bit my tongue and got 
upset…I was just a bit fed up of people being negative towards her – Melissa. 
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Many parents reflected that gaining a diagnosis might have changed this experience, 
giving the impression that diagnosis is a badge, which symbolises they have won the battle.   
 
Understanding the Outcome 
1. Lack of Closure: In discussing assessment outcomes, many parents reflected on their 
perceived lack of closure and the associated mixed feelings. 
 
It’s like having a boat and somebody holding on to the rope and that’s fine but then 
somebody lets the boat go, and your sort of going ‘ok, now what we gonna do? (…) It’s 
going to be like after until we get to a point where Oliver hmm is either diagnosed or I 
get him a statement for what he is, because he’s not functioning in mainstream, but he 
hasn’t got any particular label to peg on a board to make it easier – Jane.   
 
Jane’s metaphor described her trying to process her emotions after the assessment. She 
illustrated a sense that she believed the process was unfinished.  
Some parents doubted the outcome as they thought that professionals had only observed 
a “snap shot” of the child or saw them on “a good day”. In addition, conflicting opinions from 
health and education services and in some cases between same service professionals, led 
parents to feel confused and frustrated at the outcome.  
 
His teachers have told me they can’t understand why he hasn’t been given a diagnosis 
because they can quite clearly see that there’s something – Emma. 
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I don’t understand how one person can say “yeah he’s on the autistic spectrum” and 
somebody else can do a U-turn and say “we don’t feel that he needs any help” – Vicky.  
 
Their confusion was exacerbated by a lack of knowledge about how to access further 
support or explanation. One parent felt relieved they could access emergency appointments, 
whilst others felt like a “burden” or were too “angry” to re-contact the service.  
 
It just feels like I’ve just had a locked door…and now I’m having to find this key, that 
is on a key chain with about a million keys on it…you know it’s just been shut the door, 
lock it and that’s it – Vicky.  
 
Whilst Vicky’s quote suggested her complete closure from the service, she lacked 
personal closure and felt she alone was still searching for an answer. Her quote also 
demonstrated a sense that she was set a test of commitment to locate the key to open the door. 
Consequently, she felt let down by the service.  
 
I think you need to know that you’re not excluded from the building, ‘don’t come here 
anymore with your er with your Munchausen by proxy saying your son’s this and that 
and the other’ cos that’s not what I heard when I was in the room – Jane. 
 
In many cases, parents recommended that the service should allow parents time to 
process the outcome before being invited to further discussions. 
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2. Relief: Many parents expressed relief that their child did not meet the criteria for a diagnosis. 
Parents who felt stronger relief were those whose child was referred following advice from 
professionals, rather than originally raising the concerns themselves.  
 Sarah acknowledged the enormity of her relief by stating the impact a diagnosis could 
have on her son’s life. “It was a big relief! Because it’s not just about school, it’s about 
relationships and the rest of his life”. Martha also expressed relief, but demonstrated some 
ambiguity in terms of questioning what the problem was if not autism. She also reflected on 
the importance of understanding her son’s needs better, particularly as they worried that his 
difficulties may have been attributed to their “parenting”.   
 
A relief! And a bit of a shock! In one way, cos obviously he was showing a little bit of 
signs cos otherwise he wouldn’t have been assessed in the first place, (...) it’s a mixture 
of feeling relieved cos we know he hasn’t got it, but then a bit shocked as well cos we 
were like well why is he the way he is? – Martha. 
 
For other parents, relief was expressed as a fluid emotion that changed according to 
fluctuations in the child’s presentation. For example, Emma stated “initially I was relieved” as 
her son exhibited improvements. However as these were short lived, her journey to fight for a 
diagnosis continued. Jane who also continued to seek a diagnosis explained that “it wasn’t easy 
to hear ‘no’, but it was easier than hearing yes”. She appeared to be relieved that despite her 
own concerns, she was pleased a diagnosis was not confirmed.  
 
3. The Future: When summarising the assessment process, all parents reflected on their future 
hopes and worries. Some parents expressed concerns regarding education and their child’s 
ability to independently manage the demands of adulthood.  
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If she doesn’t get an education and she doesn’t get the social support then what’s she 
going to do, what job is she going to have and what life is she going to have? – Melissa. 
 
Many parents spoke of the value that gaining a diagnosis would have provided in terms 
of gaining educational or therapeutic support, understanding and acceptance.  
 
If I’ve got that little piece of paper, just that little piece of paper, that just says what’s 
going on, give him a break, give him a chance – Emma.  
 
Emma’s use of the phrase “that little piece of paper”, also used by two other parents, 
minimised the impact of diagnosis to just being words on paper. Ultimately, they felt that their 
child’s difficulties could be explained by an autism diagnosis, but worried that without this 
validation they would not receive the necessary support. For some parents this meant their child 
was unlikely to fulfill their potential, whilst others expressed concerns about their child’s well-
being and mental health. Parents who worried less about the future felt that the assessment 
offered a deeper understanding of their child and were pleased that they could now focus on 
moving forward.  
Despite the difficulties parents reported in navigating this process, many highlighted 
positive aspects of their experience. They described it as “sensitively managed”, professionals 
as “skilled”, “friendly” and that they “helped us understand” by highlighting the child’s 
strengths rather than focusing on their difficulties. 
 
Discussion 
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This research explored parents’ experiences of the ASD assessment process when no diagnosis 
was given. The themes illustrated issues encountered by parents in describing their child’s 
difficulties without a valid explanation, yet celebrated these differences in shaping their child’s 
personality and parents’ resilience. Parents also described the emotional and psychological 
impact of the process. They reflected on the support received and the battle they engaged in to 
gain acknowledgment and acceptance from services and the public. Receiving the assessment 
outcome triggered a range of emotions. Some parents felt relieved and positive about the future, 
whilst others felt frustrated, questioning the validity of the assessment and determined to seek 
a second opinion. Despite the difficulties raised, some parents described the process as a 
journey. They reflected on the challenges along with positive aspects of the assessment and 
their own self-growth as a parent and an individual. 
 To the authors’ knowledge, this research was the first of its kind. Nevertheless, like the 
parents whose child was diagnosed with ASD in Goin-Kochel et al., (2006) and Watson et al., 
(2011), many parents were dissatisfied with long waiting times. However, parents who 
expected this wait, usually having been informed by friends or support groups, rather than the 
service itself, were more accepting and reported that knowing a timeframe was useful. One 
parent whose child was seen urgently, reflected positively. She explained that knowing the 
outcome quickly enabled them to move forward rather than “it hanging over your head”.  
 Many parents described feeling “paranoid” that professionals would not believe or 
validate their concerns. Whilst two parents felt professionals did not listen or attend to their 
child’s needs, others experienced this fear to be unfounded. They reported that professionals 
were “friendly”, “listened” and “asked the right questions” to elicit important information. One 
parent described that being informed of their child’s strengths and weaknesses in relation to 
why the diagnosis was not made, improved her understanding and empowered her to seek 
educational support. Although mixed experiences were reported, to some extent this 
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contradicts the experience of parents who received a diagnosis in the Crane et al., (2016) study, 
who felt ignored or were re-referred to another professional.  
 Like Midence and O’Neill’s (1999) findings, most parents expressed relief at the 
outcome. The manifestation of relief differed between parents, but was predominantly 
attributed to ‘knowing’ the outcome. In their study, confirmation of the diagnosis provided 
relief as parents could work towards acceptance. However, in this research, although some 
parents were relieved not to receive a diagnosis, for others hearing that ASD symptoms were 
evident, despite not meeting the full diagnostic criteria, mitigated their perceived judgement or 
strengthened their fight for further assessment. Without the diagnosis many felt they could not 
access support, a finding consistent with Keenan et al., (2010). 
 
Clinical Implications 
Given the emotional and psychological challenges parents encountered, important clinical 
implications are raised. The difficulties reported by many parents predominantly related to 
issues before and after the assessment. For example, during the long wait parents felt alone and 
apprehensive. Following the assessment, although many felt relieved, some were confused, 
lacked closure and were concerned about the future. 
 Providing information at the point of referral about waiting times, the assessment 
process and advice to record information prior to the assessment, could alleviate parents’ 
apprehension. Adopting a similar model to the one used in dementia services, where pre and 
post assessment counselling is offered, might also provide the associated benefits of parents’ 
engagement with services and better adjustment to outcomes (La Fontaine, Buckell, Knibbs & 
Palfrey, 2014). In autism services, this counselling could enhance the parent-child-professional 
relationship and reduce their perception of the process as a battle. During pre-assessment 
counselling, parents’ concerns, their reasons for seeking diagnosis and expectations can be 
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discussed. This meeting would establish rapport, allow the professional to tailor the assessment 
and manage parents’ expectations. Offering post-assessment counselling, regardless of the 
outcome, would be beneficial to explore the impact and outcome of the assessment and 
henceforth reduce re-referral rates.  
 A child not being given a lifelong diagnosis is positive. However, many parents 
believed that a diagnosis was essential to receive support and were therefore disappointed and 
worried about the future. To challenge this perception, services should focus on developing a 
formulation to inform the families understanding of why the diagnostic criteria was not met. 
Sharing this formulation will educate other professionals involved and enhance collaborative 
working, knowledge and acceptance of neurodiversity and allow for a needs-based 
management plan. 
 Whilst implementing a more thorough assessment process is ideal to overcome some 
of the difficulties reported, the demand on services and current waiting times must be 
considered. Therefore, where appropriate, signposting to support groups or voluntary 
organisations may be beneficial.  
 In addition to service developments, the interpersonal, therapeutic and diagnostic skills 
of the professional are important. Many parents felt powerless, “paranoid” and described the 
overwhelming emotional impact of the assessment. Therefore, professionals must have the 
wappropriate skills, knowledge and attitude to conduct the assessment and provide sensitive 
feedback. Training should be offered for non-diagnosis delivery along with time to reflect on 
the impact of this during clinical supervision.  
 Ultimately, improving families’ experience of the assessment process may facilitate 
better parent-professional relationships and acceptance of the outcome. However, whilst it is 
important to consider areas of improvement to ensure best practice, positive aspects were 
highlighted, which should be recognised as areas of strength for future benchmarking. 
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Limitations and Future Research  
A number of limitations are considered. Firstly, the cross sectional design meant parents’ 
experiences were only explored at one time point. Many parents reflected on the time they 
needed to process the outcome, suggesting that their feelings and reflections may change over 
time. Therefore, future research should utilise longitudinal methodologies to ascertain whether 
the opportunity for further processing time would alter the parents’ perceptions. Additionally, 
some parents who were not completely satisfied with the outcome were keen to seek further 
assessment. A follow-up study to see whether professionals had reached the correct outcome 
or whether a diagnosis was provided at a later date and parents’ experience of this would be 
useful.  
 Secondly, recruitment difficulties meant that only six interviews were conducted. 
Furthermore, all participants were from North East Wales and one neurodevelopmental team. 
According to the responses of interviewed parents, recruitment difficulties may relate to: 1) 
limited time as parents attend multiple appointments; 2) difficulties arranging childcare for 
children with autistic characteristics; 3) avoidance of discussing the assessment due to the 
emotional impact. These factors should be considered for future recruitment. Future research 
may benefit from the inclusion of additional socio-demographic data, in particular the cultural 
identity of the participating families as this was not collected in the current study. Additionally, 
looking at the experience of male carers would be useful as only one step-father was recruited. 
 Thirdly, the interviews were conducted in the clinic where the child was assessed and 
by the first author who worked in the neurodevelopmental team that carried out the assessment. 
This may have inhibited some parents to share certain experiences.   
 This study was the first, to the authors’ knowledge, to explore parents’ experiences 
when a diagnosis is not given. However, exploring the experiences of professionals who make 
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the decision and feedback a non-diagnosis is recommended. This would further improve our 
understanding of this complicated area. 
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Introduction 
 
This research examined parents’ perceptions of Autism Spectrum Disorder (ASD) and the 
assessment process. The literature review explored parents’ beliefs about the cause and course 
of ASD, whilst the empirical paper provided a detailed insight into parents’ ASD assessment 
experiences when a diagnosis was not given. The current paper will consider the mutual 
contribution of these findings and will be presented as follows: 1) theoretical implications and 
recommendations for future research, 2) clinical implications, and 3) personal reflections. 
 
Theoretical Implications and Future Research 
The two areas studied: parents’ perceptions about ASD and assessment experiences when a 
diagnosis was not given, have thus far been neglected in research and clinical practice. Previous 
research has focused on scientific explanations about the possible causes of ASD, whilst 
research into parents’ assessment experiences has predominantly been explored with families 
who received a diagnosis. However, the current findings highlight the importance of 
understanding parents’ etiological beliefs and assessment experiences, regardless of the 
outcome.  
 A theoretical model which can be applied, and facilitate our understanding of the 
current findings is the Health Belief Model (HBM; Rosenstock, 1974). Consistent with the 
literature review, the model asserts that socio-demographic variables such as age, income and 
education along with a person’s beliefs about diagnosis, will influence health-related 
behaviours. Whilst the model was originally created to explore individuals’ perceptions of their 
own health, it was later used to understand parents’ health-behaviours (Bates, Fitzgerald & 
Wolinsky, 1994). The model includes four main components: perceived threat, benefits, 
barriers and self-efficacy. It can be applied to the context of parenting a child with autism or 
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undergoing the assessment process, as each component is thought to influence the parents’ 
beliefs and in turn their health-care decisions (Wildman, 2006). The model has also been used 
to understand parents’ satisfaction with the ASD assessment process (Saggu, 2015).  
 The first component, ‘perceived threat’ applies to the empirical paper. Parents 
considered areas of their child’s life which could be under threat: education, well-being and 
future aspirations. More systemic factors posing a threat were lengthy waiting times, 
“paranoia” that professionals would not validate their concerns and their perceived lack of 
access to support or public acceptance without a valid label. 
 The second and third components, ‘perceived benefits and barriers’ relates to how 
parents’ beliefs about the course of ASD and the efficacy of potential treatments may vary 
(Wildman, 2006). Consistently, the literature review evidenced that parents’ etiological beliefs 
were associated with treatment decisions. For example, a study conducted in the USA found 
that parents who believed autism was a gift were less likely to seek professional advice or 
intervention (Jegatheesan, Fowler & Miller, 2010). Additionally, cultural influences and 
societal judgement also impacted on health beliefs, as families living in communities such as 
those on the Kenyan Coast, who regarded autism as a bad omen predominantly focused on the 
perceived benefits of treatment, hoping for a cure (Gona et al., 2015). This component can also 
explain wider healthcare decisions. For example, if parents believed immunisations caused 
their child’s autism, they were more inclined to amend their vaccination schedules (Bazzano, 
Zeldin, Schuster, Barrett & Lehrer, 2012). Their tendency to use complimentary and alternative 
medicine (CAM) which can be expensive and lack scientific evidence, indicated their ongoing 
mistrust of medical interventions. Moreover, Saggu (2015) who assessed the ‘perceived 
benefit’ component of the HBM in relation to parents’ assessment satisfaction found that 
affluent parents, who accessed private and timely assessment facilities, were more satisfied. 
This finding was largely related to the time that practitioners invested in explaining the 
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outcome along with the implications of post-assessment support. In order to safeguard against 
non-evidence-based decisions, professionals have a duty to ensure parents are informed of the 
benefits and barriers to diagnosis and intervention. Investing time to guide parents through the 
diagnostic process and intervention options, facilitates the final component of the model, self-
efficacy. This refers to parents’ belief in their own ability to support their child (Wildman, 
2006; Saggu 2015). Conclusively, using the HBM as a psychological framework has multiple 
benefits. It allows professionals to gain a deeper understanding of parents’ beliefs and plan 
needs-based support accordingly, which as stated in the literature review, parents are more 
likely to accept (Gona et al., 2015). 
 A further theoretical framework important to the current findings is the attribution 
theory (Weiner, 1985). This explains how individuals make sense of stressful events based on 
three causal dimensions. 1) Locus (whether the cause of an event is perceived to be internal or 
external); 2) Stability (the perceived likelihood that the event will change over time); and 3) 
Controllability (whether the event can be altered by the individual or is restricted to external 
factors). Previous research found significant associations between controllability and maternal 
affect (Dale, Jahoa & Knott, 2006) and that attributions are associated with parental adjustment 
to an ASD diagnosis (Mickelson, Wroble & Heldeson, 1999). A number of plausible links can 
be made between the current findings and the dimensions detailed within the theory.  
 Regarding the locus of cause, many studies in the literature review highlighted the 
impact of internal versus external attributions. For example, parents in Jordan who attributed 
the etiology of autism to internal factors, such as genetics or carelessness during pregnancy 
experienced guilt about the diagnosis (Al-Dababneh, Al-Zboon & Baibers, 2016). 
Furthermore, Chen et al., (2015) whose sample of Taiwanese parents predominantly endorsed 
an internal cause (genetics), found that 38.5% vetoed further pregnancies due to the risk of 
having another child with ASD before consulting with medical professionals regarding their 
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reoccurrence risk. In another study conducted in the USA, parents who endorsed genetics and 
blamed themselves, were less critical of their child as they perceived the diagnosis to be beyond 
the child’s control (Wasserman, Weisman de Mamani & Mundy, 2010). Parents perception 
about the locus of cause can also influence their healthcare decisions. For example, studies that 
highlighted external causal factors, such as toxicity (Bazzano et al., 2012), found that parents 
were more likely to employ protective strategies, such as altering vaccination schedules. 
 The dimension of stability, could explain the research theme ‘the future’. In the case of 
not receiving a diagnosis, parents may view the situation as stable because without a diagnosis 
they feel unable to access appropriate intervention, and thus the child’s symptoms will remain 
unchanged. Consequently, lowering expectations and increasing worries about the future. 
Alternatively, they might perceive not having a diagnosis as unstable as they consider the future 
to be unpredictable, particularly if they continue to fight for a diagnosis. As found in the 
literature review, parents’ perception of stability can be associated with their socio-
demographic status (Zuckerman, Lindly, Sinche & Nicolaidis, 2015). For example, in receiving 
a diagnosis, parents of Caucasian compared to Hispanic children, were more likely to endorse 
the belief that autism is lifelong. 
 The third dimension, controllability, also relates to the empirical themes. Specifically, 
parents reflected on the element of control in the theme ‘impact on self’ and ‘unrelenting 
battle’. Parents who described feelings of losing control, or that services held the power to 
affect positive change for their child (external attributions of control) also reported feeling 
“helpless”. Parents perceived they “should have fought harder” to gain recognition for their 
child’s difficulties. Alternatively, one mother who believed she could help her child, through 
advocacy or teaching social and educational skills (internal controllability) was accepting of 
the outcome, despite her hope for a formal diagnosis. This finding is important, particularly 
when no diagnosis is given, because if professionals promote parent-directed interventions, it 
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may reduce parental helplessness and enhance their acceptance of the outcome. Whilst, these 
links highlight the importance of recognising parents’ attributions, further exploration is 
warranted. This would facilitate a better understanding of their beliefs, experiences and 
decision-making relevant to ASD.  
 The literature review indicated numerous factors which affect parental beliefs. These 
included, new cultural influences (Ravindran & Myers, 2012), the media (Chen et al., 2015) 
and perceived intervention success (Alqahtani, 2012). However, as these studies were cross-
sectional, longitudinal research is warranted. Moreover, psychological models such as the five-
stage model of grief (Kubler-Ross, 1970) and the cognitive adaptation model (Taylor, 1983) 
propose that parents are likely to experience several ‘stages’ before accepting or adjusting to 
their child’s diagnosis. Therefore, exploring time since diagnosis in relation to parental beliefs 
and to understand their post-assessment reaction is crucial. For example, the Kubler-Ross 
(1970) grief model, which consists of five stages “denial, anger, bargaining, depression and 
acceptance” (Watson, Hayes & Radford-Paz, 2011, pg. 47) was first related to parents of 
children with ASD by Huber (1979). Huber described that upon first noticing differences in 
their child’s development compared to their peers, parents typically make excuses for atypical 
development (denial). As they process the realisation that their child is different, they enter the 
anger phase. Parents blame themselves, each other or project this towards external influences 
such as vaccines. Bargaining begins when parents seek professional advice in the hope of 
accessing support and intervention. Following this, they experience a sense of loss as they 
realise that they must accept the situation and uncertainties of the future, leading to a period of 
depression. During the acceptance phase, parents may be more open to considering multiple 
causes beyond their control or knowledge and for those who did not receive a diagnosis, 
relinquish the battle. Improved understanding about whether parents’ beliefs or reactions to the 
assessment change according to their stage of acceptance is important. With this awareness 
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professionals could tailor advice regarding evidence-based interventions and be better 
informed about appropriate timeframes to offer a post-assessment consultation, as 
recommended in the empirical paper. 
 Ultimately both papers demonstrate the importance of professional’s investing time 
with parents to develop a good rapport based on mutual respect, trust and openness. The 
empirical paper highlighted that some parents perceived they had to battle with professionals 
and services rather than work alongside them, whilst the literature review found that parents 
who felt that professionals had disregarded their views were dissatisfied with the process 
(Jegatheesan et al., 2010). However, further research regarding specific factors associated with 
positive parent-professional interactions would be useful to guide future communication. 
 Culture and socio-demographic variables were raised as important factors in the 
literature review as they are influential on parents’ beliefs, interactions with professionals, 
treatment and family planning decisions. Although the review provided useful information, 
further questions remain and the following areas are recommended for future research, and 
especially to improve professional’s cross-cultural awareness.  
 Further exploration of the impact of private health insurance on parents’ beliefs and 
assessment experiences, as this was only explored in brief by Zuckerman, Lindly and 
Sinche (2016). 
 The perceptions of fathers and parents of girls, as they were consistently under-
represented in both the literature review and the empirical paper. Whilst the inclusion 
of fewer girls reflects current prevalence rates (Lai, Lombardo, Auyeung, Chakrabarti 
& Baron-Cohen, 2015), symptoms often manifest differently in females, leading to later 
diagnosis (Begeer et al., 2013), and thus may influence parents’ perceptions of the 
assessment process.  
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 Further insight into the direct impact of socio-demographic variables on parents’ 
experience. For example, it would be useful to apply a mixed methods approach to 
explore the association between socio-demographic variables and factors such as 
assessment satisfaction, etiological beliefs or future expectations, whilst maintaining a 
qualitative component to understand their lived experience.  
Finally, the aim of this research was to increase our understanding of assessment experiences 
when a diagnosis is not given and parents’ etiological beliefs. Whilst this has to some extent 
been achieved, it also raised awareness of further areas of uncertainty. For example, although 
some of the empirical findings are consistent with the experiences of families who received a 
diagnosis, there has been no direct comparison between parents who do and do not receive a 
diagnosis from the same service. This would serve as a useful measure to identify whether 
perceptions differ according to the outcome. Similarly, as different services use different 
diagnostic methods, it is important to determine whether the assessment method impacts on 
parents’ satisfaction and trust in the outcome. Furthermore, it would be useful to understand 
professionals’ perceptions about the assessment process. Specifically, their perceived 
competency in engaging families to discuss their etiological beliefs and expectations, providing 
evidence-based information in line with these beliefs, and sharing a non-diagnosis. These 
insights would compliment the current findings, identify training and supervision needs and 
future contribute to standardised best practice protocols. 
 
Clinical Implications 
  
The findings of both papers highlight important clinical implications, which aim to improve 
professional knowledge and practice within ASD teams and enhance the assessment experience 
for families and young people. To make recommendations for best practice based on the 
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findings, the current National Institute for Health and Clinical Excellence (NICE) guidelines 
for the recognition, referral and diagnosis of ASD in young people under the age of 19 (NICE, 
2011) must be considered. 
The NICE guidelines state that services should establish effective pathways for 
improved symptom recognition and referral, assessment should commence within three months 
of the referral and a case coordinator should be allocated. Furthermore, clinicians should 
possess the skills and competencies to conduct a thorough assessment, including an in-depth 
understanding of the families’ concerns, and be able to sensitively feedback the outcome along 
with a needs-based management plan. If uncertainties arise, a period of watchful waiting or a 
second opinion should be considered. The guidelines also advocate for good patient-
professional communication and the provision of evidenced-based information appropriate to 
families’ needs and choices.  
The current findings evidence examples of poor adherence to these recommendations 
along with important factors for inclusion in future guidelines. The relevant implications and 
recommendations for revisiting or updating the guidelines will be discussed using individual 
subheadings. 
 
Professional Training 
The development of a strategic approach to professional training will improve clinical 
competence and compliance to guidelines, enhancing the delivery of high quality standardised 
assessments. To achieve this, autism specific modules should be incorporated into 
professionals’ pre-qualification training. Furthermore, to address the issues detailed in the 
empirical theme ‘understanding the outcome’, a key element of such training should focus on 
the sensitive delivery of assessment outcomes. Medical professionals receive training in the 
breaking of bad news protocol, defined as delivering “any information that is not welcome” 
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(Arber & Gallagher, 2003). Based on this definition, bad news is dependent on the families 
hopes for the assessment outcome, which can be established during pre-assessment counselling 
and is relevant when a diagnosis is or is not given. 
 The literature review highlighted that a person’s culture can influence their etiological 
views, treatment choices and their own well-being when caring for a child with autism (Al-
Dababneh et al., 2016). Therefore, professionals must embrace a strong awareness of cultural 
diversity and the potential associated implications. Correspondingly, culture should be a 
component included in professionals training and reviewed regularly with families, as cultural 
influences are fluid and adapt according to new information (Ravindran & Myers, 2012). 
Correspondingly, NICE guidelines should be updated to stipulate that practitioners need to be 
cross-culturally competent.  
 In addition, ongoing opportunities for continuing professional development are 
essential for clinicians to remain aware of the latest evidence-based practice. The development 
of peer-supervision or expert reference groups could also be beneficial for ongoing skill 
development, complex case discussion, reflection, building a professional identity and the 
sharing of best practice locally (Newman, Nebbergall & Salmon, 2013).   
 The literature review revealed the long-lasting impact media can have on parents’ 
perceptions, regardless of new claims. For example, following the vaccine-autism link, parents 
continue to believe vaccines caused their child’s autism regardless of the claim being 
discredited (Bazzano et al., 2012). Therefore, a further necessary implication is the need for 
professionals to be aware of autism related media and counteract unfounded claims with 
evidence-based information. Additionally, researchers have a responsibility to present 
scientifically valid, robust and peer-reviewed findings. 
 Waiting times was one aspect which contributed to the parents’ view of the process as 
an ‘unrelenting battle’. In some cases, parents reported having waited over a year for 
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assessment, which exceeds the NICE recommendation and must be addressed. Autism Achieve 
Alliance (2014) found that receiving thorough information about the young person prior to 
assessment reduced waiting times. This finding suggests implications for the wider training of 
other professionals, such as GPs and education services in making comprehensive referrals.  
 
Pre and Post Assessment Counselling 
 Both papers advocate the need for comprehensive assessments and improved 
communication with parents to gain a deeper understanding of their concerns and perceptions 
of their child’s difficulties. This could be addressed by considering pre and post assessment 
counselling, which as discussed within the empirical paper has been shown to be successful in 
dementia services (La Fontaine, Buckell, Knibbs & Palfrey, 2014). This is supported by the 
recent introduction of pre and post diagnostic counselling in adult ASD services across Wales 
(Betsi Cadwaladr University Health Board, 2012). However, there is currently no such 
provision for younger service users. Although services are under pressure to provide quicker 
assessments, it was concluded that gaining thorough pre-assessment information might 
expedite the process. In addition, pre and post assessment work could be provided by other 
team members, such as neurodevelopmental support workers or assistant psychologists, thus 
creating capacity for clinicians to provide assessments. Good team communication is necessary 
so that information is shared appropriately to inform the assessment and outcome. 
 During pre-assessment work the focus should be to obtain young peoples’ and parents’ 
concerns and beliefs about their difficulties. A possible diagnostic outcome, its advantages and 
disadvantages, as well as the absence of reaching a diagnosis should be discussed and 
information detailing the process and waiting times provided. By managing parents’ 
expectations, we can alleviate pre-assessment anxiety, allowing parents to present their 
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concerns and formulate questions. Mockett, Khan and Theodosiou (2011) found that the 
provision of such pre-assessment information positively impacted on parental satisfaction. 
 During post-assessment work, the impact of the diagnosis or lack of diagnosis should 
be discussed. Regardless of the outcome, reference to the bio-psycho-social model (Engel, 
1980) is important during this discussion in order to adhere to the NICE recommendations of 
developing a needs-based management plan. Therefore, rather than subscribing purely to the 
medical model of diagnosis, a formulation of the child’s strengths and difficulties subsequent 
to the assessment is essential. This should be shared with relevant professionals and could 
contribute to the child’s pupil profile to highlight that whilst a diagnosis was not given, the 
child presented with behaviours that warranted professional assessment. 
 Pre and post assessment discussions should focus on making the family equal partners 
in the process. As highlighted in the literature review, professionals should be culturally 
sensitive and aware of factors influencing parents’ decisions, including their religious views, 
beliefs, socio-economic status and academic ability. Furthermore, specific consultation about 
their beliefs in relation to these factors are important, as they can impact on the parent-
professional relationship, maternal well-being, decisions for treatment and future family 
planning. Regardless of whether a diagnosis is given, professionals should also enquire about 
current or intended treatment use, including CAM treatments, and provide evidence-based 
information where appropriate. 
 Post-assessment work could be informed by the principles of Acceptance and 
Commitment Therapy (ACT; Hayes & Lillis, 2012). This would help parents to manage the 
outcome and accept any associated uncertainty to enable them move forward and to manage 
worries about the future. Lastly, parents should be informed of alternative services along with 
the pathway to re-accessing support from the assessment service following discharge. 
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Needs-led Service Provision 
 Services should be needs-led rather than diagnosis-led. Parents within the empirical 
research were ambivalent about their child not receiving a diagnosis. For some this was 
particularly challenging as they believed that without diagnosis, the child could not access 
appropriate support. This replicates findings from a recent document titled ‘The autism 
diagnosis crisis’ (National Autistic Society, NAS, n.d). The document highlights that without 
the correct support young people may develop mental health difficulties and consequently 
require additional support. Therefore, based on the recommendation for a formulation or needs-
based plan, young people should be able to access services regardless of diagnosis.   
 
Policy Development 
 The empirical research highlighted that many parents experienced uncertainty in the 
outcome. Examples included the perceived lack of consistency between professional opinions, 
or acknowledgement that the child presented some symptoms that parents interpreted as 
confusing or would eventually lead to diagnosis. This was expressed through the themes ‘lack 
of closure’ and ‘the future’. However, as previously mentioned, the NICE guidelines state that 
if there is any uncertainty subsequent to the assessment the child should be monitored or a 
second opinion sought. It is hoped that the other recommendations will improve assessment 
satisfaction, trust in the outcome and access to support regardless of diagnosis. However, a 
policy stating the appropriate pathways to seek a second opinion or reassessment is still 
required, and should be accessible to both professionals and parents as this is currently unclear 
within North Wales. This is particularly important as some parents in the empirical research 
were “too angry” or did not know who contact with questions or concerns following the 
assessment outcome. Additionally, services should provide clear advice about the advantages 
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and disadvantages of accessing private centres to seek a second opinion and should be 
transparent about whether they will accept a private diagnosis. 
 
Ongoing Audit and Evaluation 
 A critical aspect of implementing service improvements, as documented within the 
NICE guidelines, is the need for ongoing audit and evaluation. The empirical findings advocate 
the need for service users and their families to be part of this process. Whilst this may need to 
be conducted on a smaller scale than the current research, due to time and resource restraints, 
continued investment is vital. This is supported by a recent document, ‘The life we choose: 
shaping autism services in Wales’ (NAS, 2011). This document recognises that without 
continued investment to improve services, families will continue to perceive the process as a 
‘battle’, and their level of need will escalate, creating more pressure on costly services and 
interventions. 
 
Personal Reflections 
Reflection is a fundamental component in interpretative phenomenological analysis (IPA) 
research and in general clinical practice. Keeping a reflective journal throughout the process 
promoted self-awareness by allowing me to track my thoughts and feelings about the research. 
This helped me to remain focused, identify knowledge gaps and celebrate moments of 
achievement which may otherwise have been taken for granted amidst the demanding research 
schedule. The journal was particularly invaluable during the analysis as IPA utilises the 
principle of double hermeneutics (the researcher interpreting the interpretations of the 
participant). Acknowledging my own thoughts and preconceptions minimised bias and enabled 
me to concentrate predominantly on the participants’ experience.   
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 During my current training and previous clinical work with families and in specialist 
autism services, I have become passionate about gaining a deeper understanding of the 
experiences of families affected by neurodevelopmental conditions. I hoped that this research 
would allow me to further my own understanding whilst highlighting two areas of autism, 
which are currently under-researched yet have great clinical importance if families are to 
receive highly quality care. I was however aware that as a result of this previous work and 
witnessing the challenges faced by families with children with autism, I believed that families 
who did not receive the lifelong diagnosis would react positively. Using supervision to explore 
this preconception was essential and enabled me to remain mindful of this during the interview 
and analytic process. 
 Whilst conducting the research, I also commenced a clinical placement within the 
recruiting Neurodevelopmental team. This was useful as it provided me with knowledge of the 
service and assessment protocols, which helped me to understand the parents’ journey. Whilst 
this facilitated my rapport with some parents during the interviews, I was aware of the potential 
for a perceived power-imbalance and that this may have simultaneously limited parents’ 
honesty in sharing all aspects of their experience. To overcome this, I explained my role to 
participants, the purpose of the research, and emphasising the importance of feedback and 
confidentiality reassured them that the level of care they receive would not be impacted upon. 
Another challenge arising from my dual role as team member and researcher was that 
colleagues were interested in the feedback of families who they had contacted to participate. 
Whilst they were aware of confidentiality, I wanted to avoid concerns about the findings being 
a critical reflection on them or the service. Therefore, I shared the aims of the research with the 
team and valued time with them to reflect on the benefits of receiving feedback. 
 Conducting this research was my first exposure to qualitative analysis. I was keen to 
utilise the opportunity to broaden my research skills and this method was well suited to the 
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research objective. However, given the enormity and the importance of the research, personally 
and for contribution to the body of knowledge, this initially caused apprehension. I was aware 
of the expectation to gather rich data and represent the mutual experiences of each participant, 
rather than finding one objective truth as I was used to in quantitative research. Initially, this 
uncertainty was anxiety-provoking, but as the interviews commenced I was eager to understand 
parents’ journeys and develop themes which accurately encapsulated their experience.   
 Being genuinely interested in parents’ experiences presented a challenge during 
preliminary interviews, as some parents predominantly described the process of their child’s 
difficulties rather than their feelings about this. With the pressure to gain data that was rich 
enough, I initially felt disheartened when transcribing the interview, as I felt I had neglected 
opportunities to gain a deeper insight into their experience. However, reflecting on this, 
attending IPA training and liaising with other IPA researchers was invaluable as this reaffirmed 
the principles of IPA. I also learnt to use effective prompts to facilitate parents to reflect on 
their own interpretation of their experience. Another aspect I became aware of during 
transcription was how my feelings and interpretations altered slightly from the interview to 
listening back to the interview. In the interview, I built a rapport with parents and observed the 
non-verbal communication and emotions that accompanied their story. However, listening 
back to the interviews without these visual cues I connected more to the words rather than the 
individual. I remained mindful and reread my reflective journal several times during analysis. 
 A further consideration which arose during the interviews was the impact of parents’ 
reactions. The interviews were highly emotive, however using the skills I have learnt 
throughout clinical training I felt able to manage difficult situations confidently. Yet, at times 
I felt the urge to adopt the therapeutic role I was used to. For example, wanting to validate 
parents’ concerns yet challenge their self-critical beliefs or statements. Whilst this was 
frustrating, the awareness enabled me to focus on the researcher role and associated objectives. 
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 One parent asked whether I was a mother myself. I wondered about the intention behind 
the question. Was it simply curiosity? Was it because she felt I had not responded in an 
empathic manner? Or was it perhaps because regardless of my response the fact that I am not 
a mother, or more specifically a mother to a child with autistic traits, she felt I could never truly 
comprehend her situation? After much consideration and reflection on this during supervision, 
I determined that the importance of my role as a researcher was not be accepted by parents 
through sharing their experience, but to represent their experiences in order to support service 
development. 
 Another important reflection was the impact of hearing examples of substandard 
treatment, such as parents having waited years for assessments or perceiving the process as a 
battle. I felt disappointed for both the parent and for my colleagues who work exceptionally 
hard to provide a quality and timely service.  
 The analysis phase was both challenging and rewarding. As previously mentioned I 
was aware of my thoughts, feelings and of how my time working within the team could 
potentially influence my interpretation of the findings. This awareness along with the need to 
remain close to the data initially prevented me from having the courage to make meaningful 
interpretations, as I did not want to lose essence of what each individual was saying. 
Particularly during the cross-case analysis phase I noticed I was quite rigid in not wanting to 
abandon certain themes. However, to ease this process I adopted a creative approach by 
displaying potential themes on strips of coloured paper across a large storyboard. This approach 
afforded me the flexibility to review and change the themes until I felt satisfied that the chosen 
themes best reflected participants’ stories. Although I was anxious about my final commitment 
to these themes, I was excited to have completed this phase of the analysis, as I was one step 
closer to representing their story and hopefully making meaningful contributions to clinical 
practice.  
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 I was acutely aware of the value of qualitative research in the importance of each 
person’s experience, unlike quantitative research whereby the individual simply becomes a 
number in a dataset. Consequently, I developed a strong attachment to parents’ quotes and 
wanted to include everything they said. Whilst I appreciated the need to summarise the findings 
concisely, I found it difficult to decipher which quotes best illustrated the chosen themes. 
Incorporating reflection time and reconsidering the quotes at later date provided clarity and 
affirmed my interpretations of the findings and their clinical implications. However, I reflected 
upon how participants would feel if they were to read the quotes I had selected and whether 
they felt I had done them justice.  
 As the research came to an end and I wrote about the implications derived from both 
papers, I reflected on the huge sense of accomplishment. As someone who has previously 
questioned my own research ability, I was struck not only by the skills I had gained but how 
much I had enjoyed the challenge of the process. This, along with my passion to further 
contribute to improved service provision for both families and professionals, has fuelled my 
desire to continue this research journey as I transition into my role as a Clinical Psychologist. 
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Health and Care Wales Research Ethics Committee Provision Approval 
 
 
 
 
 
 
 
 
Gwasanaeth Moeseg Ymchwil Research Ethics Service 
 
Pwyllgor Moeseg Ymchwil Cymru 5  
Wales Research Ethics Committee 5 
Bangor 
Clinical Academic Office Ysbyty Gwynedd Hospital 
Betsi Cadwaladr University Health Board 
Bangor, Gwynedd 
LL57 2PW 
Telephone/ Facsimile: 01248 - 384.877  
Email:   Rossela.Roberts@wales.nhs.uk  
Website : www.nres.nhs.uk 
21st May 2016 
 
Miss Lesley-Anne Bendik Trainee Clinical Psychologist 
North Wales Clinical Psychology Programme School of Psychology 
Bangor University, Bangor, Gwynedd 
LL57 2DG psp511@bangor.ac.uk 
 
Dear Miss Bendik, 
 
Study title: Parents experiences of the Autistic Spectrum Disorder assessment process when the child did 
not receive a diagnosis. REC reference: 16/WA/0164 Protocol number: Bangor university: 1568 IRAS 
project ID: 201170 
 
The Research Ethics Committee reviewed the above application at the meeting held on 19 May 2016. 
 
Provisional opinion: The Committee would be content to give a favourable ethical opinion of the research, 
subject to receiving a complete response to the request for further information set out below. Authority to 
consider your response and to confirm the Committee’s final opinion has been delegated to the Chair. Further 
information or clarification required 
 
In the Protocol 
 
1. The protocol should include information on the process in place to handle incidental disclosures of 
abuse/malpractice. 
 
2. The Committee requested that the opt-out process is changed to opt-in and participants should be 
asked to complete the form or confirm in an email, by telephone or by post, that they are willing to 
be approached by the researcher to discuss their potential participation in the research project. 
 
In the Participant Information Sheet and Consent Form 
 
1. The letter of Invitation to Participants should be amended to reflect the opt-in process as described 
above. 
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2. The Information Sheet should explain how incidental disclosures of abuse or malpractice will be 
handled, and explicit consent should be sought to breach confidentiality to action those disclosures 
which do not carry a Statutory Duty to report. 
 
3. The paragraph “What are the possible benefits of taking part” should identify a direct benefit to the 
participant aside from the £10 remuneration. If no direct benefit can be identified, the paragraph 
should clarify that there are no direct benefits to the participant. 
 
4. The paragraph “What will happen if I do not want to carry on with the study?” should also clarify 
whether the £10 remuneration will still be paid if the participant withdraws. 
 
5. In paragraph “What is the purpose of the study?” the wording “young person has been given a 
positive diagnosis”, should be replaced with “a diagnosis of ASD” 
 
If you would find it helpful to discuss any of the matters raised above or seek further clarification from a 
member of the Committee, you are welcome to contact Dr Rossela Roberts, RES Manager, using the contact 
details in the letterhead. 
 
When submitting a response to the Committee, the requested information should be electronically submitted 
from IRAS.  A step-by-step guide on submitting your response to the REC provisional opinion is available 
on the HRA website using the following link: http://www.hra.nhs.uk/nhs-research-  ethics-committee-rec-
submitting-response-provisional-opinion/ 
 
Please submit revised documentation where appropriate underlining or otherwise highlighting the changes 
which have been made and giving revised version numbers and dates. You do not have to make any changes 
to the REC application form unless you have been specifically requested to do so by the REC. 
 
The Committee will confirm the final ethical opinion within a maximum of 60 days from the date of initial 
receipt of the application, excluding the time taken by you to respond fully to the above points. A response 
should be submitted by no later than 20 June 2016. 
 
Summary of the discussion at the meeting 
 
Ethical issues raised by the Committee: 
 
Care and protection of research participants; respect for participants’ welfare and dignity;    data 
protection and confidentiality 
The Committee discussed the respect for potential and enrolled research participants’ welfare & dignity, 
the arrangements made to protect privacy through confidentiality and raised no issues. 
 
Data protection & research participant’s confidentiality 
The information governance aspects of the study were discussed, where and for how long will data be 
stored, and clarified who will have access to the data. 
The Committee concluded that the information about subjects will be appropriately handled, but 
requested that the protocol includes information on the process in place to handle incidental disclosures of 
abuse/malpractice, as per the Bangor University Policy / Procedure. 
 
Redress 
The Insurance and indemnity (negligent/ non-negligent harm) mechanism has been clarified and 
compensation arrangements are in place 
 
Trial Registration 
The Committee noted that the study will be registered on the Bangor University repository. 
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Informed Consent process and the adequacy and completeness of participant information 
The Committee discussed the provision of information to research participants about the purpose of the 
research, its procedures, potential risks, benefits, and alternatives, and whether it includes all procedures as 
described in the protocol. 
 
The Committee noted that written informed consent is taken as part of a process - with participants having 
adequate time to consider the information, and opportunity to ask questions. The language used is 
understandable to the research participants, the information is clear as to what the participant consents to, 
and there is no inducement or coercion. 
 
However, it was noted that participants are approached by the clinician (either in person or in 
correspondence) and they are required to compete an opt-out form if they do not wish to be contacted by 
the researcher with a view to be invited to take part in the research project; 
The Committee requested that the opt-out process is changed to opt-in and participants should be asked to 
complete the form or confirm or in an email, by telephone or by post  that they are willing to be approached 
by the researcher to discuss their potential participation in the research project. 
 
The Committee agreed that the procedures described in the protocol have been adequately addressed in the 
Information Sheet, but felt that minor amendments should be made to ensure that individuals understand 
the information and can make a voluntary informed decision to enrol and continue to participate. 
Information should be given on how incidental disclosures of abuse or malpractice will be handled, and 
explicit consent should be sought to breach confidentiality to act on those disclosures which do not carry a 
Statutory Duty to report. 
The paragraph “What are the possible benefits of taking part” should identify a direct benefit to the 
participant aside from the £10 remuneration. If no direct benefit can be identified, the paragraph should 
clarify that there are no direct benefits to the participant. 
The paragraph “What will happen if I do not want to carry on with the study?” should also clarify whether 
the £10 remuneration will still be paid if the participant withdraws. 
In paragraph “What is the purpose of the study?” the wording “young person has been given a positive 
diagnosis”, albeit technically correct, may imply to a lay person that this is the best outcome. The 
Committee requested that this is replaced with “a diagnosis of ASD” 
 
 
Other ethical issues were raised and resolved in preliminary discussion 
 
Based on the information provided, the Committee was satisfied with the following aspects of the 
research: 
 
 Social or scientific value; scientific design and conduct of the study 
 Recruitment arrangements and access to health information, and fair participant selection 
 Favourable risk benefit ratio; anticipated benefit/risks for research participants 
 Informed consent process Suitability of the applicant and supporting staff 
 Independent review 
 Suitability of supporting information 
 Other general issues 
 Suitability of the summary of the research 
 
 
The Committee identified issues with the following aspects of the research: 
 
 Care and protection of research participants; respect for participants’ welfare and dignity 
 The adequacy and completeness of participant information 
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Documents reviewed 
 
The documents reviewed at the meeting were: 
 
 
 
Membership of the Committee 
 
The members of the Committee who were present at the meeting are listed on the attached sheet No 
declarations of interest were made in relation to this application. 
 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees and complies fully with the Standard Operating Procedures for Research Ethics Committees 
in the UK. 
 
 
 
 
 
 
Yours sincerely 
 
 
 
Dr Jason Walker, MB BCh BAO, FRCA Vice-Chair 
 
  E-mail:  rossela.roberts@wales.nhs.uk 
 
 
Enclosure: List of names and professions of members who were present at the meeting and those who 
submitted written comments. 
Document Versio
n 
Date 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors only) 
[Evidence of Sponsor Insurance or indemnity (non-NHS sponsor only)] 
1 20 July 2015 
Interview schedules or topic guides for participants [Interview schedules or 
topic guides for participants] 
1 04 May 
2016 
IRAS Checklist XML [Checklist_12052016]  12 May 
2016 Letters of invitation to participant [Letters of invitation to participant] 1 04 May 
2016 Other [Other (Opt-Out Form)] 1 04 May 
2016 Other [Other (Telephone Protocol)] 1 04 May 
2016 Participant consent form [Participant consent form] 1 04 May 
2016 Participant information sheet (PIS) [Participant Information Sheet] 1 04 May 
2016 REC Application Form [REC_Form_12052016]  12 May 
2016 Research protocol or project proposal [Research Protocol or project 
proposal] 
1 04 May 
2016 Summ ry CV for Chief Investigator (CI) [Summary CV for Chief 
Investigator (CI)] 
1 04 May 
2016 Summary CV for supervisor (student research) [Summary CV for supervisor 
(student research)] 
1 04 May 
2016 
16/WA/0164 Please quote this number on all correspondence 
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Copy to: Sponsor: Mr Hefin Francis 
 School of Psychology 
Adeilad Brigantia, 
Penrallt Road 
Bangor 
LL572AS h.francis@bangor.ac.uk 
 
 
Academic Supervisor:   Dr Freya Spicer-White 
Clinical Psychologist 
Child Health Psychology Service Children's Outpatients 
Department  
Clan Clwyd Hospital,  
Rhyl Denbighshire 
LL18 5UJ Freya.Spicer-White@wales.nhs.uk 
 
 
R&D Office:    Miss Debra Slater  
Clinical Academic Office  
Ysbyty Gwynedd 
Bangor, LL57 2PW debra.slater@wales.nhs.uk 
 
 
 Wales Research Ethics Committee 5 Attendance at Committee meeting on 19 May 2016 
 
Committee Members in attendance 
 
 
 
  
Name Profession Capacity Present 
Dr Karen BE Addy Clinical Psychologist Expert Yes 
Dr Swapna Alexander Consultant Physician Expert Yes 
Mrs Kathryn Chester Research Nurse Expert No 
Ms Geraldine Jenson Retired College Vice-Principal Lay + No 
Mr Eliezer Lichtenstein Student Lay + Yes 
Dr Mark G Lord Consultant Pathologist Expert No 
Dr Pamela A Martin-Forbes WCRW Research Officer Expert Yes 
Dr Paul G Mullins Reader, MRI Physicist Lay + No 
Mr VishwanathPuranik Associate Specialist ENT Surgeon Expert Yes 
Mrs Lynn C Roberts Matron, Emergency Department Expert No 
Dr Judith L Roberts Research Officer Expert Yes 
Mrs Rachel L Roberts-Jones Student Lay + Yes 
Dr Jason D Walker Consultant Anaesthetist (Vice-Chairman, in the 
Chair) 
Expert Yes 
Dr Philip W White General Practitioner (Chairman) Expert No 
Ms Sydna A Williams Lecturer Lay + Yes 
Dr Rossela Roberts Clinical Governance Officer / RES Manager 
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Appendix B (continued) 
 
Amendments: Researcher Response to the Researcher Health and Care Wales Research 
Ethics Committee 
 
 
Response to request for further information (New Document) 
09/06/2016 
IRAS ID: 201170 - Ref: 16/WA/0164 
Bangor University Ethics Application Number: 15685 
Experiences of the ASD Assessment when a diagnosis is not received 
 
 
Response to request for further information 
 
 
Thank you for your recent letter regarding my research ethics application. I have addressed all of the 
amendments detailed in your letter and have provided a summary of these below. These amendments can 
also be viewed as ‘tracked changes’ in new versions of the supporting documents, as requested in your letter.  
 
Research Protocol or Project Proposal v2: 
 The opt-out process has been changed to an opt-in process. 
 Information on the process to handle incidental disclosures of abuse/malpractice has been included.  
 Clarification that the participant will still receive the £10 voucher regardless of whether they 
withdraw from the study has been included. 
 
Participant Information Sheet (PIS) v2: 
 The wording “young person has been given a positive diagnosis” has been replaced with “a 
diagnosis of ASD”.  
 The opt-out process has been changed to an opt-in process. 
 Information on the process to handle incidental disclosures of abuse/malpractice has been included.  
 Clarification that the participant will still receive the £10 voucher regardless of whether they 
withdraw from the study has been included. 
 Information that the participant will receive no direct benefits from participating in the study is 
stated. 
 
Participant Consent Form v2 
 Explicit consent to breach confidentiality in the event that disclosures of abuse or malpractice are 
made has been included. 
 
Letters of Invitation to participant v2 
 The opt-out process has been changed to an opt-in process.  
 
Opt-in Form (New Document) 
 The opt-out form has been replaced by an opt-in form, which details that individuals can opt-in to 
being contacted by the researcher to discuss their potential participation by post, email or telephone.  
 
I hope these amendments are satisfactory. Upon confirmation of the decision, if the amendments are 
satisfactory, all tracked changes will be accepted prior to printing. 
  
Yours Sincerely,  
Ms Lesley-Anne Bendik (Principal Researcher).
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Appendix B (continued) 
 
Health and Care Wales Research Ethics Committee Final Approval 
 
 
 
Gwasanaeth Moeseg Ymchwil 
Research Ethics Service 
 
 
 
Pwyllgor Moeseg Ymchwil Cymru 5 Wales Research Ethics Committee 5 
Bangor 
Clinical Academic Office Ysbyty Gwynedd Hospital 
Betsi Cadwaladr University Health Board 
Bangor, Gwynedd 
LL57 2PW 
Telephone/ Facsimile: 01248 - 384.877  
Email: Rossela.Roberts@wales.nhs.uk 
 Website : www.nres.nhs.uk
19 June 2016 
 
Miss Lesley-Anne Bendik Trainee 
Clinical Psychologist 
North Wales Clinical Psychology Programme School of 
Psychology 
Bangor University, 
Bangor, Gwynedd 
LL57 2DG 
psp511@bangor.ac.uk 
 
Dear Miss Bendik, 
 
Study title: Parents experiences of the Autistic Spectrum Disorder assessment 
process when the child did not receive a diagnosis. 
REC reference: 16/WA/0164 
Protocol number: Bangor university: 1568 
IRAS project ID: 201170 
 
Thank you for your letter of 13 June 2016, responding to the Committee’s request for further information on the 
above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, together with your 
contact details. Publication will be no earlier than three months from the date of this opinion letter. Should you 
wish to provide a substitute contact point, require further information, or wish to make a request to postpone 
publication, please contact the REC Manager, Dr Rossela Roberts, rossela.roberts@wales.nhs.uk. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on the 
basis described in the application form, protocol and supporting documentation as revised, subject to the 
conditions specified below Conditions of the favourable opinion 
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The REC favourable opinion is subject to the following conditions being met prior to the start of the study. 
 
 
Management permission must be obtained from each host organisation prior to the start of the study at the site 
concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in accordance with 
NHS research governance arrangements. Each NHS organisation must confirm through the signing of agreements 
and/or other documents that it has given permission for the research to proceed (except where explicitly specified 
otherwise). 
 
Guidance on applying for NHS permission for research is available in the Integrated Research Application System, 
www.hra.nhs.uk or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential participants to 
research sites ("participant identification centre"), guidance should be sought from the R&D office on the 
information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the procedures of the 
relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on a publically 
accessible database within 6 weeks of recruitment of the first participant (for medical device studies, within the 
timeline determined by the current registration and publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the earliest opportunity e.g. when 
submitting an amendment. We will audit the registration details as part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but for non-clinical trials 
this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. Guidance on where to 
register is provided within IRAS. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with before the start of the study 
or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management permission being 
obtained from the NHS/HSC R&D office prior to the start of the study (see "Conditions of the favourable 
opinion"). 
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Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document Versi
on 
Date 
REC Application Form [REC_Form_12052016] - 12 May 2016 
Other [Response for request for further information] 1 09 June 2016 
Research protocol or project proposal 2 09 June 2016 
Letters of invitation to participant 2 09 June 2016 
Other [Opt in form] 1 09 June 2016 
Participant information sheet 2 09 June 2016 
Participant consent form 2 09 June 2016 
Other [Telephone Protocol] 1 04 May 2016 
Interview schedules or topic guides for participants 1 04 May 2016 
Summary CV for Chief Investigator 1 04 May 2016 
Summary CV for supervisor 1 04 May 2016 
Evidence of Sponsor insurance or indemnity - 20 July 2015 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics Committees 
and complies fully with the Standard Operating Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed guidance on reporting 
requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes in reporting 
requirements or procedures. 
 
User Feedback 
 
The Health Research Authority is continually striving to provide a high quality service to all applicants and 
sponsors. You are invited to give your view of the service you have received and the application procedure. If you 
wish to make your views known please use the feedback form available on the HRA website:  
 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance
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HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days – see details at  
http://www.hra.nhs.uk/hra-training/ 
 
 
 
With the Committee’s best wishes for the success of this project.  
Yours sincerely 
 
 
 
 
 
Dr Philip Wayman White,  
MBChB, MRSM Chair 
E-mail: rossela.roberts@wales.nhs.uk 
 
 
Enclosure: “After ethical review – guidance for researchers” 
 
 
 
Copy to: Sponsor: Mr Hefin Francis 
 School of Psychology 
Adeilad Brigantia, 
Penrallt Road 
Bangor 
LL572AS 
h.francis@bangor.ac.uk 
 
 
Academic Supervisor: Dr Freya Spicer-White 
Clinical Psychologist 
Child Health Psychology 
Service Children's 
Outpatients Department 
Clan Clwyd Hospital, 
Rhyl Denbighshire 
LL18 5UJ 
Freya.Spicer-White@wales.nhs.uk 
 
 
   R&D Office:    Miss Debra Slater 
       Clinical Academic Office 
       Ysbyty Gwynedd 
       Bangor 
       LL57-2PW 
       Debra.Slater@wales.nhs.uk  
 
  
Please quote this number on all correspondence 
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Appendix C 
 
Bangor University School of Psychology Ethics Committee Email Approval 
 
 
Ethical approval granted for 2016615685 Parents Experiences of the 
Autistic Spectrum Disorder Assessment Process when the Diagnosis is Negative. 
 
ethics@bangor.ac.uk 
Mon 04/04/2016 10:06 
 
To: Lesley-Anne Bendik <psp511@bangor.ac.uk>; 
 
 
Dear Lesley-Anne, 
 
2016615685 Parents Experiences of the Autistic Spectrum Disorder Assessment Process when the 
Diagnosis is Negative. 
 
Your research proposal number 2016615685 has been reviewed by the Psychology Ethics and Research 
Committee and the committee are now able to confirm ethical and governance approval for the above 
research on the basis described in the application form, protocol and supporting documentation. This 
approval lasts for a maximum of three years from this date. 
 
Ethical approval is granted for the study as it was explicitly described in the application. 
 
If you wish to make any non-trivial modifications to the research project, please submit an amendment 
form to the committee, and copies of any of the original documents reviewed which have been altered 
as a result of the amendment. Please also inform the committee immediately if participants experience 
any unanticipated harm as a result of taking part in your research, or if any adverse reactions are 
reported in subsequent literature using the same technique elsewhere. 
 
 
https://outlook.oﬃce.com/owa/?viewmodel=ReadMessageItem&…%2FOmAAFyxfDFAAA%3D
&IsPrintView=1&wid=13&ispopout=1&path= 
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Appendix D 
 
Betsi Cadwaladr University Health Board Research and Development Committee 
Approval 
 
 
 Panel Arolygu Mewnol Y&D 
 R&D Internal Review Panel 
Betsi Cadwaladr University Health Board 
Ysbyty Gwynedd  
Clinical Academic Office Bangor,  
Gwynedd 
LL57 2PW 
 
Chairman/Cadeirydd – Dr Nefyn Williams PhD, FRCGP 
Email: rossela.roberts@wales.nhs.uk  
debra.slater@wales.nhs.uk 
 sion.lewis@wales.nhs.uk  
Tel/Fax: 01248 384 877 
 
Miss Lesley-Anne Bendik 
North Wales Clinical Psychology Programme School of Psychology 
Bangor University Bangor 
LL572DG  
psp511@bangor.ac.uk 
 
Dear Miss Lesley-Anne Bendik 
Re: Confirmation that R&D governance checks are complete / R&D approval granted 
Study Title Experiences of the ASD Assessment when a diagnosis is not received 
IRAS reference 201170 
REC Reference 16/WA/0164 
 
The above research project was reviewed at the meeting of the BCUHB R&D Internal Review 
Panel 
 
Thank you for responding to the Panel’s request for further information. The R&D office 
considered the response on behalf of the Panel and is satisfied with the scientific validity of the 
project, the risk assessment, the review of the NHS cost and resource implications and all other 
research management issues pertaining to the revised application. 
 
The Internal Review Panel is pleased to confirm that all governance checks are now complete 
and to grant approval to proceed at Betsi Cadwaladr University Health Board sites as described 
in the application. 
 
The documents reviewed and approved are listed below 
Document: Version: Date: 
R&D Form V5.3.1 14/07/2016 
SSI Form V5.3.1 14/07/2016 
Protocol V2 09/06/2016 
Information sheet V2 09/06/2016 
Consent Form V2 09/06/2016 
OPT-in form V1 09/06/2016 
Invitation letter V2 09/06/2016 
Telephone protocol V1 04/05/2016 
Interview guide V1 04/05/2016 
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The study should not commence until the Ethics Committee reviewing the research 
has confirmed final approval (‘favourable opinion’). 
 
All research conducted at the Betsi Cadwaladr University Health Board sites must 
comply with the Research Governance Framework for Health and Social Care in 
Wales (2009).  An electronic link to this document is provided on the BCUHB R&D 
WebPages. Alternatively, you may obtain a paper copy of this document via the R&D 
Office. 
 
Attached you will find a set of approval conditions outlining your responsibilities 
during the course of this research. Failure to comply with the approval conditions will 
result in the withdrawal of the approval to conduct this research in the Betsi 
Cadwaladr University Health Board. 
 
If your study is adopted onto the NISCHR Clinical Research Portfolio (CRP), it will be 
a condition of this NHS research permission, that the Chief Investigator will be 
required to regularly upload recruitment data onto the portfolio database. To apply 
for adoption onto the NISCHR CRP, please go to: 
http://www.wales.nhs.uk/sites3/page.cfm?orgid=580&pid=31979. Once adopted, 
NISCHR CRP studies may be eligible for additional support through the NISCHR 
Clinical Research Centre. Further information can be found at:  
http://www.wales.nhs.uk/sites3/page.cfm?orgid=580&pid=28571 and/or from your 
NHS R&D office colleagues. 
 
To upload recruitment data, please follow this link:  
http://www.crncc.nihr.ac.uk/about_us/processes/portfolio/p_recruitment.  Uploading 
recruitment data will enable NISCHR to monitor research activity within NHS 
organizations, leading to NHS R&D allocations which are activity driven. Uploading 
of recruitment data will be monitored by your colleagues in the R&D office. 
 
If you need any support in uploading this data, please contact 
debra.slater@wales.nhs.uk or  sion.lewis@wales.nhs.uk 
 
If you would like further information on any other points covered by this letter please 
do not hesitate to contact me. 
 
On behalf of the Panel, I would like to take this opportunity to wish you every 
success with your research. 
 
Yours sincerely, 
 
Summary CV: Bendik  04/05/2016 
Summary CV: Spicer-White  04/05/2016 
Evidence of Insurance (UMAL)  Expires 31/07/2017 
Risk Assessment  26/07/2016 
REC favourable opinion letter  19/06/2016 
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Dr. Nefyn Williams PhD, FRCGP Director of R&D 
 
Copy to: 
 
Sponsor: Hefin Francis Bangor University Bangor LL57 2AS 
  h.francis@bangor.ac.uk 
 
Academic Supervisor: Dr Freya Spicer-White Wrexham CAMHS PO Box 2073 
   Wrexham Maelor Hospital LL13 7ZA 
   Freya.Spicer@wales.nhs.uk 
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Appendix E 
 
Letter of Invitation 
 
 
 
 
 
Letter of Invitation to Participant 
 
Title of Project: Parents experiences of the Autistic Spectrum Disorder assessment 
process when the child did not receive a diagnosis. 
 
 
Dear Parent/Guardian, 
 
I am writing to tell you about a study being conducted within Betsi Cadwaladr University 
Health Board.  
 
My colleague, Lesley-Anne Bendik, is looking at parent’s experiences of their child going 
through an assessment for Autistic Spectrum Disorder (ASD) when the outcome did not 
result in a diagnosis. Following your child’s recent assessment, you would be eligible to 
take part in this research. I am not a member of the research team.  However, I am 
contacting some of my patients to let them know about the research in case they might 
be interested in learning more.  
 
It is important to know that this letter is not to tell you to join this study.  It is your 
decision.  Your participation is voluntary. Whether or not you participate in this study 
will have no effect on the care you receive from the NHS. 
 
I have enclosed some information for you to read about the study at your leisure.   
 
Once you have read the information, the researcher, Lesley-Anne Bendik, would like to 
contact you to ask whether you have any questions and to discuss your potential 
participation in the research in more detail. If you are happy for Lesley-Anne to contact you, 
please complete and return the opt-in form enclosed with this information.  
 
Alternatively, you can confirm your interest by email (psp511@bangor.ac.uk) or telephone 
(01978 725 242 – please ask for Lesley-Anne Bendik). If Lesley-Anne is unavailable via 
telephone, please leave a message with your name and contact number and she will get back 
to you as soon as possible.   
 
Thank you for taking the time to read this information,  
 
Yours Sincerely, 
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Llythyr Gwahoddiad i Gyfranwyr 
 
Teitl y Project: Profiadau rhieni o'r broses asesu Anhwylder Sbectrwm Awtistig pan na 
chafodd y plentyn ddiagnosis. 
 
 
Annwyl Riant/Gwarcheidwad, 
 
Rwy’n ysgrifennu atoch i sôn am astudiaeth a gynhelir ym Mwrdd Iechyd Prifysgol Betsi 
Cadwaladr.  
 
Mae fy nghydweithiwr, Lesley-Anne Bendik, yn edrych ar brofiadau rhieni o gael eu 
plentyn yn cael asesiad am Anhwylder Sbectrwm Awtistig (ASD) pan na chafwyd 
diagnosis ar y diwedd. Yn dilyn asesiad diweddar eich plentyn, byddech chi yn gymwys i 
gymryd rhan yn yr ymchwil hon. Nid wyf yn aelod o'r tîm ymchwil. Ond rwyf yn cysylltu 
â rhai o'm cleifion i roi gwybod iddynt am yr ymchwil rhag ofn y byddai ganddynt 
ddiddordeb mewn dysgu mwy.  
 
Mae'n bwysig ichi wybod nad llythyr i ddweud wrthych am gymryd rhan yn yr astudiaeth 
yw hwn. Eich penderfyniad chi ydyw. Eich dewis chi yw cymryd rhan neu beidio. Ni fydd 
cymryd rhan neu beidio yn yr astudiaeth hon yn cael unrhyw effaith o gwbl ar y gofal a 
dderbyniwch gan y GIG. 
 
Rwyf wedi amgáu gwybodaeth am yr astudiaeth i chi ei darllen yn eich amser eich hun.   
 
Unwaith ichi ddarllen y wybodaeth, hoffai'r ymchwilydd, Lesley-Anne Bendik, gysylltu â 
chi i ofyn a oes gennych unrhyw gwestiynau, ac i drafod y posibilrwydd o gymryd rhan 
yn yr ymchwil. Os ydych yn fodlon i Lesley-Anne gysylltu â chi, llenwch a dychwelwch y 
ffurflen gydsynio sydd ynghlwm wrth y wybodaeth hon, os gwelwch yn dda.  
 
Fel arall, gallwch gadarnhau eich diddordeb dros e-bost (psp511@bangor.ac.uk) neu ar y ffôn 
(01978 725 242 – gofynnwch am Lesley-Anne Bendik). Os nad yw Lesley-Anne ar gael ar y 
ffôn, gadewch neges gyda'ch enw a rhif cyswllt a bydd hi'n cysylltu â chi cyn gynted ag y bo 
modd.   
 
Diolch i chi am gymryd amser i ddarllen y wybodaeth hon.  
 
Yn gywir, 
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Appendix F 
 
Participant Information Sheet 
 
 
 
 
 
Participant Information Sheet 
 
Title of Project: Parents experiences of the Autistic Spectrum Disorder assessment 
process when the child did not receive a diagnosis. 
 
You are invited to take part in a research study being carried out by Bangor University 
and Betsi Cadwaladr University Health Board (BCUHB). The purpose of this information 
sheet is to tell you what the research is, why it is being carried out and what it will involve. 
It is important for you to understand this information before you choose to take part. 
Please read the information sheet and if you have any questions please email the principal 
researcher, Lesley-Anne Bendik  (psp511@bangor.ac.uk). If you would prefer talk on the 
phone, please email Lesley-Anne your contact details and she will get back to you.  
 
Research Team 
 Lesley-Anne Bendik (Trainee Clinical Psychologist). Lesley-Anne is currently 
employed by Betsi Cadwaladr University Health Board and is studying for a Doctorate 
in Clinical Psychology at Bangor University. This research will contribute to the thesis 
required to achieve the Doctorate in Clinical Psychology qualification.  
 Dr Freya Spicer-White (Lead Clinical Psychologist, Neurodevelopmental Team, East) 
is supervising this research.  
 
What is the purpose of the study? 
Previous research in the area of Autistic Spectrum Disorders (ASD) has looked at family 
member’s experiences of the ASD assessment process when the outcome is that their 
child or young person has been given a diagnosis of ASD. There is also research that looks 
at the experiences of these families after the diagnosis is given in terms of the support 
they are able to access. However, there is very limited research on the experience of the 
assessment process and of the support available afterwards to those who go through the 
same assessment process but for whom do not receive a diagnosis. This refers to 
occasions when the young person’s difficulties are not consistent with, or do not meet the 
criteria for, a diagnosis of ASD. 
 
The aim of the present study is to explore the experience of parents/guardians whose 
child/young person is assessed for ASD but who do not receive a diagnosis following the 
assessment. It is hoped that the outcome of this research will help clinicians understand 
how best they can support families through the assessment process. It is also hoped that 
the research will help services to improve their approach to providing good quality 
information and provide guidelines on how best to feedback a non-diagnosis to family 
members.  
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Why am I being invited to participate? 
We have invited any parents and/or guardians of young people aged 5-19 years who have 
been through the ASD assessment process within a Child and Adolescent Mental Health 
Service (CAMHS) in past 12 months and as a result, a diagnosis of ASD was not given. 
More than one family member can participate if they have been part of the assessment 
process.   
 
Do I have to take part? 
No. It is entirely your decision whether or not you want to take part in the research. You 
can withdraw from the study at any time without giving a reason. If you decide that you 
don’t want to take part or choose to withdraw from the study at any time, this will not 
affect the care you receive from any service within the NHS. 
 
What will happen if I/We decide to take part? 
This information sheet will have been given to you during your feedback appointment or 
sent to you in the post. Once you have read the information sheet and taken some time to 
think about it, the researcher, Lesley-Anne Bendik, would like to discuss the information 
with you in further detail and ask whether you have any questions.  If you are happy for 
Lesley-Anne to contact you to discuss your potential participation in the research, please 
complete the opt-in form provided and return this in the enclosed envelope. 
Alternatively, you can confirm this by telephone or email. Details of how you can do this 
can be found on the opt-in form.  
 
If you decide you would like to participate in the research, Lesley-Anne will arrange a 
convenient time to meet with you. The meeting will take place at the local CAMHS service 
where you attended for your assessment and feedback appointment. This is to ensure 
that the interview occurs in a place that you are familiar with and that will be quiet so 
you can talk about your experiences in private. More than one family member/guardian 
can participate if they have been involved in the assessment process. Please note in this 
situation, you will be invited to attend the interview together. 
 
When you meet with Lesley-Anne, she will ask you to read and sign a consent form. You 
will have the opportunity to ask Lesley-Anne any questions about the research before 
you sign the form. If you are happy to provide consent to take part, Lesley-Anne will ask 
you some questions about the age and gender of your child, your relationship to them 
and how long the assessment process has taken. She will then ask you some short 
questions about your experience of the process in an informal interview. Please be 
assured there are no right or wrong answers, and should you wish to not answer a 
question or stop the interview at any time this is okay.  
 
The same questions will be asked to all participants. These questions have been approved 
by the ethics committee at Bangor University and Betsi Cadwaladr University Health 
Board. Lesley-Anne will record all interviews on a digital audio recorder. This is to keep 
a record of the interview and help Lesley-Anne to listen to your experiences without 
interrupting you or writing notes.  
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The interview will take approximately 45-90minutes. You will be given the opportunity 
to have breaks during the interview if needed.   
 
What are the possible risks or disadvantages of taking part? 
We hope that this study will not cause you any distress. However, we are aware that 
sharing personal experiences can be difficult and on occasions can cause upset, stress or 
worry. If you feel upset or distressed at any point during the interview, it is important 
that you make Lesley-Anne aware. Lesley-Anne is a Trainee Clinical Psychologist and has 
the skills to manage difficult emotional responses. You are encouraged to say if there are 
questions that you do not want to answer or if you would like to stop the interview at any 
point.  
 
Should you feel upset or distressed during the interview or afterwards as a result of the 
interview, you are advised to talk to Lesley-Anne, who can sign post you access the 
appropriate support or to contact your GP.  
 
It is difficult to include all of the information you provide in the final results. Therefore, 
whilst some of your experiences may be included, this is not guaranteed as it can be hard 
to include everyone’s experiences. This does not mean that the experiences you share 
with us are not of great value.  
 
What are the possible benefits of taking part? 
You will not benefit directly from taking part in this research, however you may find it 
helpful or enjoyable to share your experiences. You may also find it enjoyable to be part 
of a research project that aims to understand and improve the experiences of people who 
go through the ASD diagnosis process. 
The research team would like to offer a token gesture of a £10 voucher to all participants 
for sharing their time and experiences to improve our professional knowledge and help 
us understand how we can improve patients and family members experience of the ASD 
assessment process in the future. As the interview will be held at your local CAMHS 
service, your travel expenses will be covered.  
 
Will my information be kept private and confidential? 
Yes. All the information that you share with Lesley-Anne will be kept private and 
confidential within the research team. There is one exception to this and that is if you 
disclose any information that you or any other person is directly or indirectly at risk of 
harm, or causing harm to others. In this circumstance, Lesley-Anne will have to breach 
confidentiality to ensure you are given the appropriate support. In the first instance, 
Lesley-Anne will discuss this information with the Lead Clinical Psychologist, Dr Freya 
Spicer-White. Following this, Lesley-Anne Bendik or Dr Freya Spicer-White may need to 
share this information with the local Child Protection Team in line with NHS policy and 
will seek further advice from this team as appropriate. Lesley-Anne will discuss this with 
you in further detail if this situation arises.  
 
Throughout the research all participants will be assigned a participant number to protect 
their identity. The research team will keep a record of the participant’s name and 
corresponding participant number. We keep this record so that should you wish to 
withdraw your information from the study it can be located.  
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The interviews will be recorded on a digital recorded and will be transcribed 
anonymously onto an encrypted device following the interview. All information collected 
throughout the project will strictly be stored and managed in accordance with BCUHBs 
information governance policy and the Data Protection Act (1998). 
 
When the results of the study are written up, direct quotes from your interview may be 
included. However, the researchers have to follow strict guidelines to ensure that your 
personal information is not included and that no-one reading the report will be able to 
identify you from the quotes or information included. For example, your name will be 
changed and any identifiable information will be removed.  
 
What will happen to the recordings of what I have said? 
Lesley-Anne will record your interview on a digital record. After the interview, this will 
be kept in a locked filing cabinet until it is transcribed onto an encrypted device and then 
deleted from the recorder; the information will be anonymised prior to being transcribed. 
This means that you will be identified by a participant number rather than your name. 
The encrypted device can only be accessed by the research team. 
 
Upon completion of this study, the research team may wish to access the information for 
future research studies. If so, they have to contact you again to ask for your consent. The 
research team will destroy the transcript of your interview 5 years after the study has 
finished.  
 
What will happen to the results of the research? 
The results of the research will be summarised and sent to you in a leaflet. You will also 
be invited to contact Lesley-Anne to discuss the results in more detail if you wish.  
 
This research is being conducted as part of a thesis for a professional Doctorate of Clinical 
Psychology and the findings will be written and submitted to Bangor University. The 
research will also present the findings at an annual stake-holders conference organised 
by the North Wales Clinical Psychology Programme at Bangor University. In addition, the 
results will be written for publication in at least one research journal for the benefit of 
other professionals and future practice.  
 
 
Welsh Language 
All written information about the research study will be provided in Welsh and English. 
However, if you choose to take part the research, please note that the interview will only 
be conducted in English, as unfortunately Lesley-Anne can not speak Welsh.  
 
What will happen if I don’t want to carry on with the study? 
It is entirely up to whether you want to take part in the research. If you do choose to take 
part, you can change your mind at any time and you do not have to give a reason. This 
will not affect the care you receive within the NHS. If you wish to withdraw from the study 
following your interview, your information will be removed without question and you 
will still receive the £10 voucher for your time. 
 
Who is funding the research? 
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This research is being funded by the North Wales Clinical Psychology Programme at 
Bangor University.  
 
Who has reviewed the study? 
All research conducted within the NHS is examined at by independent group of people 
who come together to form a ‘Research Ethics Committee’. This committee examine all 
research before is it conducted to protect your interests and ensure is it conducted in an 
ethical manner. This research study has been granted ethical approval by the Bangor 
School of Psychology Ethics and Governance Committee and the Health Research 
Authority Wales (Rec 5) Committee. 
 
What if there is a problem? 
If you have any concerns about any aspect of taking part in this study, please contact a 
member of the research team Lesley-Anne Bendik (psp511@bangor.ac.uk) or Dr Freya 
Spicer-White (Freya.Spicer@wales.nhs.uk). They will try to answer any questions or 
concerns you have about the research. However, if you feel your concerns have not been 
addressed and you wish to make a formal complaint you are encouraged to use the 
contact details provided below.   
 
For a University complaint:  Hefin Francis (School Manager) 
School of Psychology 
Adeilad Brigantia 
Penrallt Road 
Gwynedd LL57 2AS 
Email: h.francis@bangor.ac.uk 
Tel: 01248 388339 
 
For an NHS complaint:  Concerns Team  
Betsi Cadwaladr University Health Board   
Ysbyty Gwynedd  
Bangor  
Gwynedd 
LL57 2PW 
Email: ConcernsTeam.bcu@wales.nhs.uk 
Tel: 01248 384194 
 
Further information and contact details 
If you have any questions of require more information about the research before you 
deciding whether you would like to part, please do not hesitate to contact Lesley-Anne 
(psp511@bangor.ac.uk).  
 
Thank you for taking the time to read this information.  
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Taflen wybodaeth i rai sy'n cymryd rhan 
 
Teitl y Project: Profiadau rhieni o'r broses asesu Anhwylder Sbectrwm Awtistig pan na 
chafodd y plentyn ddiagnosis. 
 
Gwahoddir chi i gymryd rhan mewn astudiaeth ymchwil a gynhelir gan Brifysgol Bangor 
a Bwrdd Iechyd Prifysgol Betsi Cadwaladr (BCUHB). Diben y daflen wybodaeth hon yw 
dweud wrthych beth yw yr ymchwil, pam mae’n cael ei chynnal, a’r hyn fydd yn digwydd 
yn ystod yr ymchwil. Mae’n bwysig eich bod yn deall y wybodaeth hon cyn dewis cymryd 
rhan. Darllenwch y daflen wybodaeth ac, os oes gennych unrhyw gwestiynau, anfonwch 
e-bost at y prif ymchwilydd, Lesley-Anne Bendik (psp511@bangor.ac.uk). Os yw'n well 
gennych siarad ar y ffôn, e-bostiwch eich manylion cyswllt at Lesley-Anne ac fe wnaiff hi 
gysylltu â chi.  
 
Y Tîm Ymchwil 
 Lesley-Anne Bendik (Seicolegydd Clinigol dan Hyfforddiant). Mae Lesley-Anne ar hyn 
o bryd yn cael ei chyflogi gan Fwrdd Iechyd Prifysgol Betsi Cadwaladr ac yn astudio 
am ddoethuriaeth mewn Seicoleg Glinigol ym Mhrifysgol Bangor. Bydd yr ymchwil 
hon yn cyfrannu at y thesis sy'n angenrheidiol i ennill y cymhwyster doethuriaeth 
mewn Seicoleg Glinigol.  
 Mae Dr Freya Spicer-White (Prif Seicolegydd Clinigol, Tîm Niwroddatblygiadol, 
Dwyrain) yn goruchwylio'r ymchwil hon.  
 
Beth yw diben yr astudiaeth? 
Mae ymchwil blaenorol ym maes Anhwylder Sbectrwm Awtistig (ASD) wedi edrych ar 
brofiadau aelodau o'r teulu o'r broses asesu ASD pan mae eu plentyn neu eu person ifanc 
yn cael diagnosis o ASD. Mae yna hefyd ymchwil sy'n edrych ar brofiadau'r teuluoedd hyn 
yn dilyn derbyn y diagnosis o ran y gefnogaeth sydd ar gael iddynt. Fodd bynnag, ychydig 
iawn o ymchwil sydd wedi ei wneud i brofiadau rhai sy'n mynd drwy'r un broses asesu, 
ond nad ydynt yn derbyn diagnosis o'r broses asesu ei hun, a'r gefnogaeth ar ôl hynny. 
Mae hyn yn cyfeirio at achlysuron pan nad yw anawsterau’r person ifanc yn gyson neu'n 
cwrdd â'r meini prawf ar gyfer diagnosis o ASD. 
 
Amcan yr astudiaeth bresennol yw archwilio profiad rhieni/gwarcheidwaid yr asesir eu 
plentyn/person ifanc am ASD ond nad ydynt yn derbyn diagnosis yn dilyn yr asesiad. 
Gobeithir y bydd canlyniad yr ymchwil yn helpu clinigwyr i ddeall sut orau i gefnogi 
teuluoedd drwy'r broses asesu. Gobeithir hefyd y bydd yr ymchwil yn helpu 
gwasanaethau i wella eu dull o roi gwybodaeth o ansawdd uchel a darparu canllawiau ar 
sut i adrodd am ddiffyg diagnosis i aelodau o'r teulu. 
 
Pam rydw i’n cael gwahoddiad i gymryd rhan? 
Rydym wedi gwahodd rhieni a/neu gwarcheidwaid pobl ifanc rhwng 5-19 oed sydd wedi 
bod drwy'r broses asesu ASD mewn Gwasanaeth Iechyd Meddwl Plant a'r Glasoed 
(CAMHS) yn y 12 mis diwethaf lle na roddwyd diagnosis o ASD. Gall mwy nag un aelod 
o'r teulu gymryd rhan os ydynt wedi bod yn rhan o'r broses asesu.   
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Oes rhaid imi gymryd rhan? 
Nac oes. Eich penderfyniad chi yn unig yw a ydych eisiau cymryd rhan yn yr ymchwil. 
Gallwch dynnu’n ôl o’r astudiaeth ar unrhyw adeg heb roi rheswm. Os penderfynwch nad 
ydych am gymryd rhan, neu os ydych yn penderfynu rhoi’r gorau iddi ar unrhyw adeg, ni 
fydd hynny’n effeithio ar y gofal a dderbyniwch gan unrhyw wasanaeth yn y GIG. 
 
Beth fydd yn digwydd os byddaf i / byddwn ni yn penderfynu cymryd rhan? 
Bydd y daflen wybodaeth hon wedi ei rhoi ichi yn ystod eich apwyntiad adborth, neu ei 
hanfon atoch drwy'r post. Unwaith ichi ddarllen y daflen wybodaeth, a chymryd amser i 
feddwl am y peth, hoffai'r ymchwilydd, Lesley-Anne Bendik, drafod y wybodaeth gyda chi 
a gofyn a oes gennych unrhyw gwestiynau. Os ydych yn fodlon i Lesley-Anne gysylltu â 
chi i drafod cymryd rhan yn yr ymchwil, llenwch y ffurflen gydsynio a ddarparwyd, a'i 
dychwelyd yn yr amlen amgaeedig. Fel arall, gallwch gadarnhau hyn dros y ffôn neu drwy 
e-bost. Ceir manylion am sut i wneud hyn ar y ffurflen gydsynio. 
 
Os penderfynwch yr hoffech gymryd rhan yn yr ymchwil, bydd Lesley-Anne yn trefnu 
amser cyfleus i gwrdd â chi. Cynhelir y cyfarfod yn y gwasanaeth CAMHS lleol lle 
cynhaliwyd eich asesiad a'ch apwyntiad adborth. Pwrpas hyn yw sicrhau bod y cyfweliad 
yn digwydd mewn lle yr ydych chi'n gyfarwydd ag ef, ac mewn lle tawel fel y gallwch chi 
drafod eich profiadau mewn preifatrwydd. Gall mwy nag un aelod o'r teulu / 
gwarcheidwad gymryd rhan os ydynt wedi bod yn rhan o'r broses asesu. Yn y sefyllfa hon, 
cewch wahoddiad i gael eich cyfweld gyda'ch gilydd. 
 
Pan fyddwch yn cyfarfod â Lesley-Anne, bydd hi'n gofyn ichi ddarllen ac arwyddo ffurflen 
gydsynio. Cewch gyfle i ofyn unrhyw gwestiynau am yr ymchwil i Lesley-Anne cyn ichi 
arwyddo'r ffurflen. Os ydych yn fodlon cydsynio i gymryd rhan, bydd Lesley-Anne yn 
gofyn cwestiynau ichi ynglŷn ag oedran a gender eich plentyn, eich perthynas â nhw a 
faint o amser mae'r broses asesu wedi ei gymryd. Bydd hi wedyn gofyn cwestiynau byr 
ichi am eich profiad o'r broses mewn cyfweliad anffurfiol. Cofiwch nad oes atebion cywir 
neu anghywir, ac mae hi'n berffaith iawn ichi beidio ateb cwestiwn neu ddod â'r cyfweliad 
i ben ar unrhyw adeg.  
 
Gofynnir yr un cwestiynau i bawb sy'n cymryd rhan. Mae'r cwestiynau hyn wedi eu 
cymeradwyo gan bwyllgor moeseg Prifysgol Bangor a Bwrdd Iechyd Prifysgol Betsi 
Cadwaladr. Bydd Lesley-Anne yn recordio pob cyfweliad ar beiriant recordio digidol. 
Diben hyn yw cadw cofnod o'r cyfweliad a helpu Lesley-Anne i wrando ar eich profiadau 
heb dorri ar draws neu wneud nodiadau.  
 
Bydd y cyfweliad yn para tua 45-90 munud. Bydd cyfle i gymryd seibiannau yn ystod y 
cyfweliad os oes angen.   
 
Beth yw’r risgiau neu’r anfanteision posibl o gymryd rhan? 
Gobeithiwn na fydd yr astudiaeth hon yn peri unrhyw ofid ichi. Fodd bynnag, rydym yn 
ymwybodol y gall rhannu profiadau personol fod yn anodd ac ar brydiau gall beri gofid, 
straen, neu bryder. Os ydych yn teimlo'n boenus neu'n ofidus ar unrhyw adeg yn ystod y 
cyfweliad, mae'n bwysig eich bod yn dweud hynny wrth Lesley-Anne. Mae Lesley-Anne 
yn Seicolegydd Clinigol dan Hyfforddiant, ac mae ganddi’r sgiliau i reoli ymatebion 
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emosiynol anodd. Fe'ch anogir i ddweud os oes unrhyw gwestiynau y byddai'n well 
gennych beidio â'u hateb, neu os hoffech stopio'r cyfweliad ar unrhyw adeg.  
 
Os ydych yn teimlo'n boenus neu'n ofidus yn ystod y cyfweliad neu wedyn oherwydd y 
cyfweliad, fe'ch cynghorir i siarad â Lesley-Anne, a all eich cyfeirio at gefnogaeth addas 
neu at eich meddyg teulu. 
 
Mae'n anodd cynnwys yr holl wybodaeth a roddwch yn y canlyniadau terfynol. Felly, er y 
gall rhai o'ch profiadau gael eu cynnwys, nid oes sicrwydd o hynny gan y gall fod yn anodd 
cynnwys profiadau pawb. Nid yw hynny’n golygu nad yw’r profiadau a rannwch gyda ni 
yn werthfawr iawn.  
 
Beth yw’r manteision posibl o gymryd rhan? 
Ni fyddwch yn cael budd uniongyrchol o gymryd rhan yn yr ymchwil, ond efallai y bydd 
rhannu eich profiadau yn gymorth neu’n bleserus. Efallai hefyd y cewch fwynhad o fod 
yn rhan o broject ymchwil sy'n ceisio deall a gwella profiadau pobl sy'n mynd drwy'r 
broses ddiagnosis ASD. 
Hoffai'r tîm ymchwil gynnig taleb £10 fel arwydd o'n diolchgarwch i bob cyfrannwr am 
rannu eu hamser a'u profiadau er mwyn gwella ein gwybodaeth broffesiynol a'n helpu i 
ddeall sut y gallwn wella profiadau cleifion a'u teuluoedd o'r broses asesu ASD yn y 
dyfodol. Gan y bydd y cyfweliad yn cael ei gynnal yn eich gwasanaeth CAMHS lleol, telir 
costau teithio.  
 
Fydd y wybodaeth amdanaf yn cael ei chadw’n breifat a chyfrinachol? 
Bydd. Cedwir unrhyw wybodaeth a rannwch gyda Lesley-Anne yn breifat a chyfrinachol 
o fewn y tîm ymchwil. Yr unig eithriad i hyn yw pe baech yn datgelu unrhyw wybodaeth 
eich bod chi neu unrhyw un arall mewn perygl uniongyrchol neu anuniongyrchol o 
niwed, neu o achosi niwed i eraill. Mewn achos fel hyn, byddai'n rhaid i Lesley-Anne dorri 
cyfrinachedd er mwyn sicrhau eich bod chi'n cael cefnogaeth addas. Yn y lle cyntaf, bydd 
Lesley-Anne yn trafod y wybodaeth gyda'r Prif Seicolegydd Clinigol, Dr Freya Spicer-
White. Yn dilyn hyn, efallai y byddai angen i Lesley-Anne neu Dr Freya Spicer-White 
rannu'r wybodaeth hon gyda'r Tîm Gwarchod Plant lleol yn unol â pholisi'r GIG, a byddant 
yn ceisio rhagor o gyngor gan y tîm hwn fel bo'n briodol. Bydd Lesley-Anne yn trafod hyn 
yn fanylach gyda chi os bydd y sefyllfa'n codi. 
 
Drwy gydol yr ymchwil bydd pob cyfrannwr yn cael rhif cyfrannwr er mwyn gwarchod 
pwy ydynt. Bydd y tîm ymchwil yn cadw cofnod o enw'r cyfrannwr a'i rif cyfatebol. 
Rydym yn cadw'r cofnod hwn fel y gellir cael gafael arno'n hawdd pe byddech yn dymuno 
tynnu’n ôl o’r astudiaeth.  
 
Caiff y cyfweliadau eu recordio ar recordydd llais digidol a'u trawsgrifio'n ddienw ar 
ddyfais wedi eu hamgryptio ar ôl y cyfweliad. Bydd yr holl wybodaeth a gesglir drwy 
gydol y project yn cael ei storio a'i rheoli yn unol â pholisi rheoli gwybodaeth Bwrdd 
Iechyd Prifysgol Betsi Cadwaladr a'r Ddeddf Diogelu Data (1998). 
 
Pan fydd canlyniadau'r astudiaeth yn cael eu hysgrifennu, efallai y defnyddir dyfyniadau 
uniongyrchol o'ch cyfweliad. Fodd bynnag, rhaid i'r ymchwilwyr ddilyn canllawiau llym 
er mwyn sicrhau nad yw eich gwybodaeth bersonol yn cael ei chynnwys ac na fudd 
unrhyw un fydd yn darllen yr adroddiad yn gallu eich adnabod o'r dyfyniadau na'r 
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wybodaeth. Er enghraifft, caiff eich enw ei newid a bydd y manylion personol yn cael eu 
dileu.  
 
Beth fydd yn digwydd i’r recordiadau o’r hyn ddywedais i?  
Bydd Lesley-Anne yn recordio eich cyfweliad ar recordydd digidol. Ar ôl y cyfweliad, 
cedwir hwn mewn cwpwrdd ffeilio dan glo tan iddo gael ei drawsgrifio ar ddyfais wedi 
eu hamgryptio ac yna caiff ei ddileu oddi ar y recordydd; gwneir y wybodaeth yn ddienw 
cyn ei thrawsgrifio. Golyga hyn y cewch eich adnabod wrth rif cyfrannwr yn hytrach na'ch 
enw. Dim ond aelodau’r tîm ymchwil fydd yn gallu cael mynediad at y ddyfais wedi'i 
hamgryptio. 
 
Unwaith i'r astudiaeth ddod i ben, efallai yr hoffai'r tîm ymchwil gael mynediad at y 
wybodaeth at ddibenion astudiaethau ymchwil yn y dyfodol. Os felly, rhaid iddynt 
gysylltu â chi eto er mwyn gofyn am eich caniatâd. Bydd y tîm ymchwil yn dinistrio 
trawsgrifiad eich cyfweliad 5 mlynedd ar ôl i'r astudiaeth ddod i ben.  
 
Beth fydd yn digwydd i ganlyniadau’r ymchwil? 
Bydd canlyniadau'r ymchwil yn cael eu crynhoi a'u hanfon atoch mewn pamffled. Bydd 
yna hefyd wahoddiad ichi gysylltu â Lesley-Anne i drafod y canlyniadau, os hoffech 
wneud hynny.  
 
Mae’r ymchwil hon yn cael ei chynnal fel rhan o thesis ar gyfer Doethuriaeth broffesiynol 
mewn Seicoleg Glinigol a bydd y canlyniadau'n cael eu hysgrifennu a'u cyflwyno i 
Brifysgol Bangor. Bydd yr ymchwil hefyd yn cyflwyno'r canlyniadau mewn cynhadledd 
flynyddol i fudd-ddeiliaid a drefnir gan Raglen Seicoleg Glinigol Gogledd Cymru ym 
Mhrifysgol Bangor. Hefyd, caiff y canlyniadau eu hysgrifennu a'u cyhoeddi mewn o leiaf 
un cyfnodolyn ymchwil er budd gweithwyr proffesiynol eraill ac ymarfer yn y dyfodol. 
 
Yr Iaith Gymraeg  
Bydd yr holl wybodaeth ysgrifenedig am yr astudiaeth ymchwil yn cael ei darparu yn 
Gymraeg ac yn Saesneg.  Fodd bynnag, os dewiswch gymryd rhan yn yr ymchwil, nodwch 
mai dim ond yn Saesneg y gall y cyfweliad gael ei gynnal gan nad yw Lesley-Anne, yn 
anffodus, yn gallu siarad Cymraeg.  
 
Beth fydd yn digwydd os na fyddaf yn dymuno parhau â’r astudiaeth? 
Chi yn unig sydd i benderfynu a ydych eisiau cymryd rhan yn yr ymchwil ai peidio. Os 
ydych yn dewis cymryd rhan, gallwch newid eich meddwl ar unrhyw adeg ac nid oes 
rhaid ichi roi rheswm. Ni fydd hyn yn effeithio ar y gofal a gewch gan y GIG. Os hoffech 
dynnu'n ôl o'r astudiaeth yn dilyn eich cyfweliad, dilëir eich gwybodaeth yn ddi-gwestiwn 
a byddwch yn dal yn derbyn y daleb £10 am eich amser. 
 
Pwy sy’n cyllido’r ymchwil? 
Ariennir yr ymchwil hon gan Raglen Seicoleg Glinigol Gogledd Cymru ym Mhrifysgol 
Bangor.  
 
Pwy sydd wedi adolygu’r astudiaeth? 
Mae’r holl ymchwil a gynhelir o fewn y GIG yn cael ei archwilio gan grŵp annibynnol o 
bobl sy'n dod at ei gilydd i ffurfio 'Pwyllgor Moeseg Ymchwil'. Mae’r pwyllgor hwn yn 
archwilio pob ymchwil cyn iddi gael ei chynnal er mwyn gwarchod eich buddiannau a 
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sicrhau ei bod yn cael ei chynnal mewn ffordd foesol. Mae’r astudiaeth ymchwil hon wedi 
cael cymeradwyaeth foesegol gan Bwyllgor Moeseg Ymchwil a Llywodraethol Ysgol 
Seicoleg Bangor a Phwyllgor Awdurdod Ymchwil Iechyd Cymru (Rec 5). 
 
Beth os bydd problem yn codi? 
Os oes gennych unrhyw bryderon ynghylch unrhyw agwedd ar gymryd rhan yn yr 
astudiaeth hon, cysylltwch ag aelod o'r tîm ymchwil, Lesley-Anne Bendik 
(psp511@bangor.ac.uk) neu Dr Freya Spicer-White (Freya.Spicer@wales.nhs.uk). 
Byddant yn ceisio ateb unrhyw gwestiynau neu bryderon sydd gennych ynglŷn â'r 
ymchwil. Fodd bynnag, os ydych yn teimlo nad yw eich pryderon wedi cael gwrandawiad 
teg a'ch bod eisiau gwneud cwyn ffurfiol, defnyddiwch y manylion cyswllt isod:   
 
Yn achos cwyn am y Brifysgol: Hefin Francis (Rheolwr Ysgol) 
Ysgol Seicoleg 
Adeilad Brigantia 
Ffordd Penrallt 
Gwynedd LL57 2AS 
E-bost: h.francis@bangor.ac.uk 
Ffôn: 01248 388339 
 
Yn achos cwyn am y GIG:  Tîm Pryderon  
Bwrdd Iechyd Prifysgol Betsi Cadwaladr  
Ysbyty Gwynedd 
Bangor  
Gwynedd 
LL57 2PW 
E-bost: ConcernsTeam.bcu@wales.nhs.uk 
Ffôn: 01248 384194 
 
Rhagor o wybodaeth a manylion cysylltu 
Os oes gennych unrhyw gwestiynau, neu os hoffech gael rhagor o wybodaeth am yr 
ymchwil cyn penderfynu a hoffech gymryd rhan, mae croeso ichi gysylltu â Lesley-Anne 
(psp511@bangor.ac.uk).  
 
Diolch am roi’ch amser i ddarllen y wybodaeth hon.  
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Appendix G 
 
Opt-In Form 
 
 
 
 
 
 
Opt-in Form 
 
Title of Project: Experience of the ASD assessment process when a diagnosis is not 
received. 
 
Name of Researcher: Lesley-Anne Bendik (Trainee Clinical Psychologist) 
Supervised By: Dr Freya Spicer-White (Lead Clinical Psychologist) 
 
You will have been given an information sheet about the above research study. The 
researcher, Lesley-Anne Bendik, would like to give you time to read this information and then 
contact you to ask whether you have any questions and to discuss whether you might like to 
participate in this research.  
 
If you have read the participant information sheet and are happy to be contacted by Lesley-
Anne Bendik (principal researcher) to discuss the research and your potential participation, 
please leave your contact details and signature at the bottom of this form. The completed 
form should be returned in the addressed envelope provided. Once this has been received, 
Lesley-Anne will contact you to discuss the research.   
 
Alternatively, you can email or telephone Lesley-Anne Bendik at (psp511@bangor.ac.uk) or 
(01978 725 242) to confirm if you are happy for Lesley-Anne to contact you. If Lesley-Anne 
is unavailable via telephone, please leave a message with your name and contact number and 
she will get back to you as soon as possible.  
 
My Contact Details: 
 
Name: _______________________________________________________ 
 
Telephone (home): ________________________________________ 
 
Telephone (mobile): _______________________________________ 
 
Email: _______________________________________ 
Signature: ____________________________________  Date: ______________________________ 
 
 
Further information: If you have any questions or require more information about this study 
please contact: Lesley-Anne Bendik via e-mail psp511@bangor.ac.uk 
 
Complaints: Any complaints concerning the conduct of this research should be addressed to: Mr 
Hefin Francis, School Manager, School of Psychology, Bangor University, Gwynedd, LL57-2AS. 
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Ffurflen gymryd rhan 
 
Teitl y Project: Profiad o'r broses asesu Anhwylder Sbectrwm Awtistig pan na dderbynnir 
diagnosis. 
 
Enw’r ymchwilydd: Lesley-Anne Bendik (Seicolegydd Clinigol dan Hyfforddiant) 
Goruchwylir gan: Dr Freya Spicer-White (Prif Seicolegydd Clinigol) 
 
Byddwch wedi cael taflen wybodaeth am yr astudiaeth ymchwil uchod. Hoffai'r ymchwilydd, 
Lesley-Anne Bendik, roi amser ichi ddarllen y wybodaeth hon ac yna fe hoffai gysylltu â chi i 
ofyn a oes gennych unrhyw gwestiynau ac i drafod a hoffech chi gymryd rhan yn yr ymchwil.  
 
Os ydych wedi darllen y daflen wybodaeth ac yn fodlon i Lesley-Anne Bendik (prif 
ymchwilydd) gysylltu â chi i drafod yr ymchwil a'r posibilrwydd y gallech chi gymryd rhan, 
rhowch eich manylion cyswllt a'ch llofnod ar waelod y ffurflen hon. Ar ôl i chi ei llenwi, dylid 
dychwelyd y ffurflen yn yr amlen a ddarparwyd. Unwaith i ni dderbyn hon, bydd Lesley-Anne 
yn cysylltu â chi i drafod yr ymchwil.   
 
Fel arall, gallwch e-bostio neu ffonio Lesley-Anne Bendik ar (psp511@bangor.ac.uk) neu 
(01978 725 242) i gadarnhau eich bod yn fodlon i Lesley-Anne gysylltu â chi. Os nad yw 
Lesley-Anne ar gael ar y ffôn, gadewch neges gyda'ch enw a rhif cyswllt a bydd hi'n cysylltu â 
chi cyn gynted ag y bo modd.  
 
Fy manylion cyswllt: 
 
Enw: _______________________________________________________ 
 
Rhif ffôn (cartref): ________________________________________ 
 
Rhif ffôn (symudol): _______________________________________ 
 
E-bost: _______________________________________ 
Llofnod: ____________________________________ Dyddiad: ______________________________ 
 
 
Gwybodaeth bellach: Os oes gennych unrhyw gwestiynau, neu os hoffech gael rhagor o 
wybodaeth am yr astudiaeth hon, cysylltwch â: Lesley-Anne Bendik dros e-bost 
psp511@bangor.ac.uk 
 
Cwynion: Dylech anfon unrhyw gwynion ynglŷn â’r modd y cynhaliwyd yr astudiaeth hon at: Mr 
Hefin Francis, Rheolwr yr Ysgol, Ysgol Seicoleg, Prifysgol Bangor, Bangor, Gwynedd, LL57 2AS. 
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Appendix H 
Telephone Protocol 
 
 
 
 
Telephone Protocol 
 
Title of Project: Parents experiences of the Autistic Spectrum Disorder assessment 
process when the child did not receive a diagnosis. 
 
 
Hello, 
 
My name is Lesley-Anne Bendik. I am calling with regards to the recent appointments you 
attended at (insert relevant CAMHS team) with your (son/daughter) for the (his/her) Autism 
assessment.  
I understand that your recently saw (insert clinicians name) and that during your feedback 
appointment (he/she) gave you an information sheet regarding some research that is 
currently taking place. The research is looking at the experiences of parents whose child was 
assessed for Autism, and as a result it was felt that this diagnosis did not fit their child’s 
difficulties.  
I wonder if you have had time to read the information sheet, and whether you have any 
questions you would like to ask… and whether you think this might be something you would 
like to be involved with. Participation in the research is completely voluntary and will not 
affect any aspect of your care from the service if you decide not to take part… 
 
 
…If the individual decides they would like to be involved a suitable time will be arranged to 
meet with them at their local CAMHS facility.  
 
...If the individual does not want to be involved, they will be thanked for their time and 
reassured again that their decision will not be recorded and will have no influence on the care 
they receive. 
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Appendix I 
 
Participant Consent Form 
 
 
 
Participant Consent 
Form 
 
Title of Project: Parents experiences of the Autistic Spectrum Disorder assessment 
process when the child did not receive a diagnosis. 
Name of Researcher: Lesley-Anne Bendik (Trainee Clinical Psychologist) 
Supervised By: Dr Freya Spicer-White (Lead Clinical Psychologist) 
 
Please put your initials in the box if you agree to the following statements:             
          
1. I confirm that I have read and understand the information sheet (dated: 
________________) for the above study.  
 
2. I have had time to consider the information and have had the opportunity to ask 
Lesley-Anne to any questions I had and have had these answered. 
 
3. I understand that my participation is voluntary and that I can withdraw at any 
time without giving a reason. I understand that withdrawal from the study will 
not affect my/my child’s care in the NHS. 
 
4. I agree for Lesley-Anne to record my interview. 
 
5. I understand that all the information I provide will be made anonymous and will 
be stored securely in line with the Betsi Cadwaladr University Health Board 
Information Governance policy and the Data Protection Act (1998). 
 
6. I understand that specific quotes that I say during the interview may be included 
in the final report. However, these will be carefully selected to ensure that I 
cannot be identified. 
 
7. I understand that if I disclose any information that I, or any other person, is directly 
or indirectly at risk of harm, or causing harm to others, Lesley-Anne will have to 
breach confidentiality. In this situation, Lesley-Anne will share this information 
will the Lead Clinical Psychologist (Dr Freya Spicer-White) and potentially with 
the local Child Protection Team to seek further advice, in line with NHS policy.  
 
8. I agree to take part in the above study. 
 
 
 
 
 
 
 
 
Name of Participant: __________________________    Date: ____________________   Signature: _________    
 
Name of Researcher: __________________________    Date: ____________________   Signature: _________   
_________________________ 
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Further information: If you have any questions or require more information about this 
study please contact: Lesley-Anne Bendik via e-mail psp511@bangor.ac.uk 
 
Complaints: Any complaints concerning the conduct of this research should be addressed to: 
Mr Hefin Francis, School Manager, School of Psychology, Bangor University, Gwynedd, LL57 
2AS. 
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Ffurflen Gydsynio i Rai sy’n Cymryd Rhan 
 
Teitl y Project: Profiadau rhieni o'r broses asesu Anhwylder Sbectrwm Awtistig pan na 
chafodd y plentyn ddiagnosis. 
 
Enw’r Ymchwilydd: Lesley-Anne Bendik (Seicolegydd Clinigol dan Hyfforddiant) 
Goruchwylir gan: Dr Freya Spicer-White (Prif Seicolegydd Clinigol) 
 
Rhowch eich blaenlythrennau yn y blwch os ydych yn cytuno â’r gosodiadau isod: 
 
1. Cadarnhaf fy mod wedi darllen a deall y daflen wybodaeth (dyddiedig: 
________________) ar gyfer yr astudiaeth uchod.  
 
2. Rwyf wedi cael amser i ystyried y wybodaeth ac rwyf wedi cael y cyfle i ofyn 
unrhyw gwestiynau i Lesley-Anne, ac rwyf wedi cael atebion i'r cwestiynau 
hyn. 
 
3. Rwy'n deall fy mod yn cymryd rhan o’m gwirfodd, a bod gennyf hawl i dynnu'n 
ôl ar unrhyw adeg heb roi rheswm. Deallaf na fyddai tynnu'n ôl o'r astudiaeth 
yn effeithio ar fy ngofal i na gofal fy mhlentyn yn y GIG. 
 
4. Cytunaf i Lesley-Anne recordio fy nghyfweliad. 
 
5. Deallaf y bydd yr holl wybodaeth a roddaf yn ddienw ac yn cael ei chadw'n 
ddiogel yn unol â pholisi rheoli gwybodaeth Bwrdd Iechyd Prifysgol Betsi 
Cadwaladr a'r Ddeddf Diogelu Data (1998). 
 
6. Rwy’n deall ei bod yn bosibl y caiff dyfyniadau penodol gennyf eu cynnwys yn 
yr adroddiad terfynol. Fodd bynnag, dewisir y rhain yn ofalus fel na fydd modd 
fy adnabod trwyddynt. 
 
7. Pe bawn yn datgelu unrhyw wybodaeth fy mod i neu rywun arall mewn perygl 
uniongyrchol neu anuniongyrchol o niwed, neu achosi niwed i eraill, rwy'n 
deall y byddai'n rhaid i Lesley-Anne dorri cyfrinachedd. Yn y sefyllfa hon, bydd 
Lesley-Anne yn rhannu'r wybodaeth gyda'r Prif Seicolegydd Clinigol (Dr Freya 
Spicer-White), ac o bosibl gyda'r Tîm Gwarchod Plant lleol er mwyn cael cyngor 
pellach, yn unol â pholisi'r GIG.  
 
8. Rwy'n cytuno i gymryd rhan yn yr astudiaeth uchod. 
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Gwybodaeth bellach: Os oes gennych unrhyw gwestiynau, neu os hoffech gael rhagor o 
wybodaeth am yr astudiaeth hon, cysylltwch â: Lesley-Anne Bendik dros e-bost 
psp511@bangor.ac.uk 
 
Cwynion: Dylech anfon unrhyw gwynion ynglŷn â’r modd y cynhaliwyd yr astudiaeth hon at: 
Mr Hefin Francis, Rheolwr yr Ysgol, Ysgol Seicoleg, Prifysgol Bangor, Bangor, Gwynedd, LL57 
2AS. 
  
 
Enw’r Cyfrannwr: ____________________   Dyddiad: ____________________   Llofnod: _________    
 
Enw’r Ymchwilydd: ___________________  Dyddiad: ____________________   Llofnod: _________   
_________________________ 
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Appendix J 
 
Interview Schedule 
 
 
 
 
 
Interview Schedule 
 
1. Before we start the interview I would like to ask you some questions about 
yourself and your son/daughter. 
o Please can you tell me your relationship to your child? 
o How old was your child at the time they were assessed? 
o Which family member/guardian attended the assessment and feedback 
appointment? 
o How long did you have to wait to be seen after you were referred for an 
assessment? 
o How long did the assessment take? (months/number of appointments) 
o How many different professionals did you see? 
 
2. What brought you to want the assessment?  
o When did you first notice the difficulties? 
o Who first noticed these difficulties? 
o What difficulties did you notice?  
o Whose suggestion was it to go for an Ax? 
o What were your thoughts about attending the assessment? 
o What did you hope to gain from the outcome? 
o How did you feel when you first realised your child was displaying some 
difficulties? 
o Were there any barriers / obstacles to your child having an assessment? If so, 
what helped you to overcome these barriers? 
 
3. What was the assessment process like?  
o How did you find the assessment? 
o Did you understand the assessment process? 
o Did you feel heard, included and understood throughout the process? 
o Did you feel your child was heard, included and understood? 
o Did you feel your responses helped or hindered the process and the outcome 
in any way? 
o Did you encounter any problems during the assessment process? 
o Was there anything about the process that surprised you? 
 
4. What was it like hearing the outcome of the Ax? What was the feedback 
appointment like? 
o How did you feel when you heard the outcome of the assessment? 
o Was the outcome explained fully?  
o Did you understand the explanation? 
o How did you feel in the days/weeks/months following the outcome? 
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o How did you feel about the level of support you were offered? 
o Have you noticed any impact of this outcome on yourself, your child, your 
family?  
o Has your child had any further assessment or been given any other diagnosis 
or support since your feedback appointment? 
o What could the service have done differently to make the process better or 
easier for you and your child? 
o If you could share one thing in particular with another family going through 
the same experience as you what would that be? 
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Appendix K 
 
Example Section of a Transcript with Exploratory Coding 
 
 
Example Transcript (All names or details have been altered for anonymity)  
Emergent Themes Original Transcript 
Exploratory Comments 
Descriptive Comments: focus on describing the content of what the participant has said, the 
subject of the talk within the transcript (normal text). 
Linguistic Comments: Focus on exploring the specific use of language by the participant (italic). 
Conceptual Comments: Focus on engaging at an interrogative and conceptual level (underlined). 
 
Mums intuition 
 
Life long journey 
 
Uncertainty  
 
Difficulty describing 
differences  
 
Child is “different” – 
“not normal” 
 
Time frame / age  
 
Comparison to other 
children 
 
Number of differences 
Trying to manage the 
situation alone? 
 
Mums intuition 
 
I: What brought you to want the assessment? 
P: Well I noticed something about James when he was 9months old. I 
knew that there was something…I hate using the word different or not 
normal but it’s the only language I’ve got to described it, you know. I 
just knew that he just wasn’t the same as other children. Hmm 
couldn’t communicate, hmm as time went on, no speech from him. If 
I ever went out anywhere he would just cling to my side, not leave me, 
he wouldn’t mix with other children. Hmm he started play group and 
he would just sit by the window with his teddy and his dummy and just 
stare out of the window and that’s all he would do. It took him weeks 
and weeks and weeks to sort of get into where the children were but 
even then he would play alongside, but he wouldn’t be directly 
involved with the children himself. Hmm and as time was going on his 
aggression was getting worse. He would just have these awful 
outbursts where he would destroy things, smash the inside of my car 
to bits. He’d smash his room to bits. He’d wake up at 2 or 3 o’clock in 
the morning in a rage. I’d have to hold him till he wore himself out. So 
I knew that…actually, I know he’s my first baby but something’s not 
right here. 
 
 
 
Mums first concerns age 9months. Reflect life long journey. Perception that he has always 
been a child who required help.  
Unsure what words to use? Feels restricted – uncertainty (sense that she hasn’t been given 
guidance on this) 
Hate – strong word. 
Different to others – not normal. Physical and developmental differences described 
emphasising that he is different? 
You know – seeking reassurance / confirmation.  
 
Not meeting expected milestones. Time / age. Starting nursery – difficulties became 
apparent. Expected? Shock? Disappointment that her intuitive thoughts were confirmed? 
Listing differences – comparison with other children’s development / social skills.  
 
Repetition – weeks and weeks and weeks – emphasis, sense of a long time, longer than 
expected.  
 
Situation getting worse. Aggression. Severity of situation. 
 
Outbursts – impact of this on mum, the family home / belongings. 
 
Have to hold him - contain him – sense that she didn’t know what else she could do – 
powerless? Trying to handle it alone? Particularly with not knowing the cause of the rage. 
 
Mums intuition despite James being her first baby. 
 
 
172 
 
Impact on mum  
 
Alone 
 
Determination  
Importance of support 
/recognition from 
others 
 
 
 
Child as different 
 
 
Comparison to other 
children 
 
Struggle 
Emphasising 
difference 
 
 
 
Strong emotional 
impact on mum – 
helpless 
 
Wanting to remove 
the difficulties  
 
Impact on self 
(criticism) 
 
 
Alone 
I: How was it for you when you first picked up on those things?  
P: It’s difficult to explain really. It was awful. Yes. But all I could focus 
on was right what could I do to help him really. So once the school had 
agreed that actually you know I think we need contact someone, it was 
more of a relief than anything, cos I thought well right at least you 
know, I on my way to getting him the help that he needs.  
 
I: Can you tell me about more about how that was for you?  
P: So from 9 months you know his aggression and everything was 
getting worse and worse. Erm at play group this was when he would 
just kind of sit there and stare out of the window, but when he went 
over to nursery he used to…anything that had a string on it he would 
pick up and swing it and watch it, rather than anything that was going 
on in the classroom, that would be ‘his thing’. He would get animals 
out and sort them out into groups and stuff. He just wasn’t where he 
should be with the other children. He wasn’t communicating with the 
other children. On the basis that he couldn’t, he couldn’t string a 
sentence together at that point. So he was really really struggling at 
that point.  
 
I: And how did that feel for you as a parent? 
P: Horrendous. Horrendous. I felt helpless. You know. As his mother, I 
should be able to help him and I couldn’t. I couldn’t take it away from 
him. Whatever it was I couldn’t take it away from him. I couldn’t help 
him.  
 
I: Were other people helpful around that time. Did you get any 
support? 
P: Only from my mum. My husband was in denial for a lot of the 
time. ‘Oh he will grow out of it, it’s nothing to worry about, he’s just 
 
 
Use of the word ‘I’ suggest she felt alone / responsible. 
Awful –sense of emotional impact on mum in recognising James’ difficulties, but 
empowered by how she could help him? 
Agreed – sense of now being shared? – she wasn’t the only one.  
Relief – at the prospect of getting help/support or that someone else had recognised what 
she was seeing – confirmation, sense of feeling heard / believed. 
She felt more hopeful as managing the situation alone and feeling helpless was taken away.  
 
 
Between 9months and going to school – things deteriorated.  
 
Repetition – worse.  
Description of difficulties. 
 
‘His thing’ – sense of difference from the other children. 
Just – emphasis of lack of skills 
Comparison with other children – confirmation to mum that he was different? 
 
Developmentally he was delayed – he was struggling vs mum was struggling? 
 
At that point – has this changed now? Better? Worse? 
 
 
 
Strong emotional impact on mum. Helpless, felt horrendous.  
Mums sense of ‘should’ – sense that being a mother means you ‘should’ be able to solve 
everything, protect your child from everything – feeling like a failure – that she couldn’t 
meet his needs?  
Repetition – powerful emphasis. 
Use of of the word ‘I’ Guilt? Helplessness? Responsibility? feeling like a failure? 
 
 
 
Her mother was supportive. Husband and father in denial – impact of stigma? – Stigma = 
rejection from others = loneliness? / lack of acceptance? 
Sense that you have to be a mother / have mother’s intuition to understand. 
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Systemic impact 
 
Difference in parent 
opinion – alone?  
 
 Paranoia/perceived 
judgment 
 
Determined  
 
Emotional impact  
 
 
Relief 
 
 
 
 
Long awaited child = 
mixed emotions – 
sense of have to 
manage / get it right. 
 
 
 
 
 
 
Long journey 
 
Advise by others to 
seek help – parents 
responsibility 
 
Listing difficulties  
a naughty boy.’ Hmm and my dad was very much the same as well, it 
was like, almost like they didn’t want a stigma. Really really difficult, 
cos I knew… so erm the fact the school had said ‘you know actually 
we need to something here’. At that point he kind of sat back and 
realised ‘oh actually ok maybe there is and things kind of…that was 
the turning point, cos I just felt like people saw me as this fussy 
mother, you know, which at the time I never really thought about it 
cos I was so focused on James but to not have the support from my 
husband it was hard. It was hard at the start.  
 
I: Was it helpful when others started to notice? 
P: Yeah. It was helpful... [long pause] 
 
I: They can be difficult feelings to sit with... 
P: Yeah really difficult cos originally I didn’t think I would be able to 
have children. It was three years it was before we had James. It took 
us three years, so you know when I finally had him it was just you 
know… I’d finally got what I wanted so it was a whole mix of emotions 
going on there really.  
 
I: So when was it that other people first noticed? Was it the nursery 
teachers you mentioned?  
P: Well it actually went back to playgroup cos you know when he was 
just sitting there and not joining in and they would do little 
assessments and erm, he couldn’t recognise shapes, or numbers or 
those kind of things. They kind of said to us ‘look this is what we’ve 
seen...I don’t know whether you want to speak to the health visitor 
about it’, which he did. We took him along…he got an appointment 
with…it was Dr. Guy* but it was up to the…originally we went to our 
own GP you know just to say that I had concerns and they made us an 
 
Impact of not having your husband support? Feeling alone? Increased pressure on whether 
to share your concerns further? – could she has felt blame for the stigma? Unsupported? 
‘Really’ repetition – to emphasise extend of the difficulty. 
“I knew” – sense of responsibility 
mum intuition – high sense of responsibility – going against husband’s thoughts to get 
support for child – putting the child first. Feeling lone? 
 
Saw me as this ‘fussy mother’ – paranoia? Impact of how she feels other see her / judge her 
/ sense that at the time this wasn’t important because of the focus she had on doing what 
she felt needed to be done in terms of accessing support.  
Sense of focus = determination. 
 
 
Relief?  
Pause: reflection? Emphasis of the difficulty in talking about this? 
 
 
Added context. Didn’t think they would be able to conceive. Longed for child. Heightened 
sense of importance to get it right maybe? Being able to conceive was a gift, a miracle? 
 
Mixed emotions.   
 
Reflection.  
 
 
 
 
Went back to – sense of took a long time. Started at an early age.  
 
Nursery did some assessments and noticed developmentally not where he should be – 
advised contact with health visitor.  
 
Followed advice compliance - Contacted health visitor.  
Professional ambivalence so left up to parents? Parents responsibility? Impact on parents? 
GP > health visitor 
 
Originally – perhaps emphasises number of appointments / longevity of the process.   
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Not heard/listened to 
– impact on self 
 
 
 
Strong emotions – 
angry at professionals  
 
Lack of closure  
 
Regret? 
Lasting impact of 
professionals 
 
 
 
Impacting of seeing 
the same 
professionals  
 
Helplessness, despair? 
 
 
 
 
 
 
Emotional impact on 
mum 
 
 
 
Long process. 
appointment to see Dr. Guy, and that was at a health clinic in [local 
area]. Hmm and it was just…I was so angry when I came out of there 
because she had this piece of paper on a clip board which she never 
never took her eyes off. She got James to do a jigsaw puzzle, asked a 
few questions and basically said ‘nothing wrong with him’ to which 
point I had to get out of the room, because if I didn’t leave I was really 
scared of what I was going to do and I came out of there really upset.  
 
I: How did you process that after the assessment? 
P: I don’t think I’ve ever really processed it to be honest. It’s still 
something that really eats away at me and as it happens when we 
finally did get the school to get the ball rolling, it was Dr. Guy who saw 
him again.  
 
I: How was it seeing the same person again?  
P: I was like ‘oh God no please’ and it was more of the same 
thing...looked at her clip board and asked a few questions and James 
was actually being a nightmare. I was like ‘can you not see this?’ hmm 
and I’m not sure what happened after that. I’m a bit fuzzy about what 
happened from there. It must have been the schools input. I think it 
must have been, cos its all really really fuzzy, cause at that point I had 
a young baby as well, so I really apologise for my memory.  
 
I: Don’t worry it’s a long time ago.  
P: It is a really long time ago, a lots happened. I still, that’s the thing I 
remember the most from it, the anger that I was feeling at the time.  
 
I: And he was quite little wasn’t it. 
P: Yeah he was about 3. When he was assessed he was in reception so 
he was actually 4 when he was first assessed. Yeah. 
 
Angry – strong emotions, pauses / hesitation to emphasise this.  
 
Not heard/listened to – impact of professionals lack of thorough assessment / invalidating / 
dismissive.  
Anger. Had to get out otherwise scared of what she would do – heightened sense of impact 
at the situation – can’t be responsible for own actions.  
What would people think of her if she displayed those emotions in the room? 
Mixed emotions.  
 
 
Lack of closure from that appointment. Ongoing impact on her? Does she wish she had 
challenged it there and then rather than getting out of the room?  
Eats away at her – metaphor - regret? – impact on self? 
Future impact on trust and interaction with professionals.  
 
 
 
Fear of history repeating itself?  
 
Again invalidated – not heard, lack of observation.  
Desperation, helplessness, despair? 
 
Nightmare – emphasis of severity of his behaviours / differences. Sense of shock as to why 
professional had different opinions. Stuckness between health and education. 
 
Unable to remember details. Consciously blocked them out? 
Apologetic – pleasing interviewer?   
 
 
The anger is the strongest memory. Emotional impact on mum – emphasised by the fact 
that this has stayed with her despite being a number of years ago. 
 
 
 
Parent talking about the first time her son was assessed at this point in the interview. He 
had since undergone a recent assessment.  
Assessment started age 3-4. (Since been reassessed). 
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Regret at not asking 
more questions during 
the feedback – long 
standing impact on 
mum (self-criticism) – 
‘should’ have done 
more. 
 
Power of services?  
 
Lack of service 
provision. 
 
Emotional impact 
Regret (lost the 
‘battle’) Anger. 
‘should’ – self criticism 
Self development and 
growth 
 
Ongoing process – 
long – uncertainty – 
lack of closure 
 
Internal conflict – 
relief at outcome vs 
sense of outcome not 
being right 
 
Power of professionals 
– you have to trust 
them 
 
 
I: What was it like hearing the outcome of the assessment? 
P: When he had the actual autism assessment, obviously they had to 
go and write, you know, the reports and that. This wasn’t Dr. Guy by 
the way, this was someone else who did the actual assessment. So 
when all that, got all the information together and she came to the 
house to talk us through it. hmm an I’m still kicking myself now for not 
having the right questions ready. Cos I was told that he was…he was 
just borderline, but what she’d done is that she’d scored him just 
under because there was that many limited places in CAMHS that they 
didn’t feel that they really had enough time to give him that diagnosis.  
 
I: How was that as a parent? 
P: Really hard. But…at the time…erm suffering from depression, young 
baby, er a child…clearly something wrong. I’m angry now because I 
should have been stronger. I feel like I should have fought harder 
because she said to me were going to leave his case open for 
18months because it could, it could er…start up when he gets a little 
bit older, and then I thought well if your telling me that symptoms 
might not show until a bit older then surely this assessment is kind of 
irrelevant. Because you don’t know what’s gonna, you know happen 
in the next 18months. But at the time everything was so jumbled and 
hmm…I had all these emotions going on. One side of me was kind of 
saying right well, there’s nothing wrong so that’s good lets just you 
know…the other side was like no this isn’t right! this isn’t right! So it 
was really really difficult for me at that time and obviously being my 
first baby and never going through anything like this before, you kind 
of have to say to yourself well they’re professionals so you’ve got to, 
you’ve got to put a bit of faith in them. 
 
 
 
Sense that they had to wait for the outcome. Long process. 
 
Process and impact of not getting the diagnosis – the feedback appointment and report.  
Specified that this assessment was done by another professional. Lasting impact on mum. 
 
‘I’m still kicking myself now’ – strong sense of longstanding regret. Has this fuelled mums 
continued determination to get the right support and wanting further assessments.  
 
Told he was borderline. Seems this terminology might have been unhelpful? 
Use of the word ‘just’ – added insult?  
Uncertainty? – sense that the only reason he didn’t have the diagnosis confirmed was 
because of lack of service availability / provision? – fuelled mums anger at services? 
 
 
 
Mum reflecting on the outcome at a time when she had depression.  
Lots of hesitation, struggling to get sentence out. – sense of reflection, still working through 
how she felt about this? - maybe some resurgence of the emotion. 
Regret? Reflection? Criticism? Sense of ‘should’ – reflection on personal self growth and 
development now – stronger person.  
 
‘fought’ – sense of battle.  
 
No certainty given – case left open for 18months – longevity of process – lack of closure.  
 
Uncertainty about the future– felt left? Abandoned for 18months? 
Raised voice ‘this isn’t right’ – annoyed, regret, convincing self/researcher? 
Everything was jumbled – overwhelming? 
 
Internal conflict – relief at outcome vs sense of outcome not being right 
First baby – sense that you ‘have’ to trust professionals. Professionals are powerful? This 
being the ‘right’ thing to do – but at the same time deep down not believing this (e.g. a bit 
of faith in them) 
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Multiple professionals 
 
 
 
Relief  
 
 
Fluctuations in 
presentation 
 
 
 
Celebrating his 
personality  
 
 
Comparison to others 
– delayed – behind – 
sense of difference 
 
 
Emphasising 
differences compared 
to other children 
 
 
I: Do you feel like you had that faith? 
P: I thought I did. Until things got worse with him. 
 
I: So that was the start of the autism assessment?  
P: Yeah. 
 
I: And it was the schools suggestion to go for that initially? 
P: Yeah, a mixture, school, GP, myself. Yeah. 
 
I: So when they said it was borderline, and they’d keep it open for 
18months. How was that 18months? 
P: Well initially I thought well maybe it is the right decision cause 
initially he did improve with his reading and his writing and his 
communication. I put that down to the school though. They have been 
absolutely bloody amazing with him all the way through. I couldn’t 
have asked for anything better erm from them. Each and every 
teacher that he’s had, they’ve bonded with him, they’ve had this really 
special relationship with him. Hmm because he is so kind and sensitive 
and anyone that meets James just loves him (laughs). They do, and it’s 
so nice to hear that with all that he’s going through, you know that 
actually…he’s a good boy. So yeah that was all going quite well and 
then he was, you know moving up through to the next year and that’s 
when things started to kind of you know go down hill again he was 
behind and not coping in class, academically, and with his peers as 
well. Couldn’t kind of make those bonds, you know, still kind of playing 
alongside you know but not with. Even thought they all really you 
know, like James. Every single person in his class likes him, he just can’t 
kind of you know, cos you have groups that break off and that don’t 
you, but he just can’t, he’s always on his own. Well I say on his own 
he’s got a friend Sam* who has been diagnosed with sever autism and 
Uncertainty – change of perspective when things deteriorated.  
 
 
Lots of people involved. Where did mum fit into this? 
 
Relief? 
Fluctuating presentation. Sense that maybe it was the right decision. Ambivalence? 
Pleased with school support. Sense that she couldn’t have done it without schools support 
and input.  
Bonded with him/special relationship – words that may typically be used to describe 
mother-son relationship? 
sense that he’s different, needs this extra support. 
Teachers and school have been very helpful and supportive. All love James. Sense of pride 
in mum. 
‘With all that’s he’s going through’ – sense of big impact on James / the family, difficult 
process. He’s a good boy – confirmation? Interesting use of language – is this mum 
compensating for the possible stigma that autism would mean he is naughty? Sense of 
mum’s clarification that he can’t control his behaviour difficulties  
 
Physical descriptions used for emphasis. E.g. down hill. Sense that its hard to get back up, a 
struggle, a battle. 
 
Strong sense that he is liked by others – repetition of this – does this highlight how 
important it is for mum knowing that he is liked (despite his differences?), acceptance? 
You know – repetition – sense of seeking clarification, ensuring interviewer following her 
story (? importance of being heard) 
James’ alone – Listing difficulties / differences compared to other children.  
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Comparison of child to 
another child with 
diagnosis ‘so he must 
have it’ 
 
 
Alone 
Powerless / helpless at 
not being able to 
protect child from 
being lonely  
 
 
 
 
 
 
 
 
 
 
Celebrating friendship 
 
 
Shared identify 
 
Relief 
 
 
 
 
 
 
Importance of shared 
identify for the child 
and the mum. 
ADHD and they click. So they kind of look after each other, which is 
lovely to see.  
 
I: How does that feel when you see him on his own? 
P: It’s horrendous, to think that he might be lonely. Because when I 
drop him off at school well I can’t do anything then. I’m not there. I’m 
not in control of him. (sigh). Your heart just kind of sinks every time 
you drop him off at school. 
 
I: Has that changed at all as he has got older? 
P: No cause he’s still struggling. In fact…it’s even worse now.  
 
I: And the flip side of that, how do you feel when he’s with Sam? Does 
that change your feelings? 
P: Yeah. [sighs - laughs]. I love the fact that their funny. They are funny 
together, but even now and then when ones in a bad mood, they are 
just like brothers, they fight, fight like hell. Then five minutes later 
they’re like are ‘alright bud?’ they are really really funny to watch. 
They are like an old married couple, that’s how me and my friend 
describe them. So it’s nice because they’ve had this kind of 
relationship since they were about 3 years old, that’s when it first 
started. So it makes me feel good that he’s always going to have that 
person in his life who knows actually he’s kind of thinking, he knows 
what he’s going through, he knows his thought process.  
 
I: Do you feel in the process you’ve had someone like that, who you’ve 
been able to share your thoughts or concerns with? 
P: Oh yeah, Sam’s mum she’s my best friend in the world. That’s the 
one positive thing that comes out of it. She’s like my sister so we’re 
never apart. Crying on each other shoulder all the time. So it’s nice to 
Sense that he is similar to his friend who has a diagnosis they click – so ‘James must have a 
diagnosis’? Does observing their similarities cause mum more confusion as to why James 
was not diagnosed? 
 
Strong feelings / worry that James is lonely. Feeling that she is unable to protect him from 
this at school. – does this reflect mum’s loneliness? 
“I” – mum feels responsible. Losing control. 
Impact of this on mum – unable to take responsibility for this as she recognises she cant be 
with him all the time – guilt?  
Heart sinks – physical descriptions used for emphasis.  
 
 
Situation is worse now.  
Continued struggle. Battle. 
 
 
Sighs / laughs – expression of relief? 
 
Pleased that he has one friend who understands him. Mums delight at this. Sense that she 
knows what it feels like to be alone and this is unpleasant.  
 
Importance/value of shared identify/experiences.  
Powerful impact of friendship. Sense that having that one friends who understands him and 
see the world as he see’s it takes some pressure from mum. Eases mum’s pain? Feels guilty 
about this but comforted by the boy’s friendship knowing someone understands him even 
though she wishes it were her.  
Friendships – normality in life – this is why its so important he has this one friend? 
Kind of relationship – unique to people who are a bit different? 
Sense of difference. Only a person with autism can understand him – sense that this means 
he must also have autism? 
 
First started – longevity.  
 
 
Positive aspect of situation – friendships with other mums. Only those in the same 
situation understand 
 
Strong support from another mum in the same situation ‘best friends, sisters’  
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Situation is all 
consuming 
overwhelming, 
emotional journey 
 
Impact on mum 
 
 
 
 
 
 
Professionals 
conflicting messages 
Mum in the middle - 
powerless 
 
 
 
Hopeless, helpless 
 
Mums losing control 
 
 
 
Impact on school 
observation on a good 
day = Mum’s doubt in 
outcome – Lack of 
closure 
 
School observation = 
barrier to outcome.  
 
 
have that release. Even when there isn’t anything particular wrong, 
some days we will just turn up at each others house and cry for no 
reason (laughs) just because we can. You know, which is nice.  
 
I: It sounds important to have that support.  
P: Yeah. Definitely.  
 
I: What it is like for you now? 
P: It is upsetting now because I’ve asked for him to have another 
assessment because I can still see that something’s not right. His 
teachers have told me they can’t understand why he hasn’t been given 
a diagnosis because they can quite clearly see that there’s something… 
[sigh] that he’s on the spectrum. Hmm so to be told again that actually 
were not going to give him another assessment…but then I was here 
again last Friday for an emergency appointment with Dave* [ND 
clinician] because he was sobbing his heart out in the morning telling 
me that he couldn’t open up to me cos he needed to speak to Dave 
and he’s terrified about these episodes that he’s having where he’s 
zoning out, he’s losing time. Now I can lose him for an hour and he’s 
got no idea what’s going on at that point. He’s just blank stare. And 
he’s struggling again in the classroom. When they went out to do his 
classroom assessment at the start of the year [sigh] they went on a 
day where it was his favorite subject. It was about insects. So of course 
he was absolutely enthralled. So as far as the assessment went, you 
know…there was nothing to show cos he was complying.  
 
I: Do you feel that hindered the process? 
P: Absolutely. I really do. 
 
I: Do you think there is anything that hindered the process? 
sense of closeness as you can only understand / appreciate if you are in that situation 
together. Shared identity.  
Cry for no reason: Sense of how much impact this has – all consuming – overwhelming – 
even when there is nothing specific still want to cry at the situation as a whole 
“Because we can” – sense that this is something that she can control; whereas many other 
elements in this process she can’t.  
 
 
 
 
Wanting another assessment. Hope of difference outcome? Hope that the system was 
wrong?  
 
Conflict between school and health services opinion – mum stuck in the middle? 
 
Teachers referring to him as being ‘quite clearly’ on the spectrum – impact of this on mum 
when she has been told he is not? sense professionals must blind? 
 
Emergency appointment – crisis? 
Physical description for emphasis of her son’s emotional pain. 
 
Positive response from service.  
Sense of confusion, she doesn’t understand what is going on and this is difficult to manage.  
 
Lose him – sense of losing him not just in an absence but losing him in general? – feeling 
like she’s lost control.  
 
Struggling again – reoccurring, round in circles. A never ending Battle? 
 
School observation as part of the assessment - done on a day that he was engaged in a 
subject of interest. – sense that saw him on a good day so this influenced the outcome. 
Doubt that the outcome is right. Laughs -? disbelief, sense of her perception that the 
situation is a joke.  
Noting to show– sense you have to look harder or at the right time. Contradiction to 
physical and develop differences emphasised previously.  
 
 
One school observation and on a good day – hindered the process.  
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Battle – mums fight 
not James’ 
 
Impact of the 
fight/battle on mum  
 
systemic impact on 
family / siblings.  
 
Hope / emphasis on 
re-assessment  
 
Lack of closure  
 
 
Inadequate service  
 
 
Stuck between 
services  
 
Enmeshed? 
Assessment is for 
mum not child? 
 
 
Lack of closure – hope 
of future assessment  
 
Future hope 
 
Judgment/Paranoia? 
 
 
 
 
P: I feel like I’ve been fighting all the way. 
 
I: How is that fighting? 
P: Exhausting. I’m exhausted. Especially with having 3 other children 
as well, who all need attention too. It is, it’s exhausting…I just…if they 
did another assessment on him and you know still that came back that 
actually you know he’s still borderline. You know that’s ok. But it’s the 
fact that you know I can see it, but they’ve just got a half an hour snap 
shot out of his life and based it on that. 
 
I: How does that feel thinking that that the only bit they based the 
outcome on. 
P: It’s not good enough, that’s how I feel, it’s not good enough 
 
I: Have you felt able to say that to professionals? 
P: I haven’t had a chance yet, no. I, um, Dave…he is going to phone the 
school cos school wanted to speak to him, and I’m going to go in this 
week to have a chat with his teacher, cos I don’t know if I’ll get 
anywhere but I really want to have him assessed again. I need it.  
 
I: What do you hope to get from the assessment this time? 
P: Well like I say whether it’s… because he’s that bit older, I think from 
the assessment we’d have a clearer picture…. For him. And even if it 
did come back, well actually he’s still only borderline, well that’s ok 
cause I can work with that. It’s the fact that…you know to be told no, 
when I know… I know! (sigh) he needs it. I know he does. I’m his mum. 
I know. I’m not an overbearing mother. I know. 
 
I: You mentioned earlier that it was sometimes hard to share those 
feelings. Do you still feel like that when talking to professionals?  
 
Battle. Use of “I’ve” first person – this is mums battle – not James’. Responsibility is on 
mum. 
 
Impact of this fight. Exhausted. Battle – defeated? 
Wider impact on family – siblings – mum trying to divide attention. Impact of this – guilt? 
 
Putting a lot of emphasis / hope on having another assessment. Sense that as long as an 
assessment is given it will give some answers and regardless of the outcome that feels ok – 
but without that there is lack of closure everything is still uncertain. ?why mums feels a 
third assessment would be any different? ? implications for previous lack of trust in 
professionals, bad experiences of feeling heard or lack of explanations regarding why he 
did not meet the diagnostic criteria.   
 
Snap shot of observation blamed for outcome. Unfair, unjust? 
Service not good enough. Sense of being let down. 
 
Stuck between health professionals and school.  
 
Use of ‘I’ – mums needs the reassessment for her. Is this because she felt she ‘should have 
‘fought’ harder during the last assessment. Enmeshed? 
Want the assessment > changed to NEED the assessment. Lack of closure.  
 
As he gets older you see will it more? It’s more developed? Worse? 
 
 
Change of perspective again – previously assessment was for mum now she has switched 
back to the assessment being for James.  
 
Mum searching for a ‘workable’ explanation? Searching for an answer that she can accept 
– work with – sense that he will get diagnosis in future. 
 
Repetition of “I know” – strong emphasis. Determination – mums knows best. 
Clarification I’m not an overbearing mother – worried about other perceptions? Paranoia. 
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Determination. Mums 
knows best. 
 
Impact of others 
opinions 
 
Power of the board 
 
Powerless. 
 
Long process 
 
Mum silenced – 
determined to fight. 
 
 
 
Fight. Personal growth 
and determination. 
 
 
 
Wanting to take this 
away from him – 
protect him – fight for 
him 
P: That they don’t understand me. Um not with Dave. He’s a nurse 
here and er I get the feeling that he gets it and he’s trying to find loads 
of solutions or answers to questions erm and he took James’ case back 
to board for me. Um but I don’t see how…I don’t know what happens 
in this board, whether you know it’s just a group of people sitting 
around a table looking at a few pieces of paper. You know let me speak 
to the board. Why can’t I speak to them? 
 
I: Do you feel that would be important? 
P: Yeah. Listen to me. This has been going on now for 6 years. Nearly 
7. So please, you know, can I, can you…can you…sit down and listen to 
me. Let me tell you about it. 
 
I: How have your feelings changed? You talked a bit about that fight 
initially, can you tell me a little bit more about that and whether that’s 
changed as times gone on.  
P: Yeah. In terms of that, that…that fight inside me…that’s got stronger 
now. I’m not scared to do it.  
 
I: What do you think change is about? 
P: Because now that James has got older, he can tell me, he’s started 
to try and express him emotions. And erm as a… as a mum hearing 
that… this is my baby and this is the way he’s feeling… well you’d die 
for them. You’d take a bullet for them so… this is nothing compared 
to, you know, the feelings that I…that I have for him. Standing up in 
front of a room full of people, I’d do it any day of the week if I thought 
that’d help him. That fight will always be there…for any of them. 
They don’t understand – impact of not feel heard.  
Sense that nurse would understand because this is a medical disorder? 
Importance of feeling like someone is one your side – shared fight. 
 
Power of the board – professionals. (sitting / few pieces of paper – minismises decision) 
sense that mum feels the decision was taken too lightly) 
Don’t know what happens – confusion, uncertainty, lack of information  
Powerless. Not heard. No control. Impact on mum.  
 
 
Long process 6-7years! 
Mums wants her say – Did not feel heard previously / renewed determination perhaps 
because she felt like she wasn’t in the right place to do this before due to her depression 
etc? Sense that sharing her thoughts would help/change the outcome – she needs to have 
the opportunity to prove that he has autism? 
Please (hesitation/repetition)- begging/pleading.  
 
 
 
 
Internal fight got stronger now. Personal growth, determination. Not scared anymore.  
 
Fight is stronger now. James has confirmed her thoughts now he is verbal / can share 
things with mum – is this what has given her the strength to fight? Before she was unsure, 
based actions on her own intuition. Confirmation from James. 
Use of metaphor – take a bullet for him / die for him – mum is very clear on her priorities. 
 
Her children are her world.  
 
Use of the word baby – the most important thing to her – fight whoever to get him support 
/ protect him / his needs. 
 
Sense of it being mum ‘vs’ a room full of people 
Sense of determination – she will do whatever it takes, she will win the battle.  
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Appendix L 
 
Summary of Emergent, Sub and Superordinate Themes 
 
  
Emergent Themes Subthemes 
Superordinate 
Themes 
 Highlighting multiple differences 
 Comparison to typically developing peers  
 Comparison to siblings 
 Comparison to children with Autism Spectrum 
Disorder diagnosis 
 Parents intuition  
 Parent knows best 
 Unwanted differences 
 
Emphasising 
Difference 
 
 
 
 
 
 
 
 
 
 
“My Child is 
Different” 
 
 
 
 
 
 
 
 
 Uncertainty in describing differences 
 Impact of no legitimate label  
 Lack of evidence 
 Highlighting vs minimising differences 
 Explaining difference to the child 
 Language used to describe difference 
Talking about and 
Disclosing Difference 
 Acceptance 
 Difference is personality  
 Difference makes the child way they are  
 
Celebrating Difference 
 Isolation 
 Marginalised by others 
 Unsupported by family/professionals 
 Service as powerful 
 Parent as powerless 
 Lack of support 
 The value of shared identity 
 
 
Alone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Emotional and 
Psychological Journey 
 
 Impact of public perceptions 
 Importance of validation/being heard/listened to 
 Parental / Family conflict 
 Self-doubt 
 Searching for concrete evidence 
 School observation on a “good day” 
Judged  
 Multifaceted role of the parent  
 Parent as teacher (child & others) 
 Parent as therapist 
 Parents as advocate and protector 
 Being a detective 
Impact on self 
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 Proving the case (Getting it right/remembering 
the right information) 
 Managing the systemic impact 
 Impact of the critical self 
 Long waiting times 
 Process as all consuming/life long 
 Multiple professionals 
 Lack of understanding from professionals 
 Lack of support 
 Service has the final say 
 Impact of seeing the same professionals 
 Desire to protect the child 
 Enmeshed – (diagnosis for self or child?) 
 Diagnosis as a badge 
 Feeling determined 
 Feeling powerless, stuck and exhausted 
 Navigating health and education services (being 
stuck in the middle)  
 Battle with critical self 
 Personal growth and development 
 
 
Unrelenting Battle 
 Uncertainty, confusion and disbelief 
 Disagreement with outcome 
 Sense the outcome is not right 
 Doubt: Outcome based on a “snapshot” of child’s 
life (brief school observation) 
 The more people get to know child the more they 
will notice 
 Needing time to process 
 Idea that ASD will show in time 
 The value of diagnosis (for help and support) 
 Continued fight 
 Feeling stuck 
 Helpfulness of professional’s description regarding 
the outcome 
 Value of having the door ‘left open’/‘a safety net’ 
 Service recommendation (Value of being offered a 
feedback appointment to discuss impact of outcome 
on self and family) 
 
 
 
 
 
 
 
 
 
Lack of Closure 
 
 
Understanding the 
Outcome 
 Trust in professionals 
 Satisfaction that others were wrong 
 Moving forward 
 Hope 
 
 
Relief 
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 Continued search for explanations 
 Hope of second opinion in future 
 Acceptance 
 Fear 
 Uncertainty 
 Closed doors 
 Lack of support 
 Worries about transition 
 The ‘inevitable crisis’ will occur  
 Perception that service provision and resources are 
wasted if assessment isn’t continued – something is 
still not right 
 
The Future 
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Appendix M 
 
Summary of Superordinate and Sub Themes Relevant to Each Participant 
 
 
 
 
 
 
 
  
 
 “My child is different” The Emotional and Psychological Journey Understanding the outcome 
 Emphasising 
Difference 
Talking 
about and 
Disclosing 
Difference 
Celebrating 
Difference 
Alone 
 
Judged Impact on 
self 
Unrelenting 
Battle 
Lack of 
Closure 
Relief The Future 
Jane √ √ √ √ √ √ √ √ √ √ 
Melissa √ √ √ √ √ √ √ √ √ √ 
Martha √  √ √ √ √ √  √ √ 
Emma √ √ √ √ √ √ √ √ √ √ 
Vicky and Paul √ √ √ √ √ √ √ √  √ 
Sarah √ √    √   √ √ 
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Appendix N 
 
Illustrative Quotes for Each Theme 
 
Superordinate 
Themes 
Subthemes Example Quotes 
“My Child is 
Different” 
Emphasising 
Difference 
 
Jane: We see a lot [of professionals], cos he’s quite complex. 
 
Melissa: She’s now in the learning center, she doesn’t seem to fit in there, and we’ve tried her with [youth club name], which is a youth club 
and she doesn’t seem to fit there either, it’s like nowhere where she’s sort of fits and gels with people, so it’s quite difficult really.  
 
Martha: I wondered if he had something cos we have a nephew that has it and his mum had said to me that George was acting a bit like Samuel 
when he was his age, so that’s when we turned around and said I’m going to bring him to the doctor just to see. 
 
Emma: He would get animals out and sort them out into groups and stuff. He just wasn’t where he should be with the other children. He 
wasn’t communicating with the other children.  
 
Vicky: I’m not saying that he has got a very bad case of it cos he hasn’t, I’d say he is…he he has…he shows traits of it...my brother’s son had 
autism, has got autism, and he didn’t speak until about five years, so I know there is extreme cases. Charlie’s not like that, he’s not an extreme 
case, but he is…he does have the traits of it…I watch the programme The Undateables and there are sometimes some characters in that and 
I’ll go “that’s Charlie!”  
 
Paul: Yeah and having a brother the same age, there is ten months between them, you could see how one brother was coping compared to the 
other, you know seeing slightly different traits. 
Sarah: It’s hard cause if I say to his brother, what are you feeling? he would just come out with it, he’d say oh I’m happy or I’m worried about 
this or erm I was this, so he would just come out with it and say what was in his imagination, whereas Henry wouldn’t. 
 Talking 
about 
Disclosing 
Difference 
Jane: There is something non NT [neuro-typical] and I know that anyway, that’s not a shock and that’s perfectly fine and we will find out as 
he gets older wont we what that specifically is, if there a word for it. 
 
Melissa: I wasn’t really open with people. My friends got a little boy that’s got erm…has been diagnosed with Asperger’s and she’s very open 
to people and will say you know this is what he has difficulty with, and I think maybe because I didn’t have a diagnosis, I never sort of said 
to the other parents ‘well, she struggles with this’ or something you know so maybe I should of and maybe they would have been a bit more 
understanding. 
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Emma: I noticed something about James when he was 9 months old. I knew that there was something…I hate using the word different or not 
normal but it’s the only language I’ve got to described it, you know? I just knew that he just wasn’t the same as other children. 
 
Vicky and Paul: There is something you know, but it’s not me wanting to put a label on him cos far from it. I don’t want…I don’t want to 
think my son has like autism or like Asperger’s, I don’t want that to happen you know. So it’s not like I’m one of these parents that’s like ‘oh 
he’s got this or he’s got that’ cos I haven’t even told him my concerns. No. He doesn’t even have a clue why he’s been coming here. He’s like 
‘why do I have to go there?’ cos I don’t want to label him. I don’t want to say ‘well I think you’ve got this’ cause’ I don’t want him to ever 
say in life ‘I can’t do that because I’ve got…this problem or that problem’ do you know what I mean? 
 
Sarah: I think that erm, you know his reality of things is probably a bit different. 
 Celebrating 
Difference 
 
Jane: He’s always going to be quirky and long may he rein! Good for him! 
 
Melissa: I suppose sometimes because she had her own bit of personality I’d find it quite amusing, you know and I’d think oh that’s quirky. 
 
Martha: We do know that he is intelligent because God he can bloody name all the dinosaurs, all the big long names and that, ah I can’t even 
pronounce them. He can pronounce them perfectly, so we know he is intelligent but you know to be told that, that’s a big surprise when 
someone else sees that. I’m just proud of him cause I’m his mum, so I’m just proud of him so to be told that by someone else as well, it meant 
a lot to us I think. Cos obviously teachers and that don’t pick up on that, they sometimes go with the negatives. 
 
Emma: Even thought I want to take all this away from him, actually I don’t because if I did that wouldn’t be my James. That wouldn’t be the 
boy that he is now. So…I’d want to take the pain away from him and the struggle that’s he’s got, but I would keep everything the same. 
 
Vicky and Paul: He’s super clever where the computer is concerned. He’s designing his own games, designs web pages, helped build up his 
own computer. He’s so clever. and he’s like “I’m going to go and work for Google” and I’m like ‘you’re going to own Google’. He’s not 
going to work for them, he’s going to own them! I can actually see that happening, I can actually see him being some kind of Steve Jobs…He 
is going to be Charlie Jobs. That makes me feel really happy, you know that makes me feel…you know I’m very proud.  
The Emotional 
and 
Psychological 
Journey 
Alone Jane: If you’ve got a diagnosis they say right, we’ll take you on all these training courses and we’ll do all these things, but if you’ve got a 
diagnosis of non neuro-typical but we don’t know why, or you know something like that, not at the moment...you sort of drift and you’re 
alone. There’s no counselling if you’ve had...or no one to talk to, because you can’t talk to your husband cos it’s painful. I’d listen to him, and 
you know we were both in a bit of pain and your sort of left. 
 
Melissa: Everything is sort of for you to find out yourself and that’s ok if you’ve got that drive and that ability to do so, but if you haven’t 
then your very very isolated. 
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Martha: I’ve always thought some of his behaviours were peculiar but my husband didn’t…I always suspected there was something wrong 
with his eyes and [husbands name] was like he’s fine, but I thought it wasn’t, you know mother's intuition they do say that and obviously it 
was right. 
 
Emma: My husband was in denial for a lot of the time. ‘Oh he will grow out of it, it’s nothing to worry about, he’s just a naughty boy.’ Hmm 
and my dad was very much the same as well, it was like, almost like they didn’t want a stigma…cos I just felt like people saw me as this fussy 
mother, you know, which at the time I never really thought about it cos I was so focused on James but to not have the support from my husband 
it was hard. It was hard at the start.  
Vicky and Paul: I felt like I had nobody to turn to and just blocks put in front of me constantly. 
 Judged 
 
Jane: All the time your thinking, I did say to Dr A I hope you don’t think this is some sort of Munchausen by proxy thing. I’m not afraid to 
say that [laughs]. I’m afraid that you think that I’m thinking that, because obviously Oliver had been in and out of hospital for lots of reasons, 
medical reasons, and of course when it’s medical you can see it can’t you? He’s having an asthma attack he can’t breathe, ok erm and when 
he was in anaphylactic shock you know you can see that he’s unresponsive, erm eczema we can see that he’s covered in eczema, his eyes, you 
can see that he can’t walk in a straight line, physio agreed etc. But something like this, it’s not tangible is it?” 
 
Melissa: The information they got from that assessment um was just spot on you know, it was and it sort of highlighted everything that I had 
been saying, you know I thought well that’s good it’s not just me saying it you can see it. 
 
Martha: I was kind of relieved when I’d first seen Fiona on the first one, cos to be fair you think you doubt stuff cos you think it’s all in your 
mind. 
 
Emma: You always get the sense that when your talking to people, you know because he hasn’t had a diagnosis I kind of get the feeling that 
other people think…erm it’s just in her head because they’ve said there’s nothing you know…clearly wrong there…She’s just making it up, 
or…It used to be really really hard to deal with. Now as time’s progressing I kind of think well stuff what anyone else thinks. I’m wasting my 
energy now that could be used better you know, on something else. Because at the end of the day its doesn’t really matter what they think. 
 
Vicky and Paul: I then began to think that it was just all in my head. How was it thinking that? Upsetting…because I don’t think…I don’t 
think it is all in my head…it’s not. It’s not cos other people have seen it.  
Impact on 
self 
Jane: Well if you’ve got emotion in…not that it’s not important of course, you need emotion in it cos it is very emotional, your son, your 
children are your life, they are my absolute world. But! if you’ve got too much of that bubbling up, then you’re not thinking clearly, and it 
might come across like an emotional rant ‘and look, what about me? what about me?’ it might seem that it’s all about you, ‘what about me, 
and I’m not coping, and he’s doing this and I’m not coping.’ 
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Melissa: It’s, yeah, it’s just sort of difficult at times you know? I have to sort of, I have to adapt, and sometimes it’s difficult cos I have to 
adapt the way I sort of parent Erin…Gemma who’s the older one [sister], says ‘you treat Erin differently’ or ‘you expect um less from Erin’ 
and that causes problems. 
 
Martha: I didn’t have any barriers. I think the only one with me was my memory, cos some of the questions Fiona was asking me, I was like 
God I can’t think. 
 
Emma: It’s horrendous to think that he might be lonely, because when I drop him off at school...well I can’t do anything then. I’m not there. 
I’m not in control of him. (sigh). Your heart just kind of sinks every time you drop him off at school. Some days it’s too much to bare. 
 
Vicky and Paul: They [older siblings] sometimes struggle. They get really narky with him and…you know…I…I’m the one whose saying 
‘try and understand, try and understand why he’s being like this, he doesn’t understand…’ It’s tiring. It’s really tiring. There are times when 
I’m at home and I’m just like I can’t…I can’t cope…because it does cause friction [tearful]. I’ve got four kids not just…not just one, but 
Charlie takes up the majority of my time, he does, and erm…not even, not just sitting and talking to him but emotionally, my emotions are 
constantly worrying about Charlie and sometimes I feel that I kind of neglect the others. 
 
Sarah: I worried, I didn’t want to appear as if I talked about what the different things were as if to preempt what an outcome would be. So if 
anything I was very apprehensive about it all, because I thought oh God…I didn’t want a label more than anything because I think him having 
the Dyslexia label had made him stop and think sometimes about what he is able to do and he uses it as an excuse not to do stuff. 
 Unrelenting 
Battle 
Jane: [Says to the teachers] well we’ll need to get support, [teachers respond] ‘well we can’t, we can’t there’s not money for support!’, and 
you know then you suddenly go on the same old battle. 
 
Melissa: You just feel you’re continually fighting for services, fighting for support, fighting for a better life for her hmm sort of with the 
education board that’s been a huge battle and you know most of my days off are sort of with, like erm phoning people or erm appointments 
or something and um sort of a lot of our time at home is sort of dominated by what Erin will or wont do. 
 
Martha: She [the teacher] didn’t seem to understand, cos I said he could have it. I she said we’ve thought to have him assessed but he could 
have it but she was still…every time I went in for a meeting she was still bringing the same things up. He keeps doing this, he keeps doing 
that, even thought I explained to them, please be patient until we’ve had the assessment. So I think that’s what made me go for the assessment 
to try and get other people to understand that if he did have it, because they just didn’t seem to understand the way he was acting.  
 
Emma: Exhausting. I’m exhausted. Especially with having three other children as well, who all need attention too. It is, it’s exhausting…I 
just…If they did another assessment on him and you know still that came back that actually you know he’s still borderline, you know that’s 
ok. But it’s the fact that you know I can see it, but they’ve just got a half an hour snap shot out of his life and based it on that. 
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Vicky and Paul: Were back to square one, five years on. Upsetting…and annoying. I’m…I go through the stages of…I get upset and then I 
get angry, cause I’m like ‘For God Sake, why is he just being…nobody wants to help him. So then I get angry and defensive and…worry 
about his future. 
Understanding 
the Outcome 
Lack of 
Closure 
Jane: If it’s a yes it’s more final sorry. If it’s a yes, you’ve got a life time of this thing, if it’s a no then you’ve got some uncertainty and that 
uncertainty might be good…might it? 
 
Melissa: So I think if you didn’t have those support networks you could be really isolated. I think that’s a huge thing, I think like some post 
diagnostic after the assessment, maybe in...I don’t know...in three or four weeks’ time or something to come back and to say right these are 
the numbers, these are the groups locally or something, this is what you could be entitled to. Um, just sort of that really. Um, would have been 
really really helpful. I think just to have it and then your left (laughs). And then sometimes I think well can I ring back if I’m having problems 
or do I not? 
 
Emma: He’s struggling again in the classroom. When they went out to do his classroom assessment at the start of the year [sigh] they went on 
a day where it was his favorite subject. It was about insects. So of course he was absolutely enthralled. So as far as the assessment went, you 
know…there was nothing to show cos he was complying. 
 
Vicky and Paul: Well one person said he is on the autistic spectrum, but then the other person said well we’re not sure he is on the autistic 
spectrum, however, we do think that he does need some help with his social skills. Even if you know we were just given some help you know 
on that, you know it just feels like I’ve just had a locked door…and now I’m having to find this key, that is on a key chain with about a million 
keys on it…you know it’s just been shut the door, lock it and that’s it.  
Relief Jane: It wasn’t easy to hear ‘no’, but it was easier that hearing ‘yes’. 
 
Melissa: I think it has made me a bit more accepting of her behaviour, I think it’s made me sort of deal with things differently. Um and try 
and sort of see things from her aspect and um sort of try and do things more at her pace rather than trying to push her into doing things that 
maybe she wasn’t comfortable with and that’s why she would behaviour the way that she did. 
 
Martha: It’s helped lot you know, understanding why he is the way he is in that way cos we didn’t know. We thought maybe it was something 
we’d done, you know is it the parenting, have we treated him like a baby? To me now, he’s a normal kid. 
 
Emma: Initially I thought well maybe it is the right decision cause initially he did improve with his reading and his writing and his 
communication. I put that down to the school though. 
 
Sarah: It was a big relief! Because it’s not just about school, it’s about relationships and the rest of his life. 
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 The Future  Jane: This is another thing that you hear as well, you have to wait and see if he tips over one way or another, he’s going to tip over one edge 
or another…and it seems to be the case that you have to get to a crisis before you get to a result, do you see what I mean? That scares me for 
the future. So were obviously going to have to hit a crisis, or not, hopefully not…hmm before anything else d’know what I mean? 
 
Melissa: You think ‘oh gosh’, you know, you think well what’s the future going to hold and erm...I don’t know, but I just tried to get her to 
do normal things. 
 
Martha: It [the assessment] made us understand George a bit more I think and it’s helped us a lot and helped us know where he needs help…it 
has helped us understand where we can help to bring him up, so I’m hoping that he wont need any help going forward with that, as long as 
the school are aware of it. 
 
Emma: My thoughts are that if he was given a diagnosis, well at least there’s that piece of paper to say James needs help, you know? So for 
me it would be a relief. Because whatever else happens it’s there in black and white he needs help and there’s people that can give it to me. 
 
Vicky: He’s now 13. He’s going to be leaving school at some point and I just feel he is going to get to an age where they are going to say ‘oh 
he is too old for us to give him some help now’ and I’ve been trying for years to get him some help.  
 
Paul: What’s your biggest worry about the future? That he is gonna be taken advantage of by other people...and you never know what he said 
earlier on in life, that he shouldn’t be in this world, it could resurface again couldn’t it as he gets older, you know pressures of life? 
 
Sarah: I suppose in some ways because school then have gone back to trying to resolve the bullying it’s helped, because if it had of been the 
spectrum, then they would have just put it down to how Henry interprets things. 
All names have been replaced by pseudonyms; [text] context added by author; ... (speech hesitation); Underlined text denotes questions asked by 
the interviewer; Italicised text denotes Paul’s speech during the joint responses in their interview. 
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Appendix O 
 
Word Count Statement 
 
Main Substance of Thesis 
Thesis Title: 14 
Thesis Abstract: 299 
Chapter 1: Literature Review 
 Title Page: 64 
Abstract: 250 (keywords: 7) 
Main text (without tables, figures and references): 6623 
 Total: 6944 
Chapter 2: Empirical Paper 
Title Page: 104 
Abstract:116 (keywords: 8) 
Main text (without tables and references): 6696 
 Total: 6924 
Chapter 3: Contribution to Theory and Clinical Practice 
Title Page: 15 
Main text (without references): 4963 
Total: 4978               Main Substance of Thesis Total: 19,159 
 
General Thesis Appendices (tables, figures, references and appendices) 
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 Welcome to the Integrated Research Application System
 IRAS Project Filter
The integrated dataset required for your project will be created from the answers you give to the following questions. The
system will generate only those questions and sections which (a) apply to your study type and (b) are required by the
bodies reviewing your study. Please ensure you answer all the questions before proceeding with your applications. 
Please complete the questions in order. If you change the response to a question, please select ‘Save’ and review all the
questions as your change may have affected subsequent questions. 
Please enter a short title for this project (maximum 70 characters) 
Experiences of the ASD Assessment when a diagnosis is not received
1. Is your project research?
 Yes  No
2. Select one category from the list below:
 Clinical trial of an investigational medicinal product
 Clinical investigation or other study of a medical device
 Combined trial of an investigational medicinal product and an investigational medical device
 Other clinical trial to study a novel intervention or randomised clinical trial to compare interventions in clinical practice
 Basic science study involving procedures with human participants
 Study administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative
methodology
 Study involving qualitative methods only
 Study limited to working with human tissue samples (or other human biological samples) and data (specific project
only)
 Study limited to working with data (specific project only)
 Research tissue bank
 Research database
If your work does not fit any of these categories, select the option below:
 Other study
2a. Please answer the following question(s):
a) Does the study involve the use of any ionising radiation?  Yes       No
b) Will you be taking new human tissue samples (or other human biological samples)?  Yes       No
c) Will you be using existing human tissue samples (or other human biological samples)?  Yes       No
3. In which countries of the UK will the research sites be located?(Tick all that apply)
 England
 Scotland
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 Wales
 Northern Ireland
3a. In which country of the UK will the lead NHS R&D office be located:
 England
 Scotland
 Wales
 Northern Ireland
 This study does not involve the NHS
4. Which applications do you require?
IMPORTANT: If your project is taking place in the NHS and is led from England select 'IRAS Form'. If your project is led
from Northern Ireland, Scotland or Wales select 'NHS/HSC Research and Development Offices' and/or relevant
Research Ethics Committee applications, as appropriate.
 IRAS Form
 NHS/HSC Research and Development offices
 Social Care Research Ethics Committee
 Research Ethics Committee
 Confidentiality Advisory Group (CAG)
 National Offender Management Service (NOMS) (Prisons & Probation)
For NHS/HSC R&D Offices in Northern Ireland, Scotland and Wales the CI must create NHS/HSC Site Specific
Information forms, for each site, in addition to the study wide forms, and transfer them to the PIs or local
collaborators. 
For participating NHS organisations in England different arrangements apply for the provision of site specific
information. Refer to IRAS Help for more information.
5. Will any research sites in this study be NHS organisations?
 Yes       No
6. Do you plan to include any participants who are children?
 Yes       No
7. Do you plan at any stage of the project to undertake intrusive research involving adults lacking capacity to consent
for themselves?
 Yes       No
Answer Yes if you plan to recruit living participants aged 16 or over who lack capacity, or to retain them in the study following
loss of capacity. Intrusive research means any research with the living requiring consent in law. This includes use of
identifiable tissue samples or personal information, except where application is being made to the Confidentiality Advisory
Group to set aside the common law duty of confidentiality in England and Wales. Please consult the guidance notes for
further information on the legal frameworks for research involving adults lacking capacity in the UK.
8. Do you plan to include any participants who are prisoners or young offenders in the custody of HM Prison Service or
who are offenders supervised by the probation service in England or Wales?
 Yes       No
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9. Is the study or any part of it being undertaken as an educational project? 
 Yes       No
Please describe briefly the involvement of the student(s): 
Chief Investigator
9a. Is the project being undertaken in part fulfilment of a PhD or other doctorate?
 Yes       No
10. Will this research be financially supported by the United States Department of Health and Human Services or any of
its divisions, agencies or programs?
 Yes       No
11. Will identifiable patient data be accessed outside the care team without prior consent at any stage of the project
(including identification of potential participants)?
 Yes       No
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Integrated Research Application System
Application Form for Research involving qualitative methods only
 Application to NHS/HSC Research Ethics Committee
The Chief Investigator should complete this form. Guidance on the questions is available wherever you see this
symbol displayed. We recommend reading the guidance first. The complete guidance and a glossary are available by
selecting Help. 
Please define any terms or acronyms that might not be familar to lay reviewers of the application.
Short title and version number: (maximum 70 characters - this will be inserted as header on all forms)   
Experiences of the ASD Assessment when a diagnosis is not received
Please complete these details after you have booked the REC application for review.
REC Name:
Wales REC 5
REC Reference Number: 
16/WA/0164      
Submission date:   
12/05/2016
 PART A: Core study information
 1. ADMINISTRATIVE DETAILS
A1. Full title of the research:
Parents experiences of the Autistic Spectrum Disorder assessment process when the child did not receive a
diagnosis.
A2-1. Educational projects
Name and contact details of student(s): 
Student 1
 
 Title   Forename/Initials  SurnameMiss Lesley-Anne  Bendik
Address North Wales Clinical Psychology Programme
 School of Psychology
 Bangor University, Bangor, Gwynedd
Post Code LL572DG
E-mail psp511@bangor.ac.uk
Telephone 01248382205
Fax
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Give details of the educational course or degree for which this research is being undertaken:
Name and level of course/ degree: 
Doctorate in Clinical Psychology (D.Clin.Psy)
 
Name of educational establishment: 
Bangor University
 
 
Name and contact details of academic supervisor(s): 
Academic supervisor 1
 
 Title  Forename/Initials  SurnameDr  Freya  Spicer-White
Address Wrexham CAMHS
 PO Box 2073
 Wrexham Maelor Hospital
Post Code LL13-7ZA
E-mail Freya.Spicer@wales.nhs.uk
Telephone 01978725242
Fax
 
Please state which academic supervisor(s) has responsibility for which student(s): 
Please click "Save now" before completing this table. This will ensure that all of the student and academic supervisor
details are shown correctly. 
Student(s) Academic supervisor(s)
Student 1  Miss Lesley-Anne Bendik  Dr Freya Spicer-White
A copy of a current CV for the student and the academic supervisor (maximum 2 pages of A4) must be submitted with the
application.
A2-2. Who will act as Chief Investigator for this study?
 Student
 Academic supervisor
 Other
A3-1. Chief Investigator:
     
 Title   Forename/Initials  SurnameMiss Lesley-Anne  Bendik
Post Trainee Clinical Psychologist
Qualifications
BSc Psychology
MSc Applied Behaviour Analysis
PGCert Psychological Trauma
Employer Betsi Cadwaladr University Health Board
Work Address North Wales Clinical Psychology Programme
 School of Psychology
 Bangor University, Bangor, Gwynedd
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Post Code LL57 2DG
Work E-mail psp511@bangor.ac.uk
* Personal E-mail Lesley_anne1987@hotmail.com
Work Telephone 01248382205
* Personal Telephone/Mobile
Fax
* This information is optional. It will not be placed in the public domain or disclosed to any other third party without prior
consent.
A copy of a current CV (maximum 2 pages of A4) for the Chief Investigator must be submitted with the application.
A4. Who is the contact on behalf of the sponsor for all correspondence relating to applications for this project?
This contact will receive copies of all correspondence from REC and HRA/R&D reviewers that is sent to the CI.
     
 Title  Forename/Initials  SurnameMr  Hefin  Francis
Address School of Psychology
 Bangor University, Bangor, Gwynedd
 
Post Code LL57 2AS
E-mail h.francis@bangor.ac.uk
Telephone 01248388339
Fax
A5-1. Research reference numbers. Please give any relevant references for your study:
Applicant's/organisation's own reference number, e.g. R & D (if
available):
Sponsor's/protocol number: Bangor university: 1568
Protocol Version: 1
Protocol Date: 04/05/2016
Funder's reference number: N/A
Project
website: N/A
Additional reference number(s):
Ref.Number Description Reference Number
Registration of research studies is encouraged wherever possible. You may be able to register your study through
your NHS organisation or a register run by a medical research charity, or publish your protocol through an open
access publisher. If you have registered your study please give details in the "Additional reference number(s)"
section.  
A5-2. Is this application linked to a previous study or another current application?
 Yes       No
Please give brief details and reference numbers.
 2. OVERVIEW OF THE RESEARCH  
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To provide all the information required by review bodies and research information systems, we ask a number of
specific questions. This section invites you to give an overview using language comprehensible to lay reviewers and
members of the public. Please read the guidance notes for advice on this section.
A6-1. Summary of the study.   Please provide a brief summary of the research (maximum 300 words) using language
easily understood by lay reviewers and members of the public. Where the research is reviewed by a REC within the UK
Health Departments’ Research Ethics Service, this summary will be published on the Health Research Authority (HRA)
website following the ethical review. Please refer to the question specific guidance for this question.
Autistic Spectrum Disorder (ASD) is a life long neurological developmental disorder. The process of obtaining this
diagnosis for a child can be a difficult and emotional time for parents (Reed & Osborne, 2012). The majority of the
previous research in this area has looked at parent’s experiences of the ASD assessment process, when the
outcome has confirmed that their child or young person does meet the criteria for this diagnosis. Such research has
reflected the relief that parent’s experience upon receiving a correct diagnosis, as this is often considered to be the key
to achieving a level of acceptance and understanding of their child’s emotional, behavioural and communication
difficulties and most importantly access the appropriate support (Midence & O’Neill, 1999). However, there is very
limited research on the experience of parents who go through the same assessment process, which can be lengthy
and frustrating (Howlin & Moore, 1997), but for who their child’s difficulties do not meet the diagnostic criteria and thus
do not receive a diagnosis. 
The aim of the present study is to explore the experience of parents/guardians whose child is assessed for ASD in a
Child and Adolescent Mental Health Service in North Wales but who do not receive a diagnosis. To gain a true
understanding of the lived experience of this group of individuals, the research will adopt a qualitative approach,
whereby the participants will be asked to share their experiences in an interview with the researcher.
It is hoped that the outcome of this research will help clinicians understand how best they can support families
through the assessment process. It is also hoped that the research will inform services of how to improve their
approach to providing good quality information and provide guidelines on how best to communicate a non-diagnosis
to family members.
A6-2. Summary of main issues. Please summarise the main ethical, legal, or management issues arising from your study
and say how you have addressed them.
Not all studies raise significant issues. Some studies may have straightforward ethical or other issues that can be identified
and managed routinely. Others may present significant issues requiring further consideration by a REC, R&D office or other
review body (as appropriate to the issue). Studies that present a minimal risk to participants may raise complex
organisational or legal issues. You should try to consider all the types of issues that the different reviewers may need to
consider.
Purpose and Design:
The purpose of this research to explore the lived experience of parents whose child/young person has been through
the Autistic Spectrum Disorder (ASD) diagnosis process but have not received a diagnosis. This area has received
little acknowledgement within the literature and therefore the researcher hopes the findings will contribute to the
current evidence base and inform clinical practice. The researcher has chosen a qualitative approach to allow for a
more in-depth analysis of the perceptions and experiences felt by these individuals. The research is being completed
as part of a Doctorate in Clinical Psychological qualification and therefore its design has been approved by the
research team at Bangor University and the academic supervisor who is an experienced Clinical Psychologist working
within a Neurodevelopmental team.
Recruitment:
Clinicians working within the ASD diagnostic team within the relevant Child and Adolescent Mental Health Service
(CAMHS) will inform potential participants of the research and issue them with an information sheet as part of their
post assessment non-diagnosis pack, which is routinely provided within the current service. Potential participants will
be asked to read the information sheet in their own time. They will be informed by the clinician that they can opt-out to
being contacted by the researcher. They will also be informed that if they don't chose to opt out of being contacted, the
researcher will contact them by telephone within four weeks of their appointment. It will be highlighted that this does
not mean they have to participate. This contact will simply be to ask whether they have any questions regarding the
research, whether they need any further information and whether they would like to take part. 
Alternatively, if potential participants have already attended for their feedback appointment but who meet the criteria
(received a non-diagnosis within the past 12months), the clinician will send the information sheet and opt-out form in
the post accompanied by a letter introducing the purpose of the information. As above, they will be encouraged to
complete the opt-out form and return this in the envelope provided within 2 weeks of the date of the letter should they
not wish to be contacted. If the opt-out form is not returned, the researcher will contact them by telephone within four
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weeks of the information being sent.
Consent:
The researcher will provide detailed information regarding the study prior to obtaining the participants consent. All
participants will have the opportunity to take their time to consider this information and to ask questions. Informed
consent will obtained by the researcher in writing prior to conducting the research interview. 
Risks, Burdens and Benefits:
Betsi Cadwaladr University Health Boards (BCUHB) confidentiality procedures will apply at all times throughout the
research. Confidentiality and its limitations will be explained in detail to all participants prior to starting the interview. 
The nature of this research involves interviewing parents about a potentially difficult and stressful process of
assessment for a life long diagnosis for their child. Therefore, whilst no distress or harm is intended, the researcher
recognises that this is potentially an emotive subject, and asking parents to share their experiences may cause
distress. The researcher will discuss this with all participants prior to the interview and will remain sensitive
throughout. The participants will be encouraged to say if they do not wish to answer a question and they will be made
aware that they can have a break, or that the interview can be terminated at any point. The researcher will signpost
participants, with their consent, to their GP or to appropriate services to access support should this be necessary. 
All participant's will be offered a token gesture of appreciation (ten pound gift voucher) for their time and sharing their
expertise with the researcher. As all interviews will take place within the local CAMHS service they have previously
attended, their travel expenses will be reimbursed.
Confidentiality and Data Management:
Throughout the research all participants will be assigned a participant number to protect their identity. The research
team will keep a record of the participant’s name and corresponding participant number so that if any participants
wish to withdraw from the study their information can be located and removed.
The interviews will be recorded on a digital recorder which will be kept in a locked filing cabinet. Following the interview
these will be transcribed anonymously onto an encrypted device. All information collected throughout the project will be
stored and managed in accordance with Bangor Universities policies and procedures, BCUHBs information
governance policy and the Data Protection Act (1998).
When the results of the study are written up, direct quotes from the interview may be included. However, the researcher
will follow strict guidelines to ensure that the individuals personal information is not included and that no-one reading
the report will be able to identify the individual from the quotes or information included. For example, the participants
name will be changed and any identifiable information will be removed. On completion of the research, all data will be
deleted in line with the policies and procedures at Bangor University.
A6-3. Proportionate review of REC application  The initial project filter has identified that your study may be suitable for
proportionate review by a REC sub-committee. Please consult the current guidance notes from NRES and indicate whether
you wish to apply through the proportionate review service or, taking into account your answer to A6-2, you consider there
are ethical issues that require consideration at a full REC meeting.
 Yes - proportionate review  No - review by full REC meeting
Further comments (optional):
Note: This question only applies to the REC application.
 3. PURPOSE AND DESIGN OF THE RESEARCH
A7. Select the appropriate methodology description for this research. Please tick all that apply:
 Case series/ case note review
 Case control
 Cohort observation
 Controlled trial without randomisation
 Cross-sectional study
 Database analysis
 Epidemiology
 Feasibility/ pilot study
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 Laboratory study
 Metanalysis
 Qualitative research
 Questionnaire, interview or observation study
 Randomised controlled trial
 Other (please specify)
A10. What is the principal research question/objective? Please put this in language comprehensible to a lay person.
The principal aim of this research is to analyse parent’s perceptions and experiences of the autistic spectrum disorder
(ASD) assessment process. This question is specifically being asked to parents whose child has been through the
process but whose difficulties do not meet the criteria for diagnosis.
A11. What are the secondary research questions/objectives if applicable? Please put this in language comprehensible to
a lay person.
What were parents experiences prior to the assessment; what difficulties did their child have, when were they first
noticed and what did they hope to gain from the assessment process?
Whether they understood the assessment process and whether they felt heard, included and understood throughout
the process?
Whether they felt their responses helped or hindered the process and outcome in any way?
What were their experiences following the assessment and whether their child has undergone any further
assessment?
A12. What is the scientific justification for the research? Please put this in language comprehensible to a lay person.
Autistic Spectrum Disorder (ASD) is a complex and lifelong neurological developmental disorder, which is thought to
affect approximately 700,000 individuals within the United Kingdom (Baird et al., 2006). The process of obtaining this
diagnosis, can be extremely distressing for parents but is often required as future care and educational support
available to their child is usually dependent upon diagnosis (Keenan, Dillenburger, Doherty, Byrne & Gallagher, 2010).
In their large cross-sectional study, Keenan et al., found that parents reported their experience of the ASD assessment
process as long, unclear, difficult to understand and that future planning/interventions were limited and did not involve
full parental inclusion. They further stated that diagnosing a child at a young age and consequently providing the
necessary intervention at the earliest possible opportunity is a major protective factor for families. 
From a survey of almost 1300 parents of children involved with Autistic societies in the UK, Howlin and Moore (1997)
found that 49% reported they were ‘not very’ or ‘not at all’ satisfied with the assessment process. Factors contributing
to their dissatisfaction included long delays between raising their concerns and first being seen by a professional and
the number of professionals seen prior to the diagnosis being made. Another important factor related to the given
outcome and feedback appointment, as parent’s satisfaction reduced when a vague explanation or outcome was
given. For example, whilst almost 70% had eventually received a formal diagnosis of ASD, 26.7% of the sample
reported that the given diagnosis was described as their child having autistic ‘traits’, ‘features’ or ‘characteristics’. This
diagnosis/description was reported as being particularly confusing and unhelpful. Only 29 people of the overall
sample indicated that they had received a negative-diagnosis. However, these responses were not analysed
separately and therefore it was not possible to determine whether their experiences differed from those who did
receive a diagnosis. 
Similar research documenting the difficulties parents have in navigating the ASD assessment process was presented
by Siklos and Kerns (2007). They found that over 50% of their sample were dissatisfied both with the diagnostic
process and with the lack of advice and support in the months following the outcome of their assessment. They
highlighted that parents typically saw an average of 4.5 professionals in an attempt to obtain the correct support and
diagnosis, and that they had typically waited 3 years from the time they first sought advice to the time the assessment
was completed. 
Whilst the assessment and diagnosis process has indicated to be an extremely stressful time for parents, and that a
huge proportion of parent’s report feeling dissatisfied predominantly with the length of time the process takes and the
implications this has in terms of lack of support, the research has shown that ‘relief’ is often felt when the correct
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diagnosis is provided (Mullingan, MacCulloch, Good & Nicholas, 2012; Reed & Osborne, 2012). A clear diagnosis and
is considered to be the key to achieving a level of acceptance and understanding of their emotional, behavioural and
communication difficulties and of course access the to appropriate support (Midence & O’Neill, 1999).
It appears that the emotional impact of this process on parents whose child is diagnosed with ASD is well
documented. However, what remains unclear is the impact on parents who endure the same lengthy and frustrating
process in the hope of achieving an explanation and support for their child’s difficulties, but for who the outcome
remains inconclusive as their difficulties are not deemed to meet the diagnostic threshold. This area is largely
neglected within the wider literature and particularly within North Wales. 
Therefore, the purpose of the current study is to explore the experiences of the parents in North Wales whose child
presents with a number of social, communication and/or behavioural difficulties, and have been through the ASD
diagnosis assessment process, but who did not receive a diagnosis. It is anticipated that parents may experience a
range of emotions, which could include relief but also frustration, anger, disappointment, confusion, loss or
hopelessness. The impact of such, could potentially interfere with the parent’s ability to continue to manage their
child’s difficulties, their own health, and could also potentially have negative implications financially, if they feel they
were dissatisfied with the process and wish to seek additional support or advice privately. This later point, is
particularly relevant in North Wales at present, as there are currently no clear guidelines regarding a second opinion
policy if parents are dissatisfied with the process or outcome of the ASD assessment.
Overall, it is important to understand the lived experiences of this group of individuals and in line with the National
Service Framework and learn from service users’ perspectives, in order to improve service delivery and professional
practice. In particular, it is intended that this research will inform professionals on how to improve the ASD
assessment and diagnostic process and how best to communicate a non-diagnosis to the family following the
assessment.
A13. Please summarise your design and methodology. It should be clear exactly what will happen to the research
participant, how many times and in what order. Please complete this section in language comprehensible to the lay person.
Do not simply reproduce or refer to the protocol. Further guidance is available in the guidance notes.
Parent/guardians whose child has been assessed for ASD, and who have not received a diagnosis, will be informed
of the research by their CAMHS clinician during their routine feedback appointment and given information to read at
home. Alternatively, the clinician will be send parents/guardian information regarding the research in the post if their
feedback appointment had already taken place within the past 12 months. 
They will be encouraged to complete the opt-out form either during the appointment (or return it within 2weeks if the
information is sent by post) if they do not wish to be contacted regarding the research. If the individual is happy to be
contacted, the researcher will do so by telephone within four weeks of them receiving the information sheet during
their feedback appointment or in the post. This will give the individual ample time to read and process the information. 
If the opt-out form has not been received within this time, the principal researcher will make contact with them by
telephone to ask whether they have any questions regarding the research, whether they would like any further
information and if they would like to take part. A telephone protocol will be adhered to.
If they agree to participate the researcher will arrange a convenient time to meet with them for one meeting at their
local CAMH service.
During this meeting, the researcher will obtain written informed consent, and complete the research interview. Firstly,
this will involve asking the participant demographic questions relating to their relationship to the child, the child's age
at assessment, the child's gender, the length of referral time and the length of time since the assessment and
feedback appointment took place. Secondly, they will be asked to share their experience of the ASD assessment
process, prompted by a number of questions. The interview will last approximately 45-90 minutes in total.
Once the research interviews have been completed, the researcher will analyse the interviews using the qualitative
method of interpretative phenomenological analysis (IPA). The researcher will write a brief summary of the findings
and this will be posted to the participant by their local CAMH service.
A14-1. In which aspects of the research process have you actively involved, or will you involve, patients, service users,
and/or their carers, or members of the public?
 Design of the research
 Management of the research
 Undertaking the research
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 Analysis of results
 Dissemination of findings
 None of the above
 
Give details of involvement, or if none please justify the absence of involvement.
The participant information sheet, the opt-out form, the consent form and the interview questions have been reviewed
by a representative of service user panel, associated with the Doctorate in Clinical Psychology Programme at Bangor
University. 
 4. RISKS AND ETHICAL ISSUES
 RESEARCH PARTICIPANTS
A17-1. Please list the principal inclusion criteria (list the most important, max 5000 characters).
Inclusion Criteria:
Parents and/or carers of children (5-19 years) who have been referred for an ASD assessment, and despite
presenting with behavioural, communication and/or emotional difficulties do not meet the criteria for diagnosis. They
will only be eligible for inclusion in the research once they have attended a feedback appointment and thus it has been
confirmed that they will not receive a diagnosis based on the current assessment.
Parents and/carers must be over 18 years of age.                                                                                    
The assessment must have taken place within the past 12 months.
The parents and/or carers will be selected from families who underwent the assess process within a Child and
Adolescent Mental Health Service (CAMHS) within BCUHB. However, the principal base for recruitment will be from the
Neurodevelopment Team (Wrexham and Flintshire CAMHS).
A17-2. Please list the principal exclusion criteria (list the most important, max 5000 characters).
Exclusion Criteria:
Parents/Carers who do have the capacity to provide informed consent.
Parents/Carers whose child is already receiving professional support from another service in relation to the difficulties
they have presented with. For example; Learning Disability Services.
Parents/Carers whose child receives another diagnosis, other than ASD, from the ASD assessment process. For
example; ADHD.
 RESEARCH PROCEDURES, RISKS AND BENEFITS  
A18. Give details of all non-clinical intervention(s) or procedure(s) that will be received by participants as part of the
research protocol. These include seeking consent, interviews, non-clinical observations and use of questionnaires.
Please complete the columns for each intervention/procedure as follows:
1. Total number of interventions/procedures to be received by each participant as part of the research protocol.
2. If this intervention/procedure would be routinely given to participants as part of their care outside the research,
how many of the total would be routine?
3. Average time taken per intervention/procedure (minutes, hours or days)
4. Details of who will conduct the intervention/procedure, and where it will take place.
Intervention or
procedure 1 2 3 4
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Approached
regarding the
research during
their routine
feedback
appointment, or
sent information
regarding the
research in the
post.
1 1 10minutes The individuals regular CAMHS clinician will approach the individual about
the research during their routine feedback appointment and they will be
given an information sheet to read at home. They will be encouraged to
complete the opt-out form if they do not wish to be contacted regarding the
research. If the individual is happy to be contacted by the researcher, the
research will do so by telephone within four weeks of them receiving the
information sheet during their feedback appointment. This will give the
individual ample time to read and process the information. 
If the individual has already attended the appointment (in the past
12months) the individual will be sent the information sheet and opt-out
form in the post by their local CAMHS clinician. They will be encouraged to
return the opt-out form in the envelop provided within 2weeks of the date of
the letter. If the opt-out form has not been received within this time, the
researcher will make contact with them by telephone.  
The researcher will
contact the
individual by
telephone.
1 0 10minutes The principal researcher (Miss Lesley-Anne Bendik) will contact the
individual by telephone to ask whether they have any questions regarding
the research, whether they would like any further information and if they
would like to take part. A telephone protocol will be adhered to to ensure the
individual is not put under any pressure to participate. If they agree to
participate the researcher will arrange a convenient time to meet with them
at their local CAMH service to complete the consent form and research
interview.
Informed consent
will be obtained.
1 1 10minutes The principal researcher will discuss the research with the participant and
check whether they have any questions. Written informed consent will be
taken prior to beginning the interview.
Demographic
Questions.
1 1 15minutes The principal researcher will ask the participant questions relating to their
relationship to the child, the child's age at assessment, the child's gender,
the length of referral time and the length of time since the assessment and
feedback appointment took place.
Research Interview. 1 0 45-
90minutes
The researcher will ask the participant to give a detailed description of their
experiences of the ASD assessment process.
Feedback will be
disseminated to all
participants.
1 0 10minutes Once the research has been completed, the researcher will write a brief
summary of the findings and this will be posted to the participant by their
local CAMH service.
A21. How long do you expect each participant to be in the study in total?
The time from when the participant will be first given the information sheet regarding the research to the time they
receive a summary of the findings is anticipated to be approximately 18 months. However, the participants will only be
actively involved in the research for approximately 3 hours.
A22. What are the potential risks and burdens for research participants and how will you minimise them?
For all studies, describe any potential adverse effects, pain, discomfort, distress, intrusion, inconvenience or changes
to lifestyle. Only describe risks or burdens that could occur as a result of participation in the research. Say what steps
would be taken to minimise risks and burdens as far as possible.
The interview questions will invite the participants to share their personal experiences of their child going through the
ASD assessment process. This could potentially elicit difficult emotions for the participant as they may find sharing
their thoughts and experiences upsetting or distressing. 
The researcher will make participants aware of this potential risk in the information sheet they will receive prior to
consenting to participate in the study. This will also be discussed again during the consent process prior to the
beginning of the interview. 
The researcher will be sensitive to the needs of the participants and allow them to take regular breaks during the
interview, skip questions they do not wish to answer, or terminate the interview. Should this situation arise the
researcher will discuss this with the participant and allow additional time to work through their difficult emotions and
agree on a decision together on how best to manage their emotional distress. The researcher will ensure she has
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appropriate contact details for participants to access further support if appropriate, and with their consent will
encourage them to access their GP. The participant will also be informed of their right to withdraw from the research
at any time without reason or consequence.
It is anticipated that the participants may have certain expectations from the research team with regards to accessing
psychological support. All participants will be informed that although the researcher is a trainee clinical psychologist
and has the skills to manage emotional responses and distress during the interview, the aim of the interview is not to
provide therapeutic input.   However, as mentioned above if ongoing support is considered necessary the researcher
will sign post the individual to an appropriate service, with their consent.
The participants will also be informed through the information sheet that not all the information they provide during
the interview will be included in the final report, as this needs to be representative of all the individuals involved. They
will be informed that regardless of whether their information is included in the final report or not, all the information
they provide is extremely valuable.
A23. Will interviews/ questionnaires or group discussions include topics that might be sensitive, embarrassing or
upsetting, or is it possible that criminal or other disclosures requiring action could occur during the study?
 Yes       No
If Yes, please give details of procedures in place to deal with these issues:
The interview questions will invite the participants to share their personal experiences of their child going through
the ASD assessment process. This is a potentially emotive subject and at times participants may find sharing these
experiences upsetting or distressing. The researcher will be sensitive to the needs of the participants and allow
them to take regular breaks during the interview, skip questions they do not wish to answer, or terminate the
interview. The participant will be informed of this prior to the interview and their right to withdraw from the research at
any time without reason or consequence will be highlighted. 
A24. What is the potential for benefit to research participants?
The researcher would like to offer a token gesture of a £10 voucher to all participants for sharing their time,
experiences and expertise to improve professional knowledge and help the service and profession improve patients
and family members experience of the ASD assessment process in the future. The participants will also be asked to
attend their local CAMH service to complete the interview and therefore their travel expenses will be reimbursed. 
Participants may also find it helpful or enjoyable to share their experiences and contribute to scientific research, which
will potentially improve the service and experiences of other families who go through the same process in the future.
All participants will be sent a summary of the results at the end of the study.
A26. What are the potential risks for the researchers themselves? (if any)
The nature of conducting in-depth interviews with participants who may share emotive experiences might have an
impact on the emotions of the researcher. The researcher is a Trainee Clinical Psychologist who   has the skills to
manage difficult emotional responses and can access regular supervision from a Clinical Psychologist to discuss
and manage her emotions if necessary.
 RECRUITMENT AND INFORMED CONSENT
 In this section we ask you to describe the recruitment procedures for the study. Please give separate details fordifferent study groups where appropriate.
A27-1. How will potential participants, records or samples be identified? Who will carry this out and what resources
will be used?For example, identification may involve a disease register, computerised search of GP records, or review of
medical records. Indicate whether this will be done by the direct healthcare team or by researchers acting under
arrangements with the responsible care organisation(s).
Potential participants will be identified by the clinician who is in charge of assessing the child/young person and
providing feedback regarding the outcome of diagnosis to the family. These clinicians will all be employed by BCUHB
and will be embedded within the CAMHS team where the child is assessed. In all feedback appointments, the family
are routinely provided with an information pack to take home regarding the outcome of their assessment. When a
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diagnosis has not been given the clinician will introduce the research at the end of the feedback appointment and
include the participant information sheet within their pack. The potential participant will be encouraged to read this in
their own time if they think they might like to be involved with the research. They will also be given the opportunity to
complete an opt-out form. Completion of this form will mean the researcher will not contact them to discuss the
research further. The clinician will inform the potential participant that if they do not complete this form, the researcher
will contact them via telephone within four weeks of the appointment to ask if they have any questions, require more
information about the research and to see if they would like to take part. They will be clearly informed that this does not
mean that they are consenting to be involved in the research. Likewise, they will be clearly informed that should they
wish to compete the opt-out form, they do not have to give a reason, and the care they receive from the NHS will not be
affected. 
Alternatively, if potential participants have already attended for their feedback appointment but who meet the inclusion
criteria (did not receive a diagnosis following their assessment, within the past 12months), the clinician will send the
information sheet and opt-out form in the post accompanied by a letter introducing the purpose of the research. As
above, they will be encouraged to complete the opt-out form and return this in the envelope provided within 2 weeks of
the date of the letter should they not wish to be contacted. If the opt-out form is not returned, the researcher will contact
them by telephone within four weeks of the information being sent.
In the event that potential participants do not complete the opt-out form, and thus are happy to be contacted by the
researcher, the clinician will provide the researcher with the individuals name and contact telephone number. This
information will be given to the researcher, who is also employed within BCUHB, at the relevant service location (e.g.
Wrexham CAMHS) and the researcher will make all telephone calls to the individual's from within the service base.
This means that no personal information is taken off-site at any time; all information will be kept in a locked filing
cabinet, in a locked room within the CAMHS service. 
Once the researcher has made contact with the individual (using the telephone protocol) they will either arrange an
appropriate time to meet with the individual if they wish to be involved in the research, or if they do not wish to be
involved their contact details will be destroyed immediately.
A27-2. Will the identification of potential participants involve reviewing or screening the identifiable personal
information of patients, service users or any other person?
 Yes       No
Please give details below:
The individuals regular clinician will identify potential participants and inform them of the research at their feedback
appointment or by post if they have already attended their feedback appointment within the past 12months. The
information sheet given by the clinician will clearly explain that should they not wish to be contacted by the researcher
they can compete the opt-out form, without reason or consequence. It will also be clearly detailed that if they don't not
complete the opt-out form, this does not mean they are consenting to participate in the research, just that the
researcher will contact them once they have had chance to read the participant information sheet to ask whether they
have questions and whether at that point they would like to participate. Prior to any involvement in the research, the
researcher will obtain written informed consent from all participants.
A28. Will any participants be recruited by publicity through posters, leaflets, adverts or websites?
 Yes       No
A29. How and by whom will potential participants first be approached?
The participants will first be approached by their CAMHS (Child and Adolescent Mental Health Service) clinician during
their feedback appointment. The clinician will provide the parent/guardian with the information sheet in the information
pack that all families are routinely given by the service following their assessment if the outcome is that a diagnosis is
not given. The clinician will inform the family that the information sheet is included. They will have the opportunity to
complete an opt-out form at the time if they do not wish to hear any further information regarding the research. If they
do not chose to opt-out, the clinician will provide the researcher with their name and telephone number, and the
researcher will contact them within 4 weeks of receiving the information to ask if they have any questions and discuss
their participation further. It will be made clear to each individual that it is their choice whether they participate in the
research.
Alternatively, if potential participants have already attended for their feedback appointment but who meet the criteria
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(did not receive a diagnosis following their ASD assessment, within the past 12months), the clinician will send the
information sheet and opt-out form in the post accompanied by a letter introducing the purpose of the information. As
above, they will be encouraged to complete the opt-out form and return this in the envelope provided within 2 weeks of
the date of the letter should they not wish to be contacted. If the opt-out form is not returned, the researcher will contact
them by telephone within four weeks of the information being sent.
A30-1. Will you obtain informed consent from or on behalf of research participants?
 Yes       No
If you will be obtaining consent from adult participants, please give details of who will take consent and how it will be
done, with details of any steps to provide information (a written information sheet, videos, or interactive material).
Arrangements for adults unable to consent for themselves should be described separately in Part B Section 6, and for
children in Part B Section 7.
If you plan to seek informed consent from vulnerable groups, say how you will ensure that consent is voluntary and
fully informed.
A detailed information sheet will be provided to potential participants in writing. They will also be given an opt-out form
which the potential participant can complete should they not wish to be contacted by the researcher. The researcher
will contact the potential participant within four weeks of them receiving the information to enquire whether they have
any questions, require further information and whether they wish to participate in the research. 
Prior to the interview the researcher will discuss all aspects of the information sheet and consent form with the
participant and obtain written consent from them.
 
If you are not obtaining consent, please explain why not.
Please enclose a copy of the information sheet(s) and consent form(s).
A30-2. Will you record informed consent (or advice from consultees) in writing?
 Yes       No
A31. How long will you allow potential participants to decide whether or not to take part?
The researcher will allow four weeks for potential participants to read the information sheet before contacting them to
ask whether they have any questions and whether they would like to take part in the research.
A33-1. What arrangements have been made for persons who might not adequately understand verbal explanations or
written information given in English, or who have special communication needs?(e.g. translation, use of interpreters)
All written information about the research study (e.g. information sheet, opt-out form, consent form) will be provided in
Welsh and English. However, the interview will only be conducted in English, as unfortunately the researcher is not a
Welsh speaker. 
As the research is qualitative in nature and therefore requires participants to provide detailed descriptions of their
experiences, any individuals who have a significant communication or learning difficulties will not be able to participate
in the research.
A33-2. What arrangements will you make to comply with the principles of the Welsh Language Act in the provision of
information to participants in Wales?
All written information about the research study (e.g. information sheet, opt-out form, consent form) will be provided in
Welsh and English. However, the interview will only be conducted in English, as unfortunately the researcher is not a
Welsh speaker. 
A35. What steps would you take if a participant, who has given informed consent, loses capacity to consent during the
study?  Tick one option only.
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 The participant and all identifiable data or tissue collected would be withdrawn from the study. Data or tissue which
is not identifiable to the research team may be retained.
 The participant would be withdrawn from the study. Identifiable data or tissue already collected with consent would
be retained and used in the study. No further data or tissue would be collected or any other research procedures carried
out on or in relation to the participant.
 The participant would continue to be included in the study.
 Not applicable – informed consent will not be sought from any participants in this research.
 Not applicable – it is not practicable for the research team to monitor capacity and continued capacity will be
assumed.
 
Further details:
If you plan to retain and make further use of identifiable data/tissue following loss of capacity, you should inform
participants about this when seeking their consent initially.
 CONFIDENTIALITY  
 In this section, personal data means any data relating to a participant who could potentially be identified. It includespseudonymised data capable of being linked to a participant through a unique code number.
 Storage and use of personal data during the study
A36. Will you be undertaking any of the following activities at any stage (including in the identification of potential
participants)?(Tick as appropriate)
 Access to medical records by those outside the direct healthcare team
 Access to social care records by those outside the direct social care team
 Electronic transfer by magnetic or optical media, email or computer networks
 Sharing of personal data with other organisations
 Export of personal data outside the EEA
 Use of personal addresses, postcodes, faxes, emails or telephone numbers
 Publication of direct quotations from respondents
 Publication of data that might allow identification of individuals
 Use of audio/visual recording devices
 Storage of personal data on any of the following:
   
 Manual files (includes paper or film)
 NHS computers
 Social Care Service computers
 Home or other personal computers
 University computers
 Private company computers
 Laptop computers
Further details:
Following the ASD assessment process, a clinician within the service will complete a feedback appointment with the
family. At this appointment the family are provided with an information pack about what it means not to receive a
diagnosis of ASD. For the purpose of this research, to recruit participants, clinicians will add the research information
sheet and an opt-out form into the information pack that is routinely provided. The clinician will inform families of this
and provide highlight that should they not wish to consider the research they can complete the out-out form
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attached.This will mean they will not be conducted by the researcher. If they are happy to be contacted, and thus do not
complete the opt-out form, the researcher will contact the family within four weeks of their feedback appointment to
discuss the researcher in further detail. They will clearly be informed that it is entirely up to them whether they would
like to be contacted and be involved in the research. 
Alternatively, if potential participants have already attended for their feedback appointment but who meet the criteria
(did not receive a diagnosis following their ASD assessment, within the past 12months), the clinician will send the
information sheet and opt-out form in the post accompanied by a letter introducing the purpose of the information. As
above, they will be encouraged to complete the opt-out form and return this in the envelope provided within 2 weeks of
the date of the letter should they not wish to be contacted. If the opt-out form is not returned, the researcher will contact
them by telephone within four weeks of the information being sent.
If potential participant's are happy to be contacted, the clinician will provide the researcher with their name and
telephone number. The researcher will telephone the individual from the CAMHS location they attended for
assessment, to avoid any personal information being taken off-site. Once they have been contacted their details will
be destroyed. Any personal details and contact information will be sorted in a locked filing cabinet in a locked room at
the relevant CAMHS base.
When the results of the study are written up, direct quotes from the interview may be included. This will be clearly
explained the participant in the information sheet prior to the interview, and there will be a separate box to tick on the
consent form if the participant agree to this.
The researcher will record all interviews on a digital record. After the interview, this will be kept in a locked filing cabinet
until it is transcribed onto an encrypted USB-stick and then deleted from the recorder; the information will be
anonymised prior to being transcribed. The encrypted device can only be accessed by the research team.
A38. How will you ensure the confidentiality of personal data?Please provide a general statement of the policy and
procedures for ensuring confidentiality, e.g. anonymisation or pseudonymisation of data.
Once the researcher has contacted the potential participants to ask if they would like to participate in the research and
if so to arrange the interview this information will be destroyed. All participants will be given a participant identification
number to protect their identity throughout the research.
A40. Who will have access to participants' personal data during the study? Where access is by individuals outside the
direct care team, please justify and say whether consent will be sought.
Unless the potential participant completes the opt-out form, the clinician will provide their name and contact telephone
number to the researcher. The individual will be made aware of this. If at this point the individual decides they do not
wish to participate, their information will be destroyed immediately. If they do wish to participate, an interview time will
be arranged and once they have attended for interview their contact details will be destroyed. In the meantime, these
details will securely stored in a locked filing cabinet in a lockable room at the relevant CAMHS location. These details
will never been removed from the CAMHS base and no-one outside the research team will have access to this
information.
 Storage and use of data after the end of the study
A43. How long will personal data be stored or accessed after the study has ended?
 Less than 3 months
 3 – 6 months
 6 – 12 months
 12 months – 3 years
 Over 3 years
 INCENTIVES AND PAYMENTS
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A46. Will research participants receive any payments, reimbursement of expenses or any other benefits or incentives
for taking part in this research?
 Yes       No
If Yes, please give details. For monetary payments, indicate how much and on what basis this has been determined.
The research participants will receive a ten pound gift voucher for as a token gesture of appreciation for sharing their
time, experiences and expertise that will contribute to future service planning, protocols and the research evidence
base. This gesture will not be used to entice people into participating in the research.
As all interviews will be held at their local Child and Adolescent Mental Health Service (CAMHS) their travel expenses
will be reimbursed.The typical travel claims form at the relevant service will be used.
A47. Will individual researchers receive any personal payment over and above normal salary, or any other benefits or
incentives, for taking part in this research?
 Yes       No
A48. Does the Chief Investigator or any other investigator/collaborator have any direct personal involvement (e.g.
financial, share holding, personal relationship etc.) in the organisations sponsoring or funding the research that may
give rise to a possible conflict of interest?
 Yes       No
 NOTIFICATION OF OTHER PROFESSIONALS
A49-1. Will you inform the participants’ General Practitioners (and/or any other health or care professional responsible
for their care) that they are taking part in the study?
 Yes       No
If Yes, please enclose a copy of the information sheet/letter for the GP/health professional with a version number and date.
 PUBLICATION AND DISSEMINATION
A50. Will the research be registered on a public database?
 Yes       No
Please give details, or justify if not registering the research.
Registration of research studies is encouraged wherever possible.
You may be able to register your study through your NHS organisation or a register run by a medical research charity,
or publish your protocol through an open access publisher. If you are aware of a suitable register or other method of
publication, please give details. If not, you may indicate that no suitable register exists. Please ensure that you have
entered registry reference number(s) in question A5-1.
A51. How do you intend to report and disseminate the results of the study?Tick as appropriate:
 Peer reviewed scientific journals
 Internal report
 Conference presentation
 Publication on website
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 Other publication
 Submission to regulatory authorities
 Access to raw data and right to publish freely by all investigators in study or by Independent Steering Committee
on behalf of all investigators
 No plans to report or disseminate the results
 Other (please specify)
A53. Will you inform participants of the results?
 Yes       No
Please give details of how you will inform participants or justify if not doing so.
The results of the research will be summarised and sent to all participant's in a leaflet. This leaflet will be sent out via
the service so the researcher does not have to gain access to the participants address. Participants will also be
invited to contact the researcher to discuss the results in more detail if they wish.
 5. Scientific and Statistical Review
A54. How has the scientific quality of the research been assessed?Tick as appropriate:
 Independent external review
 Review within a company
 Review within a multi−centre research group
 Review within the Chief Investigator's institution or host organisation
 Review within the research team
 Review by educational supervisor
 Other
Justify and describe the review process and outcome. If the review has been undertaken but not seen by the
researcher, give details of the body which has undertaken the review:
The development of this research was discussed and refined within the research team, which consists of experienced
clinicians and researchers. A written proposal of the research was also approved by the North Wales Clinical
Psychology research team at Bangor University.
For all studies except non-doctoral student research, please enclose a copy of any available scientific critique reports,
together with any related correspondence.
For non-doctoral student research, please enclose a copy of the assessment from your educational supervisor/ institution.
A59. What is the sample size for the research?  How many participants/samples/data records do you plan to study in
total? If there is more than one group, please give further details below.
Total UK sample size: 10 
Total international sample size (including UK):  
Total in European Economic Area:  
Further details:
The study will recruit a maximum number of 10 participants. 
The research will adopt a qualitative approach, and thus the research team will aim to recruit a sample size of
between 5-8 participants, as this will enable a thorough analysis of the participants lived experiences.
A60. How was the sample size decided upon?  If a formal sample size calculation was used, indicate how this was done,
giving sufficient information to justify and reproduce the calculation.
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Smith, Flowers and Larkin (2010) recommend that researchers should recruit 4-10 participants when conducting
research for Doctoral level qualifications using Interpretative Phenomenological Analysis (IPA).
A62. Please describe the methods of analysis (statistical or other appropriate methods, e.g. for qualitative research) by
which the data will be evaluated to meet the study objectives.
The research will be qualitative in nature and the information will be analysed using Interpretative Phenomenological
Analysis (IPA; Smith, Flowers & Larkin, 2009). IPA involves presenting the participants with a number of open ended
questions to gain an insight into how they made sense of a given experience. This method will also enable the
researcher to explore the meaning the participant has attributed to the given experience. IPA involves the researcher
identifying themes within the participant’s responses and using their interpretation to expand the themes further. The
theory of IPA recognises that although the researcher aims to understand the participants true lived experience, this is
reliant on their own conceptions, which are required to interpret the personal account provided by the participant.   
 6. MANAGEMENT OF THE RESEARCH
A63. Other key investigators/collaborators. Please include all grant co−applicants, protocol co−authors and other key
members of the Chief Investigator’s team, including non-doctoral student researchers.
 
 Title  Forename/Initials  SurnameDr  Freya  Spicer-White
Post Lead Clinical Psychologist (Neurodevelopmental Team)
Qualifications BSc (Hons) PsychologyD.Clin.Psych (Doctorate in Clinical Psychology)
Employer Betsi Cadwaladr University Health Board
Work Address Wrexham CAMHS
 PO Box 2073
 Wrexham Maelor Hospital
Post Code LL13-7ZA
Telephone 01978725242
Fax
Mobile
Work Email Freya.Spicer@wales.nhs.uk
 A64. Details of research sponsor(s)
A64-1. Sponsor  
Lead Sponsor
Status:  NHS or HSC care organisation
 Academic
 Pharmaceutical industry
 Medical device industry
 Local Authority
 Other social care provider (including voluntary sector or private
organisation)
 Other
  Commercial status:   
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If Other, please specify:  
Contact person
 
Name of organisation Bangor University, School of Psychology
Given name Hefin
Family name Francis
Address School of Psychology
Town/city Bangor, Gwynedd
Post code LL57 2AS
Country  UNITED KINGDOM
Telephone 01248388339
Fax
E-mail H.Francis@bangor.ac.uk
Is the sponsor based outside the UK?
 Yes       No
Under the Research Governance Framework for Health and Social Care, a sponsor outside the UK must appoint a
legal representative established in the UK. Please consult the guidance notes.
A65. Has external funding for the research been secured?
 Funding secured from one or more funders
 External funding application to one or more funders in progress
 No application for external funding will be made
What type of research project is this?
 Standalone project
 Project that is part of a programme grant
 Project that is part of a Centre grant
 Project that is part of a fellowship/ personal award/ research training award
 Other
Other – please state: 
A67. Has this or a similar application been previously rejected by a Research Ethics Committee in the UK or another
country?
 Yes       No
Please provide a copy of the unfavourable opinion letter(s). You should explain in your answer to question A6-2 how the
reasons for the unfavourable opinion have been addressed in this application.
A68-1. Give details of the lead NHS R&D contact for this research:
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 Title  Forename/Initials  SurnameDr  Rossela  Roberts
Organisation Betsi Cadwaladr University Health Board
Address Clinical Academic Office, Ysbyty Gwynedd
 Bangor
 
Post Code LL57 2PW
Work Email rossela.roberts@wales.nhs.uk
Telephone 01248384877
Fax
Mobile
Details can be obtained from the NHS R&D Forum website: http://www.rdforum.nhs.uk
A69-1. How long do you expect the study to last in the UK?
Planned start date: 01/07/2016
Planned end date: 29/09/2017
Total duration:  
Years: 1 Months: 2 Days: 29 
A71-2. Where will the research take place? (Tick as appropriate)
 England
 Scotland
 Wales
 Northern Ireland
 Other countries in European Economic Area
Total UK sites in study
Does this trial involve countries outside the EU?
 Yes       No
A72. Which organisations in the UK will host the research?Please indicate the type of organisation by ticking the box and
give approximate numbers if known:
 NHS organisations in England  
 NHS organisations in Wales 1 
 NHS organisations in Scotland  
 HSC organisations in Northern Ireland  
 GP practices in England  
 GP practices in Wales  
 GP practices in Scotland  
 GP practices in Northern Ireland  
 Joint health and social care agencies (eg
community mental health teams)
 
 Local authorities  
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 Phase 1 trial units  
 Prison establishments  
 Probation areas  
 Independent (private or voluntary sector)
organisations
 
 Educational establishments  
 Independent research units  
 Other (give details)  
  
Total UK sites in study: 1
 A76. Insurance/ indemnity to meet potential legal liabilities  
 Note: in this question to NHS indemnity schemes include equivalent schemes provided by Health and Social Care(HSC) in Northern Ireland
A76-1. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of the
sponsor(s) for harm to participants arising from the management of the research?  Please tick box(es) as applicable.
Note: Where a NHS organisation has agreed to act as sponsor or co-sponsor, indemnity is provided through NHS schemes.
Indicate if this applies (there is no need to provide documentary evidence). For all other sponsors, please describe the
arrangements and provide evidence.
 NHS indemnity scheme will apply (NHS sponsors only)
 Other insurance or indemnity arrangements will apply (give details below)
Bangor University will meet any legal liability of the sponsor for harm to participants arising from the deign and
management of the research. For information please see the attached letter. 
Please enclose a copy of relevant documents.
A76-2. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability of the
sponsor(s) or employer(s) for harm to participants arising from the design of the research?  Please tick box(es) as
applicable.
Note: Where researchers with substantive NHS employment contracts have designed the research, indemnity is provided
through NHS schemes. Indicate if this applies (there is no need to provide documentary evidence). For other protocol
authors (e.g. company employees, university members), please describe the arrangements and provide evidence.
 NHS indemnity scheme will apply (protocol authors with NHS contracts only)
 Other insurance or indemnity arrangements will apply (give details below)
Bangor University will meet any legal liability of the sponsor for harm to participants arising from the design and
management of the research. For information please see the attached letter. 
Please enclose a copy of relevant documents.
A76-3. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability of
investigators/collaborators arising from harm to participants in the conduct of the research? 
Note: Where the participants are NHS patients, indemnity is provided through the NHS schemes or through professional
indemnity. Indicate if this applies to the whole study (there is no need to provide documentary evidence). Where non-NHS
sites are to be included in the research, including private practices, please describe the arrangements which will be made at
these sites and provide evidence.
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 NHS indemnity scheme or professional indemnity will apply (participants recruited at NHS sites only)
 Research includes non-NHS sites (give details of insurance/ indemnity arrangements for these sites below)
Please enclose a copy of relevant documents.
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 PART C: Overview of research sites  
Please enter details of the host organisations (Local Authority, NHS or other) in the UK that will be responsible for the
research sites.   For NHS sites, the host organisation is the Trust or Health Board. Where the research site is a primary care
site, e.g. GP practice, please insert the host organisation (PCT or Health Board) in the Institution row and insert the research
site (e.g. GP practice) in the Department row.
Research site Investigator/ Collaborator/ Contact
 
Institution name Neurodevelopment Team (East)
Department name Child and Adolescent Mental Health Service
Street address Maelor Hospital, Croesnewydd Road
Town/city Wrexham
Post Code LL13-7ZA
 
Title Dr
First name/
Initials Freya
Surname Spicer-White
 
Institution name Neurodevelopment Team (East)
Department name Child and Adolescent Mental Health Service
Street address Catherine Gladstone House, Hawarden Way
Town/city Mancot, Flintshire
Post Code CH5-2EP
 
Title Dr
First name/
Initials Freya
Surname Spicer-White
 
Institution name Denbighshire Child and Adolescent Mental Health Service
Department name CAMHS Clinic,
Street address 1st Floor, Royal Alexandra Hospital, Marine Drive
Town/city Rhyl
Post Code LL18-3AS
 
Title Dr
First name/
Initials Lesley
Surname Goodson
 
Institution name Conwy Child and Adolescent Mental Health Service
Department name Child Health Premises
Street address Argyll Road
Town/city Llandudno, Conwy
Post Code LL30-1DF
 
Title Dr
First name/
Initials Helen
Surname Fitzpatrick
 
Institution name Child and Adolescent Mental Health Service
Department name Anglesey & Gwynedd CAMHS
Street address Talarfon, Holyhead Road
Town/city Bangor, Gwynedd
Post Code LL57-2EE
 
Title Dr
First name/
Initials Louise
Surname Howard
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 PART D: Declarations
D1. Declaration by Chief Investigator
1. The information in this form is accurate to the best of my knowledge and belief and I take full responsibility for
it.   
2. I undertake to abide by the ethical principles underlying the Declaration of Helsinki and good practice
guidelines on the proper conduct of research.
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full application as
approved and any conditions set out by review bodies in giving approval.
4. I undertake to notify review bodies of substantial amendments to the protocol or the terms of the approved
application, and to seek a favourable opinion from the main REC before implementing the amendment.
5. I undertake to submit annual progress reports setting out the progress of the research, as required by review
bodies.
6. I am aware of my responsibility to be up to date and comply with the requirements of the law and relevant
guidelines relating to security and confidentiality of patient or other personal data, including the need to register
when necessary with the appropriate Data Protection Officer. I understand that I am not permitted to disclose
identifiable data to third parties unless the disclosure has the consent of the data subject or, in the case of
patient data in England and Wales, the disclosure is covered by the terms of an approval under Section 251 of
the NHS Act 2006.
7. I understand that research records/data may be subject to inspection by review bodies for audit purposes if
required.
8. I understand that any personal data in this application will be held by review bodies and their operational
managers and that this will be managed according to the principles established in the Data Protection Act
1998.
9. I understand that the information contained in this application, any supporting documentation and all
correspondence with review bodies or their operational managers relating to the application:
Will be held by the REC (where applicable) until at least 3 years after the end of the study; and by NHS
R&D offices (where the research requires NHS management permission) in accordance with the NHS
Code of Practice on Records Management.
May be disclosed to the operational managers of review bodies, or the appointing authority for the REC
(where applicable), in order to check that the application has been processed correctly or to investigate
any complaint.
May be seen by auditors appointed to undertake accreditation of RECs (where applicable).
Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in response
to requests made under the Acts except where statutory exemptions apply.
May be sent by email to REC members.
10. I understand that information relating to this research, including the contact details on this application, may be
held on national research information systems, and that this will be managed according to the principles
established in the Data Protection Act 1998.   
11. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I
understand that the summary of this study will be published on the website of the National Research Ethics
Service (NRES), together with the contact point for enquiries named below. Publication will take place no earlier
than 3 months after issue of the ethics committee’s final opinion or the withdrawal of the application.   
Contact point for publication(Not applicable for R&D Forms)
NRES would like to include a contact point with the published summary of the study for those wishing to seek further
information. We would be grateful if you would indicate one of the contact points below.
 Chief Investigator
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 Sponsor
 Study co-ordinator
 Student
 Other – please give details
 None
 
Access to application for training purposes (Not applicable for R&D Forms)
Optional – please tick as appropriate: 
 I would be content for members of other RECs to have access to the information in the application in confidence
for training purposes. All personal identifiers and references to sponsors, funders and research units would be
removed.   
This section was signed electronically by Miss Lesley-Anne Bendik on 05/05/2016 11:07.
Job Title/Post: Trainee Clinical Psychologist
Organisation: BCUHB
Email: psp511@bangor.ac.uk
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D2. Declaration by the sponsor's representative
If there is more than one sponsor, this declaration should be signed on behalf of the co−sponsors by a representative
of the lead sponsor named at A64-1.
I confirm that:
1. This research proposal has been discussed with the Chief Investigator and agreement in principle to
sponsor the research is in place.
2. An appropriate process of scientific critique has demonstrated that this research proposal is worthwhile and
of high scientific quality.
3. Any necessary indemnity or insurance arrangements, as described in question A76, will be in place before
this research starts. Insurance or indemnity policies will be renewed for the duration of the study where
necessary.
4. Arrangements will be in place before the study starts for the research team to access resources and support
to deliver the research as proposed.
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of the research will
be in place before the research starts.
6. The duties of sponsors set out in the Research Governance Framework for Health and Social Care will be
undertaken in relation to this research.
Please note: The declarations below do not form part of the application for approval above. They will not be
considered by the Research Ethics Committee.   
7. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I
understand that the summary of this study will be published on the website of the National Research Ethics
Service (NRES), together with the contact point for enquiries named in this application. Publication will take
place no earlier than 3 months after issue of the ethics committee's final opinion or the withdrawal of the
application.   
8. Specifically, for submissions to the Research Ethics Committees (RECs) I declare that any and all clinical
trials approved by the HRA since 30th September 2013 (as defined on IRAS categories as clinical trials of
medicines, devices, combination of medicines and devices or other clinical trials) have been registered on a
publically accessible register in compliance with the HRA registration requirements for the UK, or that any
deferral granted by the HRA still applies. 
This section was signed electronically by Mr Hefin Francis on 05/05/2016 11:39.
Job Title/Post: School Manager for Psychology
Organisation: Bangor University
Email: h.francis@bangor.ac.uk
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D3. Declaration for student projects by academic supervisor(s)
1. I have read and approved both the research proposal and this application. I am satisfied that the scientific content
of the research is satisfactory for an educational qualification at this level.
 
2. I undertake to fulfil the responsibilities of the supervisor for this study as set out in the Research Governance
Framework for Health and Social Care.
 
3. I take responsibility for ensuring that this study is conducted in accordance with the ethical principles underlying
the Declaration of Helsinki and good practice guidelines on the proper conduct of research, in conjunction with
clinical supervisors as appropriate.
 
4. I take responsibility for ensuring that the applicant is up to date and complies with the requirements of the law and
relevant guidelines relating to security and confidentiality of patient and other personal data, in conjunction with
clinical supervisors as appropriate.
Academic supervisor 1 
This section was signed electronically by Dr Freya Spicer-White on 12/05/2016 08:27. 
Job Title/Post: Clinical Psychologist
Organisation: Betsi Cadwaladr University Health Board
Email: freya.spicer@wales.nhs.uk
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